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Abstract  
Large numbers of inbred laboratory rat strains have been developed in the past 100 years 
by phenotype-driven selective breeding for the study of a range of disease phenotypes. The 
spontaneously hypertensive rat (SHR) is the most widely studied animal model of 
hypertension. The SHR Genome was sequenced with 10.7X coverage, and ~4 million 
genomic variants between SHR and the BN reference genome were identified. Analysis of 
the SHR genome revealed that cis expression quantitative trait locus genes were 
significantly enriched for genomic variants and that the genes harboring major mutations 
were enriched for ion transport and plasma membrane localization.  
To gain insights into the evolutionary pressures acting on inbred rat strains during 
phenotype driven selective breeding and, in turn, the molecular basis underlying disease 
phenotypes, the genomes of an additional 27 rat strains were sequenced, including 11 
models of hypertension, diabetes and insulin resistance along with their respective control 
strains. A total of 9,665,340 single nucleotide variants (SNVs), 3,502,117 indels and 
555,419 structural variants and 897,217 copy number variants were identified across the 28 
rat strains.  
Using SNVs, 96 distinct artificial selective sweeps were identified in the disease models, a 
significant proportion of which were co-localised with physiological quantitative trait loci 
mapped previously in respective rat strains. Further, clusters of genes that had co-evolved 
in the disease models were identified, human orthologous of which were enriched for the 
genes implicated in the human genome wide association studies for cardiovascular and 
metabolic phenotypes. These analyses identified both known and new genes involved in 
the renin-angiotensin pathway, in ion transport and in regulation of oxidative stress.  These 
genes may underlie disease phenotypes manifested by the rat strains thus providing novel 
insights into molecular mechanisms underlying complex traits in these rat strains. 
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PAGE Polyacrylamide gel electrophoresis 
PASS Putative artificial selective sweep 
PCA Principal component analysis  
PCR Polymerase chain reaction 
PGW Genome-wide P-value  
pQTL Physiological quantitative trait locus 
qPCR Quantitative polymerase chain reaction 
QTL Quantitative trait locus 
RAS Renin-angiotensin system  
RGD Rat Genome Database  
RI Recombinant inbred 
RNA Ribonucleic acid 
ROC Receiver operating characteristic 
RSD Relative SNV density 
RV Right ventricle 
SBH Sabra hypertensive  
SBN Sabra normotensive  
SC Synonymous coding 
SD Sprague-Dawley  
SFS Site frequency spectrum 
SHR Spontaneously hypertensive rat 
shRNA short hairpin RNA  
SHRSP Spontaneously hypertensive rat stroke prone 
SNV  Single nucleotide variants  
SOLiD Sequencing by oligo ligation detection 
SR Dahl salt resistant rat 
SS Dahl salt sensitive rat 
SV Structural variant 
TN True negative 
TP  True positive 
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TSS Transcription start site  
VEP Variant effect predictor  
VGSC Voltage-gated Na+ channel  
WAG Wistar Albino Glaxo 
WGSS-MP Mate-pair whole genome shotgun library 
WGSS-PE Paired-end whole genome shotgun libraries  
WHO World health organisation  
WKY Wistar-Kyoto rat 
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1.1 Inbred rat strains  
For many centuries animals have been used for understanding human biology (Doggrell 
and Brown, 1998). The laboratory rat (Rattus norvegicus) was the first mammalian species 
domesticated for scientific research and has been used as animal model for physiology, 
pharmacology, toxicology, nutrition, behaviour and immunology for over 150 years 
(Aitman et al., 2008; Jacob, 1999).  The first inbred rat strain was developed by King in 
1909 (Lindsey, 1979), and since then,  over 500 inbred rat strains have been developed for 
a variety of biochemical and patho-physiological phenotypes as well as disease models 
(Aitman et al., 2008).  Some of the widely studied rat strains for cardiovascular and renal 
phenotypes that were sequenced in this study are described below.  
1.1.1 Rat models of hypertension 
1.1.1.1 The spontaneously hypertensive rat  
The spontaneously hypertensive rat (SHR) was selectively bred for high blood pressure 
(BP), without any dietary or environmental intervention, by Okamoto and Aoki in 1963 in 
Kyoto, Japan (Okamoto and Aoki, 1963) by mating a spontaneously hypertensive Wistar 
male with a female with elevated BP, and subsequent brother-sister crossing with selection 
for spontaneous hypertension (Rapp, 2000b).  The SHR strain has been inbred for over 130 
generations and is the most widely studied animal model of human hypertension. In 
addition, the SHR displays a large number of other physiological and pathophysiological 
phenotypes including insulin resistance and dyslipidemia. Many of these traits have been 
mapped to the genome as quantitative trait loci (QTLs) (Rat Genome Database; 
http://rgd.mcw.edu). The BXH/HXB panel of rat recombinant inbred (RI) strains was 
derived by crossing the hypertensive SHR/OlaIpcv with the normotensive Brown Norway 
(BN.Lx) rat (Pravenec et al., 1989). Through integrating gene expression profiling and 
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linkage analysis, thousands of expression quantitative trait loci (eQTLs) have been mapped 
in multiple tissues in the BXH/HXB RI panel (Hubner et al., 2005; Petretto et al., 2006). 
Subsequently, the integration of eQTL and physiological data led to identification of Cd36, 
Ogn and Ephx2 as genes for insulin resistance and hypertension, cardiac hypertrophy, and 
cardiac failure respectively  (Aitman et al., 1999; Monti et al., 2008; Petretto et al., 2008; 
Pravenec et al., 2008a).   
1.1.1.2 The spontaneously hypertensive rat stroke prone   
Before complete inbreeding of SHR, rats with exceptionally high blood pressure and 
increased incident of stroke were selected and inbreeding was performed to derive the 
stroke prone SHR (SHRSP) strain (Okamoto, 1974).  Two loci (Bp1 and Bp2) for high 
blood pressure in the SHRSP have been mapped using a cross between SHRSP and the 
normotensive WKY, on chromosomes 10 and 18 (Jacob et al., 1991). The Bp1 loci 
contained a rat gene that encodes for angiotensin-converting enzyme (ACE), an enzyme 
that plays a major role in blood pressure homeostasis and is an important target for anti-
hypertensive drugs (Jacob et al., 1991).  Linkage to locus Bp2 was significant but weaker 
and no gene was identified under Bp2 locus. In an independent study using a congenic 
strain derived from SHRSP and WKY and gene expression profiling, the Gstm1 gene has 
been identified as an underlying cause of hypertension in SHRSP (McBride et al., 2005; 
McBride et al., 2003; Movassat et al., 1995). Further, using a cross between the SHRSP 
and SHR rat strains, three QTLs (STR1-3) for stroke (blood pressure independent) have 
been mapped in SHRSP which contribute 28% of the variability in this phenotype (Rubattu 
et al., 1996).    
1.1.1.3 The Dahl salt sensitive and salt resistant rat 
The Dahl salt-sensitive (S) rat was developed as a model of hypertension that is "sensitive" 
to dietary salt (sodium chloride, NaCl).  Dahl salt-sensitive (S) and Dahl salt-resistant (R) 
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rats were bred on the basis of their BP after being fed a high salt (8% NaCl) diet. The 
original strains were maintained as an outbred stock (Iwai, 1987) and inbred strains were 
developed from these by John Rapp and are designated as SS/Jr and SR/Jr for Dahl salt 
sensitive and Dahl salt resistant respectively (Rapp, 2000a; Rapp and Dene, 1985). When 
dietary salt is supplemented in the Dahl rat diet, the arterial blood pressure of SS/Jr 
increases, to a level much greater than that of the SR/Jr, suggesting strong interaction of 
BP between the strains and dietary salt (Kurtz and Morris, 1985). The genetic loci 
underlying salt-sensitive blood pressure in the SS strain were mapped to the SS genome in 
experimental crosses between SS and SR, Wistar-Kyoto (WKY), Lewis (LEW) and Milan 
normotensive strain (MNS) rats (Rapp, 2000a). BP QTLs have been located on almost 
every chromosome in these experimental crosses. One QTL was identified on chromosome 
7 using S and R rats which was subsequently narrowed down to a 0.54 centiMorgan (cM) 
region on chromosome 7. The gene Cyp11b1 was identified as a candidate gene for blood 
pressure at this locus (Cicila et al., 2001; Garrett and Rapp, 2003). In addition, using an F2 
population of 233 rats derived from Dahl S and Dahl R strains, a 34.2 cM BP QTL on 
chromosome 9 was identified (Rapp et al., 1998). By multiple iterations of substitution 
mapping using congenic strains the BP QTL was localised to a 2.4 cM interval (Garrett et 
al., 2005). Loci on other chromosomes have similarly been refined by derivation and 
analysis of congenic strains.  
1.1.1.4 The Milan hypertensive rat strain  
The Milan hypertensive rat strain was derived from the outbred Wistar colony by selecting 
10 rats with systolic blood pressure ranging from 160 to 180 mmHg, along with the 
normotensive control strain ‘Milan normotensive strain’ in Milan, Italy (Bianchi et al., 
1974).  The MHS and MNS differ in their respective  phenotypes, including blood pressure 
and heart rate (Jong, 1984).  Hypertension develops in the MHS rats soon after weaning 
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(Bianchi et al., 1974). The comparison of kidney and erythrocyte function, before the 
development of a difference in blood pressure between the two strains, showed that MHS 
had increased glomerular filtration rate and urinary output as well as lower plasma renin 
and urine osmolality (Ferrari et al., 1987).  Previous studies strongly suggested a genetic 
and functional link in MHS between cell membrane cation transport abnormalities and 
hypertension (Bianchi et al., 1990). Missense mutations in alpha adducin and beta adducin 
genes (Add1 and Add2) were identified as genes underlying hypertension in MHS (Bianchi 
et al., 1994).  
1.1.1.5 The Lyon hypertensive rat strain 
Three strains with genetically different blood pressure levels were developed from the 
Sprague-Dawley colony in Lyon, France (Dupont et al., 1973) with the aim to develop 
three strains with spontaneously different blood pressure levels (high, normal and low).  
The strain with highest blood pressure was designated as the Lyon hypertensive (LH) rat 
strain, while the remaining two strains (LL and LN) showed normal but similar blood 
pressure levels, thus providing two control strains for LH. The LH rat was selectively bred 
for high blood pressure however, it shows several phenotypes of metabolic syndromes 
such as high body weight, high cholesterol levels, high triglyceride levels, increased 
insulin and insulin/glucose ratio as well as high blood pressure (Florin et al., 2001; Vincent 
et al., 1996; Vincent et al., 1984; Vincent and Sassard, 1980). Previous studies in the F2 
intercross between the LH and LN strains identified quantitative trait loci (QTL) across 
eight different rat chromosomes related to various phenotypes which include but are not 
exclusive to; BP, body weight, plasma lipids, glucose and insulin (Bilusic et al., 2004).  
1.1.1.6 The Sabra hypertensive rat  
Sabra hypertensive (SBH) and Sabra normotensive (SBN) rats were derived from the Ben-
Ishay’s stock on the basis of BP response to a dosage of deoxycorticosterone (DOCA) plus 
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1% NaCl (Ben-Ishay et al., 1980; Ben-Ishay et al., 1972). Using an F2 crosses between the 
SBH and SBN rats, three QTLs have been mapped for DOCA-salt sensitive hypertension 
on chromosome 1 and 17 (SS1a, SS1b and SS17) (Yagil et al., 1998). Subsequently, the 
presence of QTL for DOCA-salt sensitive hypertension on chromosome 1 was confirmed 
using a congenic strain (Yagil et al., 2003).  
1.1.1.7 The Fawn-hooded hypertensive rat      
The fawn-hooded (FH) rat was initially derived from a cross between the German-brown 
and white Lashley rats (Rapp, 2000b).  This outbred strain was characterized by a platelet 
abnormality which results in a mild bleeding disorder (Tschopp and Zucker, 1972) and by 
glomerular sclerosis (Kreisberg and Karnovsky, 1978). Later it was observed that the blood 
pressure of FH rats was markedly increased compared to the control Wistar rats. It was 
also found that FH develops glomerular lesions at a very early age which results in end 
stage renal failure (Kuijpers and Gruys, 1984; Kuijpers et al., 1986). Subsequently, two 
strains were developed from the FH rat strain by selective inbreeding, one strain which was 
selected for hypertension (FHH)develops progressive hypertension and proteinuria, and 
one which was selected for normal blood pressure (FHL) shows a small increase in blood 
pressure and no renal damage (Verseput et al., 1997). Through linkage analysis on the F2 
animals obtained after crossing FHH with the renal failure resistant strain, August 
Copenhagen Irish (ACI), five renal failure QTLs (Rf-1 to Rf-5) and a blood pressure QTL 
(Bpfh-1) have been mapped in the FHH strain (Brown et al., 1996; Shiozawa et al., 2000).  
1.1.2 Rat models of diabetes  
1.1.2.1 The Goto-Kakisaki rat 
The Goto-Kakisaki (GK) rat was developed in 1975 through selective breeding, over many 
generations, of the Wistar rats with high blood glucose (Goto, 1975).  GK is a widely used 
genetic model of non-insulin dependent diabetes mellitus (NIDDM) in non-obese 
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individuals (Galli et al., 1996). GK show an increased plasma glucose concentration, a 
decreased plasma insulin level (Portha et al., 1991), and a reduced pancreatic beta cell 
mass (Movassat et al., 1995). Three QTLs Niddm1, Niddm2 and Niddm3 were mapped to 
chromosome 1, 2 and 10 respectively in the crosses between the GK and the non-diabetic 
rat strain Fischer 344 (F344). The locus Niddm1 appears to affect the early stages of insulin 
secretion as it shows its largest effect on postprandial hyperglycemia and no effect on 
fasting hyperglycemia, whereas the Niddm2 and Niddm3 loci affect both phenotypes/traits 
(Galli et al., 1996). 
1.1.2.2 The bio breeding diabetes prone rat  
The bio breeding diabetes prone (BBDP) rat strain was derived from the Canadian colony 
of outbred Wistar rats in which spontaneous hyperglycemia and ketoacidosis occurred in 
the 1970s (Mordes et al., 2004).  The inbred colony of spontaneously diabetic rats was 
established using rats which displayed these phenotypes as founders, at Worcester, 
Massachusetts and the strain was designated as the diabetes-prone BB rats (BBDP/Wor) 
(Akerblom et al., 2002). The BBDP rats showed profound T-cell lymphopenia (Yale et al., 
1985), which is characterized by a severe reduction in the number of CD4+ T-cells 
(Jackson et al., 1981) and a nearly complete absence of the CD8 T-cell subset (Jackson et 
al., 1983). Two genes that contribute to disease phenotypes in BBDP have been identified, 
the first being the RT1u allele (Iddm1) and the second being Gimap5, a GTPase immunity-
associated protein family member 5 (Iddm2). T-cell lymphopenia in BBDP is due to a 
frameshift deletion in a novel member (Ian5) of the Immune-Associated Nucleotide (IAN)-
related gene family, also known as Gimap5, which results in a truncation of a significant 
portion of the protein (Hornum et al., 2002; MacMurray et al., 2002). Furthermore, eight 
type 1 diabetes susceptibility loci, on chromosome 1, 2, 3, 6 (two loci), 12, 14 and 17 were 
mapped using 574 F2 animals from a cross-intercross between BBDP and type 1 diabetes-
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resistant double congenic rats, where both Iddm1 and Iddm2 were fixed (Wallis et al., 
2009). 
1.1.3 Wistar-Kyoto rat 
The Wistar-Kyoto (WKY) rat is widely used as a normotensive control strain for 
hypertensive rat strains such as SHR, as it was derived from the same outbred Wistar stock 
as SHR. WKY also shows marked susceptibility to crescent formation in the glomerulus of 
the kidney in experimentally induced nephrotoxic nephritis (NTN) and has been used 
extensively as an experimental model of crescentic glomerulonephritis (Tam et al., 1999). 
WKY rats are uniquely susceptible to NTN, developing progressive proteinuria and 
proliferative necrotising crescentic glomerulonephritis at doses of nephrotoxic serum 
(NTS) that are subnephritogenic in the other rat strains such as Lewis, Wistar and BN 
(Aitman et al., 2006; Kawasaki et al., 1992). The unique susceptibility demonstrated by the 
WKY rat compared to the Lewis rat, with which it shares the same MHC haplotype, led to 
the study of the underlying genetic determinants (Aitman et al., 2006). Using the WKY rat, 
loci for crescentic glomerulonephritis were mapped in F2 rats generated by a reciprocal 
cross between WKY and Lewis rats, a strain that is resistant to nephrotoxic nephritis.  
Seven significant susceptibility loci were localised and the genes underlying the two most 
significant loci, Fcgr3, the gene encoding the activatory Fc receptor for IgG (Aitman et al., 
2006), and Jund, the gene encoding a member of the AP-1 transcription factor family 
(Behmoaras et al., 2008), were identified as responsible genes at these loci.  
F344 rats are relatively resistant to hypoxia-induced right ventricular (RV) hypertrophy 
compared with the WKY strains. The WKY and the F344 rats show similar pulmonary 
artery pressures at rest when exposed to normal oxygen levels, although WKY rats have a 
lower systemic BP and a greater cardiac mass.  Exposure to hypoxia (FIO2 10%) for 21 
days was associated with an increase in the mean pulmonary artery pressure and right 
!
!
28!
!
ventricular (RV) weight in both strains, but the increase was significantly higher in the 
WKY strain. LV mass also increased more in the WKY strain despite a further fall in the 
systemic BP (Zhao et al., 2001). Using F2 rats generated from the WKY X F344 cross, a 
quantitative trait locus (QTL) for RV weight was identified on rat chromosome 17 with a 
logarithm of odd score (LOD score) of 6.5, that accounted for 22% of the total variance of 
RV weight in the F2 population and was independent of pulmonary artery pressure (Zhao 
et al., 2001). 
To date there are 1,912 QTLs for multiple physiological, behavioral and disease 
phenotypes reported in the Rat Genome Database (RGD; http://rgd.mcw.edu) which are 
mapped to the rat genome in various strain combinations. More than 50% of these QTLs 
were mapped for cardiovascular or metabolic phenotypes. For BP alone, 350 QTLs have 
been mapped to almost every chromosome of the rat genome in various combinations of 
hypertensive and normotensive rat strains. Even though large numbers of QTLs have been 
mapped in rat models, only 22 genes have been positionally cloned (Aitman et al., 2008) 
and only one gene Cyp11a1 was positionally cloned for BP QTLs (Aitman et al., 2008; 
Cicila et al., 2001; Garrett and Rapp, 2003).  Progress in identifying underlying QTL genes 
in disease models and therefore understanding the molecular basis of disease phenotypes, 
has been limited by the continuing absence of the genome sequences of these rat strains.  
1.2 Next generation sequencing technologies 
In 1977, Frederick Sanger developed a DNA sequencing technology which was based on a 
chain-termination method (also known as Sanger sequencing). In 1987, after years of 
improvement, Applied Biosystems introduced the first automatic sequencing machine 
(namely AB370), adopting capillary electrophoresis which made the sequencing faster and 
more accurate (Liu et al., 2012). Automated sequencing machines have led to monumental 
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achievements including completion of the finished grade human genome sequence 
(International Human Genome Sequencing, 2004). However, conventional capillary 
sequencing technique is too expensive, labor intensive, and time consuming for broad 
application in human sequence variation studies (Metzker, 2005). Limitations of automated 
Sanger sequencing showed a need for new and improved technologies for sequencing large 
numbers of human genomes and genomes of model organisms (Metzker, 2010). The 
automated Sanger method is considered as a 'first-generation' technology, and newer 
methods are referred to as next-generation sequencing (NGS) (Metzker, 2010). 
1.2.1 Roche 454 
The Roche 454 was the first commercially available next generation sequencing platform 
which uses pyrosequencing technology (Liu et al., 2012). Emulsion based sample 
preparation involves the generation of random libraries of DNA fragments by shearing an 
entire genome and isolating single DNA molecules by limiting dilution. Specifically, steps 
include random fragmentation of the entire genome, addition of specialized common 
adapters to the fragments, capture of the individual fragments on their own beads and 
within the droplets of an emulsion, clonal amplification of the individual fragment 
(Margulies et al., 2005). Following this, sequencing by synthesis occurs simultaneously in 
the open wells of a fiber-optic slide using a modified pyrosequencing protocol. Typically, a 
single run generates over 25 million bases with a Phred quality score of 20 or higher 
(Margulies et al., 2005). 
1.2.2 Illumina GA / Hiseq  
In 2006, Solexa released the Genome Analyzer (GA), a company that was later purchased 
by Illumina (Liu et al., 2012).  The initial sequencing steps involve the generation of high-
density single-molecule arrays of genomic DNA fragments attached to the surface of the 
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reaction chamber (the flow cell) followed by bridge amplification to generate a cluster of 
each DNA fragment (Bentley et al., 2008).  The next steps include the addition of universal 
primers for sequencing after making the DNA in each cluster single-stranded and then 
sequencing each DNA template by repeated cycles of polymerase-directed single base 
extension. Paired end sequencing includes an additional step of conversion of DNA 
template to double stranded DNA and removing the original strand, leaving the 
complementary strand as a template for the second sequencing reaction (Bentley et al., 
2008).     
1.2.3 Sequencing by Oligo Ligation Detection (SOLiD) 
SOLiD (Sequencing by Oligonucleotide Ligation and Detection) DNA sequencing 
technology was developed by Life Technologies and has been commercially available 
since 2006. SOLiD sequencing uses a DNA ligase-based synchronous ensemble detection 
method. The ABI SOLiD system employs 2 base encoding (McKernan et al., 2009).   
1.2.4 Overall context of NGS 
These high throughput sequencing (HTS) technologies revolutionized research in the area 
of genomics, transcriptomics and methylom  amongst others by rapidly driving down the 
cost and greatly increasing the capacity of DNA and RNA sequencing. By taking 
advantage of the high throughput and the reduced cost of sequencing, genomes of more 
than 1000 human individuals from 14 different populations have been sequenced by the 
1000 genome sequencing consortium, which provided functional insights into genetic 
variants within and across populations (Abecasis et al., 2012).  Further, using next 
generation sequencing (NGS) technologies, the genome sequences of multiple strains of 
model organisms such as Arabidopsis thaliana and mouse have been generated (Cao et al., 
2011; Gan et al., 2011; Keane et al., 2011). NGS platforms have also made possible large 
!
!
31!
!
scale sequencing of non-model organisms such as the silkworm, chicken, dog, yak, and 
flycatcher genomes which has facilitated evolutionary analysis of domestication, 
adaptation and species divergence (Axelsson et al., 2013; Ellegren et al., 2012; Qiu et al., 
2012; Rubin et al., 2010; Xia et al., 2009). With the advent of NGS technologies, multiple 
strains of model organisms can now be sequenced with high accuracy and within a 
reasonable cost and time which facilitates more sophisticated evolutionary analysis 
towards the understanding of novel biology.    
1.3 Genomic variants 
The advent of NGS has enabled the inquiry of nearly every base in the genome thus 
facilitating reliable identification and interpretation of millions of variants between 
genomes (Koboldt et al., 2013). In terms of NGS data, genomic variants are defined as the 
differences in the DNA sequence of the reference strain and the re-sequenced strain. 
Genomic variants include single nucleotide variants (SNVs), short insertions and deletions 
(1-15bp), structural variants (large deletions, insertions, inversions and translocations) and 
copy number variations (deletions or duplications).  
1.3.1 Single nucleotide variants 
A single nucleotide variant is the aberration at a single nucleotide position between two 
individuals, this being the single nucleotide differences between the reference genome and 
the re-sequenced genome in terms of NGS. In contrast, single nucleotide polymorphism 
signifies a variation at the single nucleotide level in the population.  
1.3.2 Short insertion and deletions 
Short insertion or deletions (indels) are defined here as the deletion or insertion of the 
nucleotide sequences ranging from a single base to 15 bases. In terms of NGS, indels 
!
!
32!
!
signify insertions or deletions of up to 15 bases in the re-sequenced genome compared to 
the reference genome.   
1.3.3 Structural variants 
Structural variants (SV) are defined as the structural differences in an individual’s 
chromosome. SVs include copy neutral insertion, deletions, translocations and inversions 
of size equal to or greater than 100 bp.     
1.3.4 Copy number variants  
Copy number variants are a form of structural variants where alteration in the DNA of the 
genome results in an abnormal number of copies of the DNA segment. Copies are either 
deleted or duplicated in the genome and are usually 1Kb or larger in size.  
1.4 Complex diseases: hypertension, diabetes and metabolic 
syndrome 
Complex diseases are caused by a combination of genetic, environmental, and lifestyle 
factors, most of which have not yet been identified (Craig, 2008). Some of the medically 
important diseases that fall in this category include hypertension, diabetes and metabolic 
syndrome. Complex diseases do not obey the standard Mendelian patterns of inheritance,  
instead only a small fraction (less than 1%~7%) of affected individuals show a single 
mutant gene transmitted by Mendelian inheritance (Scheuner et al., 2004).  
1.4.1 Hypertension 
Hypertension is a chronic medical condition in which the BP in arteries is elevated. High 
BP is characterized by the persistent blood pressure at or above 140/90 mmHg.  
Hypertension is classified in to two types, primary hypertension also known as essential 
hypertension and secondary hypertension. Of all hypertension cases 90-95% cases belong 
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to essential hypertension, high BP without any obvious underlying medical cause.  Small 
proportions of cases (5-10%) of high BP are categorized as a secondary hypertension 
which is caused by other conditions that affect kidney, heart, arteries or the endocrine 
system.  
According to the world health organization (WHO; the world health statistics 2012 report) 
one in three adults worldwide as having elevated blood pressure, a condition that 
contribute to around half of all deaths from stroke and heart disease.  Hypertension is the 
number 1 risk factor for premature death worldwide and responsible for 12.8% (7.5 
million) of total deaths worldwide!(World health statistics 2012 report).   
1.4.2 Diabetes  
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough 
insulin or when the body cannot effectively use the insulin it produces. Diabetes is 
characterized by a persistent increase in blood sugar levels. Hyperglycaemia, or raised 
blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious 
damage to many of the body's systems, especially the nerves and blood vessels. Diabetes 
resulting from the failure of the pancreas to produce sufficient insulin is termed as type 1 
diabetes, while diabetes caused due to cellular resistance to insulin is termed as type 2 
diabetes.  
According to the WHO report, 347 million people worldwide have diabetes (WHO fact 
sheet No. 312, March 2013). Hyperglycemia and diabetes are important causes of mortality 
and morbidity worldwide, through both direct clinical sequelae and increased mortality 
from cardiovascular and kidney diseases (Danaei et al., 2011; Danaei et al., 2006; 
Nakagami, 2004). 
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1.4.3 Metabolic syndrome   
In 1988, Reaven noted that several risk factors (dyslipidemia, hypertension, and 
hyperglycemia) for cardiovascular disease cluster together and these were subsequently 
termed as ‘syndrome X’ (Reaven, 1988). Following this, Reaven and others suggested that 
insulin resistance may underlie syndrome X (Grundy et al., 2004; Reaven, 1988). Soon 
after, the term ‘syndrome X’ was changed to metabolic syndrome to avoid the suggestion 
that the insulin resistance is the primary or only cause of the associated risk factors 
(Grundy et al., 2004). There is no internationally agreed definition of metabolic syndrome. 
According to WHO (Alberti and Zimmet, 1998) metabolic syndrome is defined as: 
• Glucose intolerance  
• IGT or diabetes mellitus and/or  
• Insulin resistance  
Together with two or more of the other components listed below. 
• Raised arterial pressure  
• Raised plasma triglycerides and/or low HDL-cholesterol 
• Central obesity 
• Microalbuminuria 
 
1.5 Co-evolutionary gene clusters  
1.5.1 Phylogenetic profiling 
Functionally linked proteins evolve in a correlated fashion, and therefore, they tend to have 
similar phylogenetic history (Pellegrini et al., 1999), based on this hypothesis Pellegrini 
developed method of phylogenetic profiling. The phylogenetic profile is a vector that 
encodes for the presence and absence of the protein in every known genome (Pellegrini et 
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al., 1999). Functionally linked proteins, defined by their participation in common structural 
complexes or metabolic processes, tend to have correlated phylogenetic profiles. 
Investigation of the phylogenetic profiles of Arabidopsis proteins across organisms that 
belong to the three domains of life (Eukarya, Bacteria and Archaea) revealed 3,848 
Arabidopsis proteins that are unique to green plants (Gutierrez et al., 2004).  Phylogenetic 
profiling approach has been successfully used for predicting functions of uncharacterized 
genes and proteins (Levesque et al., 2003; Marcotte et al., 1999; Ranea et al., 2007) and 
predicting functional links between interacting proteins (Gavin et al., 2002; Mellor et al., 
2002).  Phylogenetic profiling has also been used to link poorly characterized proteins to 
known mitochondrial pathways and to predict proteins important for function of complex I 
of the electron transport chain (Pagliarini et al., 2008). Most recently this approach has 
been used to identify a set of small RNA pathway genes (Tabach et al., 2013).  These 
examples suggest a wide acceptance of the phylogenetic profiling approach towards the 
identification of functionally linked genes and proteins.   
1.5.2 Mirror tree approach 
The phylogenetic profiling approach is based on the binary information i.e. presence or 
absence of genes in different species with the assumption that if two proteins are 
interacting, both need to co-exist in a species to perform their desired function. In 2001, 
Pazos and Valencia developed a mirror tree approach which uses the information contained 
in the full structure of a phylogenetic tree instead of using binary information (Pazos and 
Valencia, 2001).  In the mirror tree approach, similarity between the trees is measured as 
the correlation between the distance matrices used to build the trees.  One major difficulty 
in the mirror tree approach is that the phylogenetic tree of each gene retains a certain 
degree of similarity with the tree of life, which represents a global evolutionary 
relationship between organisms (de Juan et al., 2013). Some approaches use the 
!
!
36!
!
evolutionary distances between corresponding species to normalize each gene tree. One 
such approach was to use a projection operator to exclude the information about the 
phylogenetic relationship between the source organisms from the distance matrix (Sato et 
al., 2005). The phylogenetic information was extracted using three different methods i) 
using the 16S rRNA from the same source of organisms ii) averaging the phylogenetic 
vectors and/or iii), analyzing the principal component of the phylogenetic vector. 
Correcting for the population structure reduced the number of false positive predictions 
drastically (Sato et al., 2005).  In another approach, the overall evolutionary history of the 
species was used to correct for the expected background similarity between the gene trees 
due to underlying speciation events (Pazos et al., 2005).  Using the mirror tree approach, 
co-evolved and co-expressed genes have been identified in yeasts and mammals (Clark et 
al., 2012, 2013).            
1.6 Selective sweeps 
Charles Darwin in his book “On the origin of species by means of natural selection” 
published his theory of evolution, which laid the foundation for modern evolutionary 
biology (Darwin, 1859).  In his book, he proposed a theory that could explain evolutionary 
change based on two major observations: (i) species change over time, and (ii), the process 
of natural selection dictates which variations are retained (Darwin, 1859). This theory, 
coupled with the understanding of genetic inheritance that followed, revolutionized a 
modern way of thinking. The modern synthesis for evolutionary theory was based on the 
interaction between natural selection and genetic drift. 
 In the early 20th century, Godfrey Hardy and Wilhelm Weinberg proposed that under 
neutral evolution i.e. in absence of selective pressures, allele frequencies in the population 
remain constant from generation to generation, a theory known as Hardy-Weinberg 
equilibrium.    
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Consider a simple genetic locus which has two alleles A and a, then Hardy-Weinberg 
equation can be expressed as  
p2+2pq+q2 = 1 
Where, p is the frequency of allele A, q is the frequency of allele a in the population. In 
equation p2 represents frequency of homozygous genotype AA, q2 represents frequency of 
homozygous genotype aa and pq represents frequency of the heterozygous genotype Aa. 
The Hardy-Weinberg equilibrium can be achieved in the population only if  
i) Mutations are not occurring  
ii) Natural selection is not occurring  
iii) The population is infinitely large  
iv) The population is randomly mating 
v) All members of population breed  
vi) Everyone produces the same number of offspring  
vii) There is no migration in or out of the population 
To achieve Hardy-Weinberg equilibrium, a population must satisfy all of these seven 
conditions which mean absence of evolution. However, naturally evolving populations do 
not adhere to majority of these conditions let alone all of them thus resulting in changes of 
allele frequencies.      
1.6.1 Natural selection 
Natural selection is a key mechanism of the evolution. Natural selection is the evolutionary 
process by which a biological trait is either preferred or rejected in the population resulting 
in an increased probability of survival of the individual with reproductive advantage.   
Natural selection may be categorized in to positive selection, negative selection and 
balancing selection.  Positive selection is the evolutionary process by which beneficial 
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traits, resulting from beneficial mutations are favored in a population and therefore show 
an increased frequency in the population over generations.  For a trait to undergo positive 
selection it must be beneficial, heritable and increase the probability of a species survival 
and reproduction (Schaffner and Sabeti, 2008). Beneficial traits are extremely variable, 
which could include adaptation to particular food type, protective colorization or a size and 
shape suitable for an environment niche (Schaffner and Sabeti, 2008).  The fate of 
mutations which affect the fitness of its carrier is partly determined by natural selection. 
The alleles which increase the fitness of the carrier tend to increase in frequency over time 
until they reach fixation (Duret, 2008). As a result of positive selection not only the 
beneficial mutation but also the neighboring “hitchhiking” mutations can become more 
common in the population and the resulting haplotype is known as a selective sweep 
(Schaffner and Sabeti, 2008). On the other hand, new mutations which decrease the fitness 
of the carrier tend to decrease in the population. The process of removal of the deleterious 
mutations from the population is known as negative selection or purifying selection. As a 
result of purifying selection, deleterious mutations become rare in a population (Loewe, 
2008).  Finally, alleles which are neither beneficial nor deleterious are selected randomly 
in the population. On these neutral alleles selection acts neither in favor nor against and is 
known as neutral evolution or balancing selection.              
1.6.2 Artificial selection 
Artificial selection is the intentional breeding of individuals in a population which have 
desired traits. Artificial selection is also known as selective breeding. The term artificial 
selection was first used by Charles Darwin in his book “On the origin of species” as a 
contrary to the natural selection. Human intervention plays a significant role in artificial 
selection. In agriculture, superior strains of crops are examples of artificial selection as 
they have been artificially selected for desired traits like yields, size and height. The 
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Brassicas are the good examples of artificial selection. Cabbage, broccoli, cauliflower, 
Brussels sprouts, collards, and kale are all member of species Bacssica olaracea and are 
cultivated from wild mustard by artificial selection for the flower, stem or root.  Examples 
of artificial selection can also be found in animals, domesticated animals like dogs and 
cattle are good examples of artificial selection. Many breeds of dogs and cattle have been 
selectively bred for the desired traits. Various animal models derived to study behavioral 
and pathophysiological phenotypes are also examples of artificial selection (see section 
1.1).   
1.6.3 Methods to detect selective sweep 
1.6.3.1 Allele frequency (F-statistics; FST) 
F-statistics and related statistics are the most widely used descriptive statistics in 
evolutionary and population genetics, first described by Sewall Wright in 1950 (Wright, 
1950). F-statistics describes the genetic diversity within and among the populations. Allele 
frequencies for many genetic variants differ by geographic regions. These geographic 
differences of allele frequency among populations are considered to be due to multiple 
factors including natural selection and genetic drift (Lan et al., 2007). The selective 
pressure exerted by environmental factors may lead to differences in allele frequencies 
between populations, particularly if such pressures differ between populations. F-statistics 
are the measure of the differences in allele frequencies within and between populations.   
F-statistics describe the statistically expected level of heterozygosity in the population, 
more specifically, the degree of reduction in heterozygosity compared to Hardy-Weinberg 
equilibrium. Wright introduced FST as one of three interrelated parameters to describe the 
genetic structure of diploid populations (Holsinger and Weir, 2009; Wright, 1950). FIT, the 
correlation between gametes within an individual relative to the entire population; FIS, the 
correlation between gametes within an individual relative to the subpopulation to which 
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that individual belongs; and FST, the correlation between gametes chosen randomly from 
within the same subpopulation relative to the entire population (Holsinger and Weir, 2009).  
Smaller FST values indicate the allele frequencies in each population are similar while 
larger FST values indicate allele frequencies that are different between populations. Thus 
genome wide scans of FST among the population could lead to identification of regions 
under diversifying selection (Axelsson et al., 2013; Xia et al., 2009).  
1.6.3.2 Linkage disequilibrium 
Linkage disequilibrium (LD) refers to the nonrandom association between alleles at 
different loci reflecting 'haplotypes' descended from single, ancestral chromosomes (Reich 
et al., 2001).  The term was first used in 1960 by Lewontin and Kojima (Lewontin and 
Kojima, 1960).!LD depends on at least two factors, the recombination frequency and the 
number of generation since the mutation was introduced in the population (Jorde, 1995). 
The hitchhiking effect of a beneficial mutation generates a unique distribution of allele 
frequencies and spatial distribution of polymorphic sites (Kim and Nielsen, 2004). The 
region under selective pressure tends to show higher LD, thus excess of LD is strong 
signature of a selective sweep (Kim and Nielsen, 2004).  Genome wide scan of LD 
structure was successfully used to identify selective sweeps by many researchers (Sabeti et 
al., 2007; Xia et al., 2009).    
1.6.3.3 Tajima’s D 
Tajima’s D is a statistical test that was first proposed by Fumio Tajima in 1989 (Tajima, 
1989). Tajima’s D is a widely used test of neutrality in population genetics, the main 
purpose of which is to distinguish between the stretch of genomic sequence evolving 
naturally (random evolution) and the stretch evolving under random processes such as 
positive, negative or balancing selection.  The Tajima’s D is one of the most popular 
summary statistics of the site frequency spectrum (SFS) of mutations (Larsson et al., 
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2013). The SFS has been the main source of information for demographic inferences and 
identification of selection (Larsson et al., 2013). Tajima’s D is calculated by taking the 
difference of two estimates of population mutation rates, i) the number of segregating sites 
in a sample of n sequences (θS) and ii) the average pairwise nucleotide diversity (θπ) 
(Tajima, 1989). The Tajima’s D is then defined as D = θπ - θS.  
For a large sample size, under neutrality Tajima’s D values are normally distributed with 
mean approximately at 0 and variance of 1. A negative Tajima’s D value indicates the 
excess of rare variants, while a positive Tajima’s D value indicates excess of intermediate 
frequency variants (Larsson et al., 2013). Other methods to test statistics for neutrality have 
been proposed by various population genetics scientists and these include Fu and Li’s D, 
Fay and Wu’s H and Achaz’s Y (Achaz, 2008; Fay and Wu, 2000; Fu and Li, 1993; 
Larsson et al., 2013).      
1.6.3.4 Ratio of non-synonymous to synonymous mutations  
The ratio of non-synonymous substitutions per non-synonymous site to synonymous 
substitutions per synonymous site (dN/dS) is a widely used method to quantify selection 
pressures acting on protein-coding regions (Kryazhimskiy and Plotkin, 2008). Kimura in 
1977 suggested a method to detect a positive selection in protein coding sequences based 
on synonymous and non-synonymous sequence differences between the species (Kimura, 
1977).  Synonymous substitutions do not change the encoded protein so are selectively 
neutral. If non-synonymous substitution does not affect the fitness of a protein it may 
become fixed in the population at a rate similar to the synonymous substitutions, giving 
dN/dS ratio of 1 (Massingham and Goldman, 2005).  In contrast if non-synonymous 
substitution makes a protein more or less fit then the dN/dS ratio will be either greater or 
less than 1 (Massingham and Goldman, 2005). Thus, dN/dS ratio of 1 suggests the neutral 
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selection, dN/dS ratio < 1 indicates purifying selection and dN/dS ratio > 1 suggests the 
positive selection.  
1.7 Aims of the project 
This project aims to functionally characterise genomes of rat models of human diseases 
with major focus on models of cardiovascular and metabolic disorders using next 
generation sequencing technologies. The specific objectives of my PhD project are as 
follows 
i) To analyse the genome of spontaneously hypertensive rat (SHR) strain and to 
characterise functional significance of the genomic variants identified in the 
SHR genome. 
ii) To analyse the genomes of 28 rat strains including models of hypertension and 
diabetes with their respective control strains and to identify genomic variants 
(SNVs, indels, SVs and CNVs) across 28 rat strains. 
iii) To identify clusters of genes that co-evolved and were co-selected in rat disease 
models during phenotype-driven selective breeding of these rat strains, to 
understand the polygenic inheritance of cardiovascular and metabolic disorders 
manifested in these strains. 
iv) To identify and characterise the genomic regions under selection pressure 
during phenotype-driven artificial selection in respective models of 
hypertension and diabetes.    
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Chapter 2: Materials and methods 
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2.1 Sequencing and analysis of the SHR genome 
As an initial part of this study, the SHR/OlaIpcv genome was sequenced with 10X 
coverage, in the laboratory of our collaborator Professor Steve Jones, University of British 
Columbia, Vancouver, Canada. Details of the materials and methods used for 
SHR/OlaIpcv genome sequencing and analysis are provided in this section.     
2.1.1 Rat strain used for sequencing 
The inbred SHR/OlaIpcv strain was created at the Institute of Physiology, Czech Academy 
of Sciences after importing the SHR/Ola strain in 1980 from OLAC Blackthorn Bicester, 
UK at 48th generation (F48). DNA isolated from the liver tissue of two SHR/OlaIpcv 
females at generation F130 was used for subsequent sequencing. 
2.1.2 Genotyping using 10K chip 
Genotyping using the 10K Rat Array (Affymetrix) was performed in the laboratory of our 
collaborator Professor Norbert Hubner, Max Delbruck Center for Molecular Medicine, 
Berlin, Germany to confirm the identity of the SHR/OlaIpcv female rats used for 
sequencing. Genomic DNA was extracted from the SHR/OlaIpcv liver tissue using a 
standard phenol/chloroform protocol. Genotyping was carried out as previously described 
(Saar et al., 2008). In brief, genotyping was carried out using the GeneChip Scanner 3000 
Targeted Genotyping System protocol from Affymetrix, originally described as MIP 
technology (Hardenbol et al., 2005) and genotypes were compared to previously 
determined genotype of SHR/OlaIpcv (Saar et al., 2008). 
2.1.3 Illumina genome sequencing and library preparations 
Library preparation and the sequencing of SHR genome was carried out in the laboratory 
of our collaborator Professor Steve Jones, University of British Columbia, Vancouver, 
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Canada as described previously (Atanur et al., 2010). For completeness details of library 
preparation and sequencing are provided here as below. 
10ug of genomic DNA from the liver tissue of two female SHR/OlaIpcv rats was used to 
construct paired-end whole genome shotgun libraries (WGSS-PE) with a 200bp insert size. 
Genomic DNA was prepared by standard phenol/chloroform extraction followed by 
treatment with DNAse free RNAse. DNA quality was assessed by spectrophotometry and 
gel electrophoresis before library construction. Genomic DNA was sheared for 10 min 
using Sonic Dismembrator 550 (cup horn, Fisher Scientific, Canada), and run using 8% 
polyacrylamide gel electrophoresis (PAGE). The 190-210bp DNA fraction was excised 
and eluted from the gel slice overnight at 4 °C in 300 µl of elution buffer (5:1, LoTE buffer 
(3 mM Tris-HCl, pH 7.5, 0.2 mM EDTA)-7.5 M ammonium acetate), and was purified 
using a Spin-X Filter Tube (Fisher Scientific Canada), and ethanol precipitation. The 
library was prepared by following the paired-end library protocol with 10 cycles of PCR 
amplification (Illumina Inc., Hayward, CA). For large insert mate-pair whole genome 
shotgun library (WGSS-MP) construction, 5-10ug of genomic DNA was used.  Genomic 
DNA was sheared for 15 sec using a Diagenode Biorupter (UCD-200; Diagenode, Sparta, 
NJ).  The fragemented genomic DNA was run on a 0.8% low melting point agarose gel and 
the 2.5 kb DNA fraction excised and purified using a QIAquick purification kit (Qiagen, 
Mississauga, ON).  The sequencing library was prepared following the Illumina Genome 
Analyzer Large Gap Paired-End library protocol (Illumina Inc., Hayward, CA) with 13-15 
cycles of PCR amplification. Following library construction PCR products were run using 
8% PAGE and the 400-600bp DNA fraction was excised, eluted and purified as detailed 
earlier. Constructed libraries were assessed and quantified using an Agilent DNA 1000 
series II assay and Qubit fluorometer (Invitrogen, Carlsbad, CA) respectively. The 
resulting libraries were sequenced on an Illumina Genome Analyzer II following the 
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manufacturer’s instructions. Image analysis and base calling was performed by the GA 
pipeline v1.0 (Illumina Inc., Hayward, CA) using phasing and matrix values calculated 
from a control phiX174 library run on each flowcell.  Raw Quality scores were calibrated 
by alignment to the reference BN genome (RGSC-3.4) using ELAND (Illumina Inc., 
Hayward, CA) (Atanur et al., 2010). 
2.1.4 Mapping SHR/OlaIpcv paired-end reads to reference genome  
The quality filtered paired-end reads were aligned to the BN reference genome (RGSC-
3.4), which includes unassigned contigs along with the 20 autosomes and X chromosome, 
using aligner mapping and assembly with qualities (MAQ) version 0.6.6 (Li et al., 2008). 
Default parameters were used for the paired-end reads from short-insert libraries RN001 
and RN009, while mate pair reads from the 2.5kb insert library RN0010 were mapped with 
the insert size parameter set to 2500 bp. 
2.1.5 Single nucleotide variants (SNV) prediction    
Before variant prediction, clonal reads were removed using rmdup module of MAQ. After 
removing clonal reads consensus sequence was produced from the reads aligned to the BN 
reference genome using MAQ, then the cns2SNP module of MAQ was used to predict 
SNVs between the SHR/OlaIpcv and the BN reference genome. Only SNVs which 
fulfilled the following filtering criteria were retained for further investigation i) minimum 
read depth of 3, ii) minimum consensus quality of 30, iii) minimum mapping quality of 60 
for at least one read covering the SNV and iv) no SNV call within 3bp flanking region 
around the potential indel.  
2.1.6 Short indel prediction 
MAQ aligns paired-end reads to the reference genome in two steps. In initial alignment 
step, MAQ does not allow alignment of reads with gaps; it only allows mapping reads with 
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mismatches. Thus reads which contain insertion or deletions will not be mapped in the 
initial alignment step.  Read pairs where one read is confidently mapped to the reference 
genome and another read of a pair is unaligned, MAQ then tries to map the unaligned read 
with gaps using the SW algorithm within the distance in the range of the insert size from 
the mapped pair of the read. Majority of the reads which contain indels remain unaligned 
by the MAQ algorithm, mainly because i) both the reads of the read pair contain indels ii) 
the read pair which maps outside the insert size range. The reads that remained unaligned 
to the reference BN genome, after MAQ alignment, were mapped to the BN reference 
genome using the Blast-like alignment tool (BLAT) (Kent, 2002).  Following BLAT 
alignment, reads that were mapped to a unique location in the genome with a maximum of 
two mismatches or a single indel of up to 15 bp were selected. Single reads that showed a 
gap either by MAQ or BLAT also had to satisfy paired-end mapping of the second read of 
the read-pair to the reference genome in keeping with the expected library insert size, were 
selected for indel prediction in SHR/OlaIpcv. Indels were called only when the predicted 
indel size was a maximum of 15 bp, was called by at least four non-redundant reads, and 
the number of reads called as a gap (by either MAQ or BLAT) exceeded the number of 
reads called as a mismatch. 
2.1.7 Structural variant (SV) prediction 
Structural variants were predicted using a custom developed Perl script (Appendix A, Perl 
code A.1). Deletions greater than 50bp were predicted using the paired-end reads mapped 
with an outer distance greater than 250 bp (2 SD above the average insert size) for the 
short-insert libraries and 2500 bp (2 SD above the average insert size) for the mate pair 
library. A deletion was called only when at least 4 overlapping read pairs mapped with a 
mapping quality greater than 30 and with the outer distance greater than expected. To 
discard potential false positives we filtered deletions using the following criteria: i) the 
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deletion completely overlapped with another deletion; ii) non-ambiguous reads were 
mapped within the deletion boundaries; iii) deletions which spanned within 100bp on both 
sides of the gaps in the BN reference genome assembly.  
 
Insertions were predicted from the long-insert library where read pairs were mapped with 
distance ≤ 750 bp. An insertion was called only when at least 4 reads mapped with a 
mapping quality greater than 30 with a distance of ≤ 750 bp. Probable insertions were 
predicted from “hanging reads” in the short-insert library, where only one read of the read-
pair mapped to the reference BN sequence. All single reads that mapped around BN 
genome gaps as well as chimeric reads were filtered out. Probable insertions were called 
only when the cluster of at least four single reads with a mapping quality greater than 30 
on both forward strand and the reverse strand were observed with a distance between the 
forward and reverse cluster of less than 100 bp. 
2.1.8 Copy number variation (CNV) prediction  
A test genome cannot be mapped uniquely across a reference genome as the reference 
genome varies according to the degree of uniqueness and repetitiveness of individual 
chromosomal segments. To correct for varying level of sequence uniqueness across the 
genome, read pairs from the BN reference with varying length and insert size of 200 bp 
were simulated. These simulated reads were mapped back to the reference genome using 
MAQ-0.6.6. The reference genome was then divided into non-overlapping, unequal length 
windows in which a constant number of simulated bases were mapped (Campbell et al., 
2008). A constant number of 50,000 mappable bases per window were selected as it was 
equivalent to ~5 kb of mappable sequence per window. Once the window boundaries were 
fixed, the number of bases from the SHR sequence mapping to each window was 
calculated. Based on the observed and expected number of bases mapping to each window, 
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the presence of CNVs was inferred using the R package DNAcopy, which implements a 
circular segmentation algorithm (Venkatraman and Olshen, 2007).  
Array CGH data was generated on the NimbleGen platform using SHR/OlaIpcv and 
BN/SsNHSd/Mcwi genomic DNA. Data were normalised using the loess normalisation 
method from the Limma (Smyth, 2005) package and CNVs were called using the 
DNAcopy package, both in R. 
2.1.9 Validation of SNP and accuracy 
To validate SNPs, 94 targeted genomic regions of SHR/OlaIpcv and reference BN genome, 
covering 66,052 bp, were sequenced by traditional capillary sequencing and SNPs were 
identified using Sequencher-v4.8. In addition, 20,283 SNPs genotyped across 165 rat 
strains were also used for validation. The sensitivity, specificity and accuracy of SNP 
prediction were calculated as: 
Sensitivity = TP / (TP + FN) 
Specificity = TN / (FP + TN) 
Accuracy = (TP + TN) / (P + N) 
Where, TP = True Positive, TN = True Negative, FP = False Positive, FN = False 
Negative, P = Total Positives and N = Total Negatives. 
 2.1.10 Validation of structural variants   
A set of 79 deletions, ranging in size from 56 to 10,801 bp, were selected for validation by 
PCR (Appendix B, Table B.1). To generate PCR fragments, primer pairs outside the start 
and end position of all individual deletions were designed using the BN genomic reference 
sequence as template. Sites of deletions within the SHR/OlaIpcv genome versus the BN 
reference were sequenced using Sanger sequencing on an ABI 3730 sequencer using 
standard big-dye chemistry.  
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2.1.11 Statistical and gene ontology analysis 
All statistical analysis was carried out in R. Gene ontology analysis was carried out using 
the Database for Annotation, Visualization and Integrated Discovery (DAVID) (Dennis et 
al., 2003; Huang da et al., 2009). 
2.2 Sequencing and analysis of 27 rat genomes 
2.2.1 Rat strains 
Using experience gained from sequencing of the SHR/OlaIpcv genome, the genome 
sequences of 25 new rat strains were sequenced on the Illumina Hiseq2000 and the genome 
sequences of two rat strains were sequenced on the SOLiD sequencing platform.  Genome 
sequences of the 14 new rat strains: F344/NCrl, LE/Stm, LEW/Crl, LEW/NCrlBR, 
LH/MavRrrc, LN/MavRrrc, LL/MavRrrc, MHS/Gib, MNS/Gib, SHR/NHsd, SS/Jr, SR/Jr, 
WKY/Gla and WKY/NCrl were sequenced at the Genomics Core Laboratory, MRC CSC, 
Imperial College London, London, UK. The tissues used for sequencing of majority of 
these rat strains were provided by various collaborators, Dr Michael Garrett (University of 
Mississippi Medical Center, USA), Dr Bina Joe (University of Toledo College of 
Medicine, USA), Dr Anne Kwitek (University of Iowa, USA), Professor Giuseppe Bianchi 
(University Vita Salute San Raffaele, Italy) and  Dr. Martin McBride (University of 
Glasgow, UK).        
The genome sequences of the six rat strains, ACI/EurMcwi, FHH/EurMcwi, 
FHL/EurMcwi, SBH/Ygl, SBN/Ygl and SS/JrHsdMcwi, were sequenced in the laboratory 
of Professor Howard Jacob, Medical College of Wisconsin, USA.  The genome sequences 
of four rat strains, BBDP/Wor, GK/Ox, WAG/Rij and WKY/NHsd, were sequenced in the 
laboratory of Professor Dominique Gauguier, University of Oxford, UK.   The genome 
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sequence of the SHRSP/Gla was kindly provided by the Dr. Martin McBride, University of 
Glasgow, UK. All these genomes were sequenced on the Illumina Hiseq2000.  
During initial study the SHR/OlaIpcv genome was sequenced at only 11.3X coverage. To 
achieve average coverage for the SHR/OlaIpcv comparable to other genomes which were 
planned to sequence at an average coverage of 20X to improve variant calling, libraries 
generated in the initial study were sequenced on Illumina Hiseq2000. In addition, the 
genome sequence of the rat strains BN.Lx, one of the parental strains of the BHX/HBX 
recombinant inbred line, and BN/Mcwi, the rat strain from which the reference BN rat 
genome was derived, were obtained from Dr Edwin Cuppen (Hubrecht Institute, Utrecht, 
The Netherlands).  The genomes of both BN strains were sequenced on the SOLiD 
sequencing platform.  The BN/Mcwi genome was sequenced to identify and exclude 
potential sequencing errors in the reference genome. The genome sequences of all the 28 
rat strains were analysed using same analysis pipeline to obtain uniformity in the analysis 
and the results.  
2.2.2 Genome Sequencing     
For the genomes which were sequenced on the Illumina platform at the MRC, CSC, the 
following protocols were used. Library preparation was carried out by laboratory scientists 
(Anna Garcia-Diaz and Klio Maratou) in the Professor Timothy Aitman’s laboratory at the 
MRC, CSC. Five micrograms of DNA was used to construct paired-end whole-genome 
libraries with a 300-600 bp insert size. Genomic DNA was prepared from the liver or 
spleen by standard phenol/chloroform extraction followed by treatment with DNAse free 
RNAse or using the Maxwell® 16 DNA Purification kit (Promega). DNA quality was 
assessed by spectrophotometry and gel electrophoresis before library construction. 
Genomic DNA was sheared using a Covaris S2 instrument (KBioscience, Herts, UK). 
Shearing efficiency was assessed by Qubit 2.0 fluorometer measurements (Life 
!
!
52!
!
Technologies Ltd, Paisley, UK) and gel electrophoresis. The library was prepared by 
following the Illumina Genomic DNA sample prep kit protocol (Illumina Inc., Hayward, 
CA). Constructed libraries were assessed with an Agilent 2100 Bioanalyser (Agilent 
Technologies, Edinburgh, UK) and quantified using a KAPA Illumina SYBR Universal 
Lib QPCR kit (Anachem Ltd, Bedfordshire, UK). The resulting libraries were sequenced 
on an Illumina HiSeq2000 following the manufacturer’s instructions.  
2.2.3 Mapping to the reference genome  
Quality filtered Illumina paired-end and/or mate pair reads were mapped to the BN 
reference genome RGSC-3.4 (Gibbs et al., 2004) using the read alignment software 
Burrows-Wheeler Aligner (BWA-0.5.8c) (Li and Durbin, 2009). BWA is a based on 
backward search with Burrows-Wheeler Transform (BWT), to efficiently align short 
sequencing reads against a large reference sequence such as the rat genome, allowing 
mismatches and gaps.!All the default parameters were used while mapping reads using 
BWA except for the read trimming parameter. The reads were trimmed at the end if the 
Phred scaled base quality score dropped below 20.  
Genomes sequenced on the SOLiD sequencing platform were mapped to the reference BN 
genome using BFAST-0.6.4e (Homer et al., 2009). BFAST is based on creating flexible, 
efficient whole genome indexes to rapidly map reads to candidate alignment locations, 
with arbitrary multiple independent indexes allowed to achieve robustness against read 
errors and sequence variants. The final local alignment used a Smith-Waterman algorithm, 
with gaps to support the detection of small indels (Homer et al., 2009).  While running 
BFAST, parameters required for SOLiD reads were used for all the steps which include 
initial match, local alignment and post processing. For post processing in addition to the 
parameters required for the SOLiD reads, the following parameters were used, -a 3 -z -O 1 
-R –U.  
!
!
53!
!
2.2.4 Single Nucleotide Variants (SNV) and short indel detection   
Genomic variants (SNV and short indels) were detected using the Genome Analysis 
Toolkit (GATK version 1.0.6001) (DePristo et al., 2011; McKenna et al., 2010). GATK is 
a structured programming framework designed to ease the development of efficient and 
robust analysis tools for next-generation DNA sequencers using the functional 
programming philosophy of MapReduce (McKenna et al., 2010). GATK provides various 
tools for NGS data analysis which includes tools for SNV and indel predictions.  Because 
of the robust implementation of parallel processing in the majority of the tools in GATK, it 
can be efficiently used on the high performance computing platforms. The parallel 
processing capability of GATK allows the prediction of the SNVs and indels from multiple 
genomes simultaneously.      
Before variant calling using GATK, rigorous pre-processing of the aligned reads was 
carried out as listed below 
i) Clonal reads were masked independently for each library of every rat strain 
using Picard tools (http://sourceforge.net/projects/picard/)  
ii) Reads were realigned around the indels using GATK (DePristo et al., 2011). 
First, regions for realignment were identified where at least one read contained 
an indel with a cluster of mismatching bases around it and then local multiple 
alignments were performed at target regions  
iii) Base quality scores were recalibrated using GATK, which provides empirically 
accurate base quality scores for each base in every read, while also correcting 
for error covariates like machine cycle and dinucleotide context as well as 
supporting platform-specific error covariates like colour-space mismatches for 
the SOLiD platform (DePristo et al., 2011).  
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After processing aligned reads, reads mapped with a mapping quality greater than or equal 
to 10 and bases with a base quality greater than or equal to 17 were used for variant calling 
to avoid false positives due to errors in read alignment and sequencing errors. 
After calling SNVs and indels we applied variant quality recalibration to exclude potential 
false positive variant calls. Given the set of known SNVs and the SNV annotations, soft 
filtering using the variant quality score recalibration function of GATK employs a 
variational Bayes Gaussian mixture model (GMM) to estimate the probability that each 
called variant is a true variant in the samples rather than a sequencer, alignment or data 
processing artefact (DePristo et al., 2011). As dbSNP125 (Sherry et al., 2001) contains 
only 35,186 SNVs in rat strains, the model was trained using high quality SNVs extracted 
from this dataset. The top 30% of high quality SNVs were used as the training set for the 
GMM.   
2.2.5 Structural variant (SV) prediction  
Large deletions were predicted using custom Perl script, as described in section 2.1.7, 
using mapping flags provided by BWA for paired end reads (Li and Durbin, 2009).  Read 
pairs mapped in the forward- reverse (FR) orientation and flagged as improper pairs by 
BWA were extracted. Clusters of at least 2 improper pairs were identified where at least 
one end was mapped with quality greater than or equal to 20 and deletions were predicted 
using a custom Perl script. Further deletions were filtered if they spanned less than 100 bp 
on both ends of genomic gaps. In addition, structural variants (SVs) including large 
deletions, insertions, inversions and translocations, were predicted using the software tool 
BreakDancer1.2 (Chen et al., 2009). Only reads mapped with mapping quality more than 
20 were used to call structural variants. All the SVs that spanned less than 100 bp on both 
ends of genomic gaps were filtered out. 
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2.2.6 Identification of copy number variants (CNVs) 
Copy number variants in each of the 26 rat strains sequenced on the Illumina sequencing 
platform were predicted independently using the CNVnator version 0.2.2 (Abyzov et al., 
2011).  
2.2.7 Functional consequence analysis of predicted variants 
Functional consequences of predicted variants (SNVs and short indels) were analysed 
using a “variant effect predictor (VEP) – version 2.4” Perl script (McLaren et al., 2010), 
which is based on the ENSEMBL application programming interface 
(http://www.ensembl.org). For functional consequences analysis the ENSEMBL 66 gene 
set (http://www.ensembl.org) was used.  
2.2.8 Validation of genomic variants  
To estimate the sensitivity and specificity of variant calls, the sequence of 13 bacterial 
artificial chromosome (BAC) clones from various chromosomes (~2Mb in length) of the 
LE/Stm rat were sequenced on a conventional capillary sequencing platform. The LE/Stm 
BACs were obtained from Professor Tadao Serikawa (Kyoto University, Kyoto, Japan) 
and capillary sequencing, assembly and finishing was performed in the laboratory of Dr 
David Adams (Wellcome Trust Sanger Centre, Cambridge). BAC sequences are available 
for download from the EMBL web site (accession numbers FO117624-! FO117632 and 
FO181540-!FO181543).  
To avoid differences between the variants predicted using the LE/Stm sequenced on the 
Illumina platform and the LE/Stm BACs due to the different analysis protocols used to 
analyse the two datasets, variants were predicted in both datasets simultaneously using the 
same analysis protocol.  First, 100 bp paired end reads were generated from the BAC 
sequences and mapped to the BN reference genome using BWA (Li and Durbin, 2009). 
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SNVs and indels were subsequently called using GATK (DePristo et al., 2011; McKenna 
et al., 2010). A total of 3,382 SNVs and 1,211 indels were predicted between the LE/Stm 
BAC sequences and the BN reference genome.     
The false positive rate, false negative rate and accuracy were calculated as described in 
section 2.1.9. 
  
2.2.9 Reconstruction of the phylogenetic tree 
To construct the phylogenetic tree, SNVs between all possible pairs of strains were 
identified. The distance between any pair of strains was calculated using the following 
formula: 
Distance! = !Number!of!SNVs!between!the!pair!of!strainslength!of!rat!genome  
A distance matrix was then used to construct the phylogenetic tree using the Fitch-
Margoliash method with contemporary tips, version 3.69 from package Phylip 
(Felsenstein, 1989) with 1000 bootstraps. 
2.3 Identification of co-evolutionary gene clusters   
2.3.1 Identification of phylogenetic vectors    
Co-evolutionary gene clusters were identified using a mirror tree approach. All transcripts 
which showed variants in at least one of the 26 rat strains which resulted in amino acid 
changes in encoded proteins (non-synonymous coding (NSC) variants and frameshift 
coding variants) were used to generate phylogenetic vectors. For each transcript showing 
NSC variants, the evolutionary rate was calculated in each rat strain by dividing the 
number of NSC variants by the number of synonymous coding (SC) variants, both 
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normalised by the length of the transcript. Thus, an m x n matrix of evolutionary rate was 
obtained, where m represents the number of strains and n represents the number of 
transcripts (the evolutionary rate being zero in the reference BN genome). BN.Lx was 
excluded from this analysis because BN.Lx shows a very small number of SNVs in 
comparison with the BN reference genome. Similarly phylogenetic vectors were also 
generated for each transcript showing frameshift coding variants by counting the number 
of indels causing a frameshift and normalising this to transcript length. Co-evolutionary 
gene cluster analysis was carried out independently for the transcript containing NSC 
variants and frameshift variants. 
2.3.2 Correction for population structure 
Rat strains sequenced in this study have a complex phylogenetic history and the 
phylogenetic tree constructed using the SNV data clearly shows varying degree of 
relatedness between the rat strains. This uneven relatedness between the rat strains may 
result in spurious correlations between the phylogenetic vectors obtained for each 
transcript. Therefore it is necessary to correct for the population structure by taking into 
account the uneven relatedness between rat strains during the identification of co-
evolutionary gene clusters. To account for the population structure two independent 
methods were used namely the principal component analysis and the linear mixed model. 
2.3.2.1 Principal component analysis   
Principal component analysis (PCA) was carried out using the PCAmethods package in R. 
To take into account the phylogenetic relationships (population structure) between the 
strains under consideration in the co-evolutionary cluster analysis, the major components 
responsible for variability between strains were identified using PCA analysis. PCA 
analysis was carried out using a kinship matrix derived from 9.6 million SNVs as well as 
using an evolutionary rate matrix which was derived as explained in section 2.3.1.  
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The first two principal components explained more than 70% of the variability between the 
strains; therefore first two principal components were used to exclude the effects of 
population structure. For each transcript, the phylogenetic vector was adjusted for the first 
two principal components and residuals were used as an estimate of the population 
structure-adjusted phylogenetic vector. For each pair of transcripts, the correlation between 
the population structure adjusted phylogenetic vectors was computed as a measure of the 
co-evolution of transcripts.  
2.3.2.1 Linear mixed model  
The linear mixed model as implemented in the R package EMMA (Kang et al., 2008) was 
used to correct for the population structure. EMMA was used to calculate the association 
between all possible pairwise combinations of transcript using phylogenetic vectors as 
generated in section 2.3.1. 
2.3.3 Identification of co-evolutionary gene clusters  
Co-evolutionary gene clusters were identified using transcript pairs showing significant 
correlation between the phylogenetic vectors corrected for population structure using PCA 
and the transcript pairs showing significant association using EMMA independently. To 
estimate the significance of the correlation and association, the false discovery rate (FDR) 
was calculated using the R package FDRtool (Strimmer, 2008). FDRtool estimates the 
FDR using a mixture model on the correlation coefficient with an empirical parametric 
null-distribution and a non-parametric alternate distribution. Transcript pairs with a FDR 
less than 0.1% were then selected to construct a network where nodes represent transcripts 
and edges represent significant evidence for co-evolution. Clusters were identified from a 
network by extracting components, defined as a subset of transcripts where any pair of 
transcripts is connected by at least one path in the network.  
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2.3.4 Overlap between PCA-based and EMMA-based networks 
The overlap between PCA-based and EMMA-based networks was computed by taking the 
ratio of the number of common edges and the minimum of the number of edges in both 
networks. Overlap was evaluated by assuming that a fixed number of edges were 
independently sampled in each network and the significance evaluated using Fisher's exact 
test. When considering clusters unique to a single strain, the overlap was determined as the 
fraction of edges from the PCA network compared to those present in the EMMA network. 
All the analysis was performed in R. 
2.3.5 Overlap with genome-wide association studies (GWAS) 
We screened all GWAS recorded by the National Human Genome Research Institute 
(www.genome.gov/gwastudies) on or before 26 October 2012 for relevant phenotypes.  Of 
all annotated rat transcripts, 27,199 had at least one one-to-one or one-to-many orthologs 
in the human genome as reported by ENSEMBL version 62 (http://www.ensembl.org), of 
which 1,499 had been shown to be associated with hypertension or metabolism-related 
phenotypes at a P-value threshold of P < 10-5.  
2.3.6 Calculation of Linkage disequilibrium (LD)  
LD between the SNVs within the co-evolutionary gene clusters was calculated using 
Haploview 4 (Barrett et al., 2005).   
2.4 Artificial selective sweep analysis 
2.4.1 Identification of artificial selective sweeps 
To identify genomic regions that were unique to a single rat strain or that were shared 
between different rat strains, a parameter designated here as “relative SNV density” (RSD) 
was calculated in non-overlapping 10kb windows. For the rat strains where genomes of 
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two or more substrains were sequenced and high genetic similarity was observed 
(SS/JrHsdMcwi and SS/Jr; LEW/NCrlBR and LEW/Crl; SHR/NHsd and SHR/OlaIpcv), 
SNVs from pair of substrains were pooled. For WKY-derived strains however, WKY/Gla 
showed substantial diversity from the other two WKY substrains therefore WKY/Gla was 
considered as a separate strain and SNVs from the other two WKY strains, WKY/NCrl and 
WKY/NHsd, were pooled. This defined a set of 22 genomes for selective sweep analysis. 
We excluded all polymorphic loci with missing genotypes and/or heterozygous calls in at 
least one strain, defining a set of 7.8 million high quality SNVs (out of a total of 9.6 
million SNVs) that were used for further analysis.  
For each 10 kb window in each strain RSD was calculated using the following formula:   
RSD! = Number!of!SNVs!in!strain!!Total!number!of!SNVs !!!100 
In cases where only one strain showed a set of SNVs that were different from the reference 
strain, but all other strains showed the reference allele at every site across the 10 kb 
window, the RSD value for that strain would be 100 and zero for other strains.  If two 
strains showed alternate (identical or non-identical) SNV sets with equal numbers of SNVs 
in each strain and other strains showed reference alleles, the expected RSD value would be 
50 for those two strains and zero for other strains; for three strains showing equal numbers 
of alternate SNVs, the RSD would be 33.33 and so on.  These are the ideal situations 
where 10kb windows are clearly shared between one, two or three strains but as SNV over 
10kb windows were averaged, for the majority of the windows the RSD value would differ 
from the expected values. Chi-square statistics were used to determine the goodness of fit 
to a model of equal distribution of SNVs within each 10 kb window between number of 
strains. Chi-square statistics were calculated for all possible combinations of strains 
according to: 
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!" = min !! = 1. .! (!! − !!)!!!
!
!!! ! !! 
The combination of RSDs which showed the lowest chi-square value for each 10 kb 
window was selected as the best fit model of RSD distribution across the 22 genomes.   
Segments were then merged if successive 10 kb windows were shared between the same 
strain combinations. Further smoothing was applied if two adjacent windows on both sides 
were shared between the same strain combinations. The Perl code for identification of 
selective sweep is provided as Appendix A (Perl code A.2)  
The probability of the occurrence of long genomic regions that were unique to a given 
strain or to a number of strain combinations was estimated using a permutation test (n=10 
million). The maximum length of the segment assigned to the same strain or strain 
combination was estimated for each iteration.  FDR was calculated to correct for multiple 
testing using FDRtools (Strimmer, 2008) and genomic segments with FDR less than 0.1% 
were selected.  
2.4.2 Calculation of LD  
LD between the SNVs with in the putative selective sweeps was calculated using 
Haploview 4 (Barrett et al., 2005) in a window of 0.5Mb.   
2.4.3 Coalescent simulations  
The coalescent (Hudson, 1983; Kingman, 1982) is a stochastic process to generate 
genealogies from a population by tracing randomly sampled alleles backwards in time 
(Ewing and Hermisson, 2010). The basic underlying coalescent is that, in the absence of 
selection, sampled lineages can be viewed as randomly picking their parents, as we go 
back in time. Whenever two lineages pick the same parent, their lineage coalesce. 
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Eventually, all lineages coalesce into single lineage, the MRCA of the sample. The rate at 
which lineages coalesce depends on how many lineages are picking their parents and on 
the size of the population (Rosenberg and Nordborg, 2002). Population structure as well as 
demography and recombination can be readily incorporated into a coalescent framework.  
Coalescent simulations are a stranded method to generate population sample under various 
models of evolution. One of the widely used tool for coalescent simulation is ms (Hudson, 
2002), however it does not allow selection. MSMS, which implements the functionalities 
of ms allows for selection at single diploid locus (Ewing and Hermisson, 2010).  
2.4.3.1 Coalescent simulations to generate null model  
In order to assess the significance of identified putative artificial selective sweep (PASS) 
regions and to validate the statistical method used to show evidence for selection, 
coalescent simulations were performed using the software package MSMS (Ewing and 
Hermisson, 2010). To assess the significance of selective sweep signals, a null model was 
generated without any selection but taking into account the known demographic history of 
rat strains sequenced (Ben-Ishay et al., 1972; Bianchi et al., 1974; Dupont et al., 1973; 
Ewing and Hermisson, 2010; Goto, 1975; Jackson et al., 1981; Jong, 1984; Kuijpers and 
Gruys, 1984; Lindsey, 1979; Okamoto and Aoki, 1963; Okamoto, 1974). Demographic 
history was available for all the rat strains, including the year of derivation. The size of the 
originating colony and the number of starting breeding pairs were available for every 
disease model and their respective controls except for FHH and FHL where the colony size 
was estimated at 500 and the number of breeding pairs estimated at 10 (Table 2.1). For the 
five remaining strains, breeding pair number was known for two and originating colony 
size was unknown. In these cases, breeding pair numbers were estimated at 5 and colony 
size at 500. Unknown branch points in the demographic history were estimated from the 
phylogenetic tree. 
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Rat strains were derived from multiple founder colonies and, moreover, rat strains derived 
from the same outbred founder colony were derived at different geographical locations 
where subsets of the founder colonies were distributed and then maintained. Each rat strain 
was derived either from a single pair of rats or a relatively small number of pairs and 
therefore underwent severe bottleneck effects between 100 and 200 generations ago. We 
considered each rat strain as a distinct population that went through a bottleneck and 
simulated the likelihood of unique or shared haplotype blocks for the 22 rat strains 
conditioned on the time point of selection and size of selected colony as reported. For the 
simulations we considered an average recombination rate of 0.60 cM/Mb (Jensen-Seaman 
et al., 2004) and mutation rate of 2 x10-8 per base per generation and estimated an average 
of three generations per year. We generated 10,000 chromosomes each with 30,000 
polymorphic sites corresponding to a genomic segment of length 10Mb. The command 
used for generating null model using MSMS (Ewing and Hermisson, 2010) is provided in 
Appendix B, command B.1. 
2.4.3.2 Coalescent simulations to validate RSD method used to identify PASS regions  
Two models were generated, to validate the statistical method used to identify putative 
selective sweeps, one with selection and one corresponding to the null model without 
selection. For both these models, 22 samples were generated from a single population with 
constant population size. For each model 105 chromosomes were generated with 3000 
polymorphic sites. The commands used to generate these models were provided in 
Appendix B, Command B.2 and Command B.3 
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Table 2.1: Details of parameters used for coalescent simulations 
Rat!strain! index!
Current!
generation!!
Number!of!breeding!
pair(s)!used!to!derive!
rat!strain!
Population!size!from!
which!breeding!pair(s)!
were!selected!!
WKY! 1! 130! 5! 250!
SHR! 2! 150! 1! 68!
SHRSP! 3! 125! 1! 68!
WKY/Gla! 4! 130! 5! 250!
GK! 5! 130! 9! 211!
MNS! 6! 135! 4! 500!
MHS! 7! 135! 5! 500!
LEW! 8! 175! 5! 100!
WAG! 9! 180! 1! 100!
BBDP! 10! 175! 50! 1000!
SS! 11! 150! 5! 100!
SR! 12! 150! 5! 100!
LN! 13! 125! 1! 140!
LL! 14! 125! 1! 140!
LH! 15! 125! 1! 140!
F344! 16! 195! 1! 1000!
SBH! 17! 125! 25! 500!
SBN! 18! 125! 25! 500!
FHL! 19! 100! 5! 500!
FHH! 20! 100! 5! 500!
ACI! 21! 180! 1! 1000!
LE! 22! 210! 1! 1000!
 
2.4.4 Calculation of the population genetics statistic Tajima’s D 
The population genetics statistic Tajima’s D was calculated in 10kb non-overlapping 
windows with a custom Perl script using the following formula described in the original 
paper (Appendix A, Perl code A.3) (Tajima, 1989) . 
Tajima’s D is based on two statistics i) Mean pairwise differences (π) and ii) Number of 
segregation sites (S).  These two statistics were estimated in each 10kb window and the 
Tajima’s D was then calculated as 
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!"#$%!!!! = π− S/!!!  
!! = 1/!!!!!!!  
!! = 1/!!!!!!!!  
!! = ! − 13(! − 1) 
!! = 2(!!! + ! + 3)9!(! − 1)  
!! = !! − 1/!! 
!! = !!! − ! + 2!!! + !!!!!! 
!! = !!!/!!! 
!! = ! !!/(!!! + !!) 
 
Then the Tajima’s D was calculated as 
! = π− S/!!!!! + !!!(! − 1) 
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The false discovery rate (FDR) was calculated using the null distribution of Tajima’s D 
obtained from the coalescent simulated null model: 
!"# = ! ! = 0! ! < !) 
= ! ! < !! ! = 0)!!!!(! = 0)!(! < !)  
Where,                                 
                                                 ! ! < !! ! = 0) = !".!"!!"#$%&'&()*+! !!!".!"!!"#$%&'&()*+  
! ! < ! = !"#$%&!!"#$%&$' < !!"#$%&!!"#$%&$'  
! ! = 0 ≤ 1 
 
2.4.5 Overlap of putative artificial selective sweeps with physiological 
quantitative trait loci (pQTLs) 
All pQTLs reported in RGD (http://rgd.mcw.edu/) were downloaded from the RGD FTP 
site and the pQTLs for hypertension and metabolic phenotypes were extracted. pQTL 
intervals as defined in RGD were used for analysis. Overlap between pQTL and artificial 
selective sweeps was defined by the following criteria.  
i) The start and end of the selective sweep must be within the pQTL interval as 
defined by RGD. 
ii) The pQTL must be mapped in the same strain in which the putative selective 
sweep was identified.  
The overlap between pQTLs and PASS regions was estimated based on the above criteria 
using a Perl script and the significance was estimated by permutation testing. 
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2.4.6 Gene Ontology analysis 
Gene ontology enrichment and Kyoto Encyclopedia of Genes and Genome (KEGG) 
pathway enrichment analysis was carried out using The DAVID v6.7 (Huang da et al., 
2009) as described in section 2.1.11.  
2.4.7 Data availability and accession numbers   
Sequence reads for SHR genome sequenced on Illumina GAII and Hi-seq 2000 platform 
are submitted to EBI Sequence Read Archive (SRA) with accession numbers ERA000170 
(http://www.ebi.ac.uk/ena/data/view/ERA000170) and ERP001371 
(http://www.ebi.ac.uk/ena/data/view/ERP001371) respectively. Accession number for 
BN.Lx sequence data is ERP001355 (http://www.ebi.ac.uk/ena/data/view/ERP001355).  
Sequence reads of remaining 25 genomes are deposited in the EBI SRA under accession 
number ERP002160 (http://www.ebi.ac.uk/ena/data/view/ERP002160).  
SNVs and indels for the SHR genome are deposited in dbSNP under submitter batch id 
2010-1_SHR. SNVs and indels across 28 rat strains are deposited in RGD 
(ftp://rgd.mcw.edu/pub/data_release/UserReqFiles/).  LE/Stm BAC sequences are 
deposited in EBI-EMBL under accession number FO117624-!FO117632 and FO181540-!
FO181543. All other data is provided as an appendix on the CD along with this thesis. 
2.4.8 High performance computing (HPC) facility 
All of the analyses were performed on computing resources owned by physiological 
genomics and medicine group on the HPC cluster at Imperial College London. PGM has 
12 nodes on HPC cluster, each node contain 8 core and 46GB RAM. In addition PGM has 
38 terabytes dedicated storage on HPC cluster.   
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Chapter 3: Sequencing the genome of the 
spontaneously hypertensive rat strain 
!  
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3.1 Introduction 
The spontaneously hypertensive rat (SHR) is the most widely studied animal model of 
human hypertension. In addition to hypertension, the SHR displays many other 
physiological and pathophysiological phenotypes such as insulin resistance, dyslipidemia 
and glucose intolerance collectively known as metabolic syndrome.  Scores of these 
phenotypes have been mapped to the genome as physiological quantitative trait loci 
(pQTLs; Rat Genome Database; http://rgd.mcw.edu/) and for some of the pQTLs, the 
underlying genes and nucleotide variants have been identified (Aitman et al., 2008).  
 
In the early 1980s, by crossing the SHR/Ola strain with the normotensive Brown Norway 
(BN.Lx) strain a BXH/HXB panel of recombinant inbred (RI) strains was created 
(Pravenec et al., 1989; Pravenec et al., 2004). RI panels are powerful and renewable 
resources for genetic mapping that offer the opportunity to accumulate genetic and 
physiological data over time. By integrating gene expression profiling and linkage 
analysis, thousands of expression quantitative trait loci (eQTLs) have been mapped in 
several tissues in the BXH/HXB RI panel (Hubner et al., 2005; Petretto et al., 2006). 
Subsequently the integration of eQTL and physiological data led to the identification of 
Cd36, Ogn and Ephx2 as genes responsible for insulin resistance, cardiac hypertrophy, 
cardiac failure and hypertension in SHR or SHR-derived strains (Aitman et al., 1999; 
Monti et al., 2008; Petretto et al., 2008; Pravenec et al., 2008a). 
 
The draft genome sequence of the reference rat strain, BN/SsNHsd/Mcwi, which is one of 
the sub-strain of BN and phylogenetically closely related to BN.Lx (Saar et al., 2008) was 
sequenced using a combined whole genome shotgun and BAC sequencing strategy (Gibbs 
et al., 2004). Although the sequencing of the BN genome has facilitated genetic studies in 
the rat (Aitman et al., 2008), progress in identifying SHR QTL genes, and therefore 
!
!
70!
!
understanding the molecular basis of SHR phenotypes, has been limited by the continuing 
absence of the SHR genome sequence. In this chapter, the genome sequencing of the 
spontaneously hypertensive rat (SHR) using next-generation sequence technology and in-
depth analysis of genomic variants between SHR and the reference BN genome is 
presented.  
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3.2 Results 
3.2.1 Sequencing and mapping   
The SHR/OlaIpcv genome was sequenced using paired-end sequencing technology on the 
Illumina genome analyser (GAII). Three different paired end libraries were prepared to 
minimise systematic bias in library preparation, two with a short insert size (around 200 
bp) and one with a longer insert size (around 2,000 bp).  After quality filtering, a total of 
33.78 Giga bases (Gb) from 816.5 million reads with an average read length of 41 bases 
were sequenced. Reads were mapped to the BN reference genome (RGSC-3.4) using 
MAQ-0.6.6 (Li et al., 2008). Mapping percentage was approximately 87.63% 
corresponding to 715.5 million reads, of which 684.7 million reads were mapped to the 20 
autosomes or X chromosome, while 30.83 million reads were mapped to the unassigned 
contigs. Approximately 33.71 million reads were exact duplicates of other sequences from 
the respective library, these duplicate reads were excluded from further analysis as they 
may affect the accuracy of SNV and SV calling. After filtering duplicate reads, 681.8 
million reads (28.17 Gb) could be mapped to the reference genome equating to 10.7 fold 
coverage of the SHR/OlaIpcv genome (Table 3.1; Figure 3.1). In total 99.22% of non-gap, 
non-N bases of the reference genome were covered by at least one read and 97.70% non-
gap, non-N bases of the reference genome were covered by at least three reads.  
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Table 3.1 Libraries, number of reads and mapping statistics of the SHR/OlaIpcv 
genome sequence 
Library Number of 
reads* 
Number of reads 
mapped after 
removing duplicates 
(Proportion of reads 
mapped) 
Number 
of bases 
(Gb) 
Number 
of bases 
mapped 
(Gb) 
Coverage  
RN0001 514,112,444 431,445,314 (83.92%) 18.85 15.81 6.04 
RN0009 256,515,986 215,871,547 (84.15%) 12.64 10.63 4.04 
RN0010 45,834,540 34,478,476 (75.22%) 2.29 1.72 0.65 
Total 816,462,970 681,795,337 (83.40%) 33.78 28.17 10.7 
*After quality filtering  
Note: Mapping percentage was low for RN0010 because it was a 2kb mate pair library 
 
!
Figure 3.1: The coverage distribution for SHR/OlaIpcv genome 
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3.2.2 Genomic variant calling and validation 
3.2.2.1 Calling and accuracy of single nucleotide and short indel variants 
Single nucleotide variants (SNVs) between the SHR/OlaIpcv and BN reference genomes 
were identified using the cns2SNP program of the MAQ package. The reliability of variant 
calls was evaluated by comparing the data generated on the Illumina platform, at varying 
read depths and varying consensus quality scores, with two complementary SNV datasets. 
First, Illumina data was evaluated against a set of 108 SNVs identified between 
SHR/OlaIpcv and BN.Lx in 94 different genomic regions (66,052 bp) by conventional 
capillary sequencing. The capillary sequencing was performed by lab scientists (Michelle 
Johnson and Catherine Morrissey) in Professor Timothy Aitman’s laboratory.  Second, 
Illumina data was evaluated against a set of 20,283 SNPs genotyped in multiple rat strains 
by the STAR consortium using the Affymetrix or Illumina SNP genotyping microarrays 
(Saar et al., 2008).  In 66,052 bp genomic regions corresponding to capillary sequenced 
regions, a total of 104 SNVs were identified by Illumina GAII sequencing at a read density 
≥ 3 and consensus quality ≥ 30. All 104 SNVs were confirmed by capillary sequencing 
between SHR/OlaIpcv and BN.Lx while no false positive SNVs were called in the GAII 
sequencing within the 66,052 bp of capillary sequence at this read depth and consensus 
quality score (Figure 3.2A). Of the 108 SNVs identified by capillary sequencing, the 4 
SNVs which could not be identified by Illumina sequencing either had read depth < 3 (2 
SNVs) or the consensus quality was < 30 (2 SNVs).  Thus in a 66kb region, optimal false 
positive and false negative rates were achieved for SNVs predicted at a read density ≥ 3 
and consensus quality ≥ 30 using genome sequenced on the Illumina GAII.   
Of the 20,283 SNPs genotyped by the STAR consortium alleles between the SHR/OlaIpcv 
genome and the BN reference genome differed at 13,627 loci, while at 6,461 loci, alleles 
were same. At the remaining loci the SHR/OlaIpcv allele had not been genotyped. At a 
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consensus score of ≥ 30 and read depth of ≥ 3, the GAII data detected 13,349 of the 13,627 
STAR SNPs (97.96% sensitivity). Of the 6,461 positions previously assigned as non-
variable between SHR/OlaIpcv and the BN reference genome, the SNV call from the GAII 
data correctly predicted 6,399 positions as non-variable (99% specificity; Figure 3.2A), 
whereas 62 were apparent false positives. However, for the 62 apparent false positive 
SNVs, the GAII consensus quality score was high (mean score 59.3) with high read depth 
(mean depth 12.3 reads). In addition, for 51 of these SNPs, the STAR BN/SsNHsd/Mcwi 
(the strain from which the BN reference genome was sequenced) allele was discordant 
with the BN reference genome allele, suggesting that these apparent false positive SNVs 
arose due to sequencing errors in the BN reference genome (RGSC-3.4). The extent to 
which errors in the BN reference genome sequence could have accounted for false positive 
SNVs between SHR/OlaIpcv and the BN reference genome was therefore assessed by 
comparing BN reference genome and the STAR genotype for the BN/SsNHsd/Mcwi strain. 
STAR genotypes for the 16,920 SNPs showed a concordance rate of 99.2 % between the 
BN/SsNHsd/Mcwi genotype and the BN reference sequence, indicating that sequence 
errors in the BN reference sequence are likely to have a small effect (< 1%) on the 
specificity and accuracy of SNPs detected in this study between the genome sequence of 
the SHR/OlaIpcv and the BN reference genome. 
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Figure 3.2: Receiver Operating Characteristic (ROC) curves to determine optimal 
thresholds for SNP calling. 
Evaluation of sensitivity and specificity of SNV prediction using Illumina paired-
end sequencing at various read depths and quality scores compared to A) 108 SNPs 
predicted in a 66 kb region of the genome sequenced using capillary sequencing, 
and B) the STAR SNP dataset. Each curve represents a different minimum read 
depth required to call SNP and each point represents minimum consensus quality 
scores.  
B!
A!
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The high sensitivity and specificity obtained at a read density of ≥ 3 and consensus quality 
of ≥ 30 suggested that these thresholds were optimal for variant calling. At these 
thresholds, 3,642,090 genomic locations (0.15%) were determined to be variants between 
the SHR/OlaIpcv genome and the BN reference sequence, while 2,416,312,168 (97.35%) 
genomic positions were identical between the two genomes, and 61,981,672 (2.5%) 
positions remain undetermined. Of 3,642,090 genomic locations which were variants 
between SHR/OlaIpcv and the BN reference genome, 3,590,437 SHR/OlaIpcv alleles were 
homozygous and 51,653 were heterozygous (dbSNP submitter batch id: 2010-1_SHR). 
Therefore the proportion of all nucleotides in the SHR genome that were called as 
heterozygous is 2.1 x 10-5. The average read depth was 10X for homozygous SNP 
locations and 24X for heterozygous SNP locations, suggesting that many heterozygous call 
may be due to copy number variants between the two strains or due to regions of low 
complexity.  
To predict short indels, reads which remained unmapped to the BN reference genome by 
MAQ alignment were mapped to the reference sequence using BLAT (Kent, 2002), which 
allows gapped alignment. Using the reads aligned with gaps to the reference BN genome, 
either by BLAT or MAQ, we identified 343,243 short indels of less than or equal to 15 
base pairs (dbSNP submitter batch id: 2010-1_SHR). Similar to the SNVs, a proportion of 
short indels may also be due to errors in the BN reference genome, however because of an 
unavailability of data to estimate false positive indel calls due to the errors in the BN 
reference genome, the proportion of indels due to errors in the BN reference genome was 
not possible to estimate.    
 
3.2.2.2 Structural variant calling and validation  
Structural variants (SVs), defined as insertions or deletions greater than 50 bp, were 
predicted using abnormally mapped read pairs either with an improper span size and/or 
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orientation. A total of 13,438 deletions were predicted in SHR/OlaIpcv compared to the 
BN reference (Appendix C, Table C.1). An illustration of the schema and data underlying 
prediction of deletions is shown in Figure 3.3. 
!
Figure 3.3: Illustration of deletion calling in the SHR/OlaIpcv compared to the 
reference BN genome. 
SHR/OlaIpcv read pairs (dark blue) align with expected span size to the BN 
reference (top black line). SHR/OlaIpcv read pairs that align with span size greater 
than expected are shown as a red curve. The red box represents the region of 
deletion. Brown vertical lines represent illustrative SNPs between the SHR/OlaIpcv 
and BN reference genome; green vertical lines represent short indels. Light blue 
arrow represents a gene in the BN reference. 
 
The majority of deletions (n = 10,401) were less than 1 kb in size, while 3,022 deletions 
were greater than 1 kb (Figure 3.4A), with a maximum deletion size of 1.2 Mb. The 
majority of deleted sequences were repeat elements, as previously found in human genome 
re-sequencing projects (Campbell et al., 2008; Wang et al., 2008). We also found that the 
distribution of the type of repeat in deleted sequences was non-random and depends on the 
size of the deletion, with simple sequence repeats and SINEs mostly represented in 
deletions of less than 270bp, and LINEs and LTRs in deletions of greater than 270bp 
(Figure 3.4B). 
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Figure 3.4: Distribution and the repeat content of SHR/OlaIpcv deletions 
A) Distribution of length of deletions identified in the SHR/OlaIpcv genome 
compared to the BN reference genome B) Rank analysis of repeat content in SHR 
deletions; each line represents a different type of repeat element. Deletions were 
ranked according to size and separated into bins of 500 deletions. Median size of 
deletion within each bin was plotted against content for each type of repeat 
element.  
A!
B!
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To validate SVs, 79 deletions were randomly selected from the SHR/OlaIpcv compared to 
the BN reference, for validation by PCR and, where required, conventional capillary 
sequencing. PCR primers were designed outside the region of the deletion in both the SHR 
and BN genome (Appendix B, Table B.1). The genomic sequence was determined in both 
strains and 75 of the 79 deletions were confirmed. Functioning PCR assays could not be 
designed for the remaining 4 deletions.   
 
Using a 2kb Illumina mate pair library, 835 insertions were predicted in SHR/OlaIpcv 
compared to the BN reference genome (Appendix C, Table C.2). A smaller number of 
insertions were predicted comparative to deletions firstly because of the smaller number of 
paired-end reads from the long insert library, and second because we can only predict 
insertions with a length smaller than the insert size. In addition, prediction of insertions 
from hanging reads is uncertain because hanging reads may arise due to other mechanisms 
such as high sequence variability or reduced sequence quality in one of the reads.  
 
3.2.2.3 Identification of copy number variations 
Using read coverage information across the genome (Campbell et al., 2008), 588 copy 
number variants (CNVs) were predicted between the SHR/OlaIpcv and BN genomes with 
the length ranging from 7 kb to 1.4 Mb (Appendix C, Table C.3). CNV were validated by 
comparing the CNVs predicted using read coverage with a set of 134 CNVs (Appendix C, 
Table C.4) identified by array comparative genome hybridisation (aCGH).  
 
The 588 CNVs detected by read coverage included 101 of the 134 CNVs observed in the 
aCGH data, including the CNV previously reported at the Cd36 locus (Figure 3.5) (Aitman 
et al., 1999; Glazier et al., 2002). Predicted CNVs may be due to regions of collapses in the 
BN reference genome assembly, however only 84 of the 588 CNVs fell within previously 
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predicted regions of collapse in the BN reference assembly (Guryev et al., 2008). 
!
Figure 3.5: Copy number variation in the genomic region containing Cd36 gene 
Log ratio of coverage of the SHR to the BN in 1Mb genomic region (13 to 14 Mb) 
covering Cd36 gene is plotted.  Log ratio of 0 suggests no difference in coverage 
between the SHR and the BN genome. However, the region between the 13.5 to 
13.7 Mb shows significantly negative log ratio, suggesting copy loss in SHR. 
 
3.2.3 Distribution and Density of Variants 
The origin of the laboratory rat has been partially documented (Krinke, 2000; Lindsey, 
1979) with increasing genetic evidence showing that BN is the most divergent amongst the 
inbred laboratory strains (Saar et al., 2008). The term “observed strain difference” (OSD) 
was used to describe the mean density of SNVs between the two strains adjusted for the 
ability to discover each variant. SNP-based OSD index across the genome showed strongly 
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positive correlation with the density of short indels and SVs per Mb (R2 = 0.79; Figure 
3.6). Both SNV and short indels were also correlated with SV density (R2 = 0.35 and R2 = 
0.43 respectively; Figure 3.7). 
!
Figure 3.6: Correlation between SNV and indel density 
Density of sequence variants (SNV and indels) was calculated in 1 Mb windows of 
the BN reference genome, normalised to the number of bases in the window that 
were covered at ≥ 3-fold coverage in the SHR/OlaIpcv sequence.  The SNV density 
shows significantly high correlation with the indel density.  
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Figure 3.7: Correlation of the SNV and the indel density with the SV density 
Density of sequence variants (SNV and indels) was calculated in 1 Mb windows of 
the BN reference genome, normalised to the number of bases in the window that 
were covered at ≥ 3-fold coverage in the SHR/OlaIpcv sequence. While for SV, 
numbers were counted in each 1 Mb window.  A) Correlation between the SNV 
density and the number of SVs in 1Mb region B) Correlation between the indel 
density and the number of SVs in 1Mb region 
 
A!
B!
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The distribution of OSD, normalised over 100 kb windows, shows a striking bimodal 
distribution with the highest peak at low mean SNP density (0 - 0.0004) and a second peak 
at regions with OSD (0.0015), with a long tail with much higher OSD (up to 0.01; Figure 
3.8). The regions of low SNP density are mainly accounted for by three large chromosomal 
regions of near identity between the SHR/OlaIpcv genome and the BN reference genome. 
These three regions, on chromosome 2 (124.6 Mb to 133.8Mb), chromosome 13 (92.2 Mb 
to the telomere (111.1 Mb)) and chromosome 15 (32.8 Mb to 53.4 Mb), each have a mean 
OSD less than 0.00008 and show very low density for all types of genomic variation 
(Figure 3.9).  When looked at SNPs across these three genomics regions using SNP 
genotype data (STAR consortium) and the 28 rat genomes (Chapter 4), no conservation 
was observed across multiple rat strains. In addition these three rat genomic regions did not 
show high conservation with the respective syntenic region in human or mouse genome 
sequences, suggesting that these regions most likely represent most common ancestry of 
these two rat strains.    
!
Figure 3.8: Distribution of SNV density across SHR/OlaIpcv genome 
The SNV density was calculated in 100 kb windows normalised to the number of 
bases in the window that were covered at ≥ 3-fold coverage in the SHR/OlaIpcv 
sequence.  
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Figure 3.9: SNV deserts on chromosome 2, 13 and 15 
Distribution of the SNV density (green), indel density (red) and larger deletions 
(blue inner circle) on chromosomes 2, 13 and 15 of the SHR/OlaIpcv genome. The 
blue outer circle represents the sequence coverage of the SHR/OlaIpcv genome and 
the outermost circle represents chromosomal banding. Innermost red bars represent 
copy number variations. Straight black lines delineate the chromosomal segments 
with near sequence identity between the SHR/OlaIpcv and the BN reference 
genome.  
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3.2.4 Divergence within rat, mouse and human population 
The proportion of single base pair differences provides an estimate of the divergence 
between two strains. The divergence between the SHR/OlaIpcv genome and the BN 
reference genome was 0.0015. The divergence between the reference human genome 
(NCBI build 36.1) and each of the 5 personal genomes sequenced up to 2010 (Ahn et al., 
2009; Bentley et al., 2008; Levy et al., 2007; Wang et al., 2008; Wheeler et al., 2008) was 
in the range of 0.00108 to 0.00145 (Table 3.2). However the divergence, estimated from 
the genotype data, between 11 laboratory mouse strains (Frazer et al., 2007) was in the 
range of 0.00061 to 0.00080 (Table 3.3). This shows that at least between the SHR and the 
BN rat strains the divergence is comparable to the divergence between human individuals 
and these two rat strains show higher diversity than the divergence between the different 
laboratory mice strains analysed. 
 
Table 3.2: Divergence in 5 human genomes 
Genome SNPs (with reference 
Human genome) 
Divergence Reference  
Venter's genome 3,213,401 0.001124 Levy et al. 2007 
Watson's genome 3,322,093 0.001162 Bentley et al. 2008 
Yaruba (African) 4,139,196 0.001448 Wheeler et al. 2008 
YH (Chinese) 3,074,097 0.001076 Wang et al. 2008 
SJK (Korean) 3,439,107 0.001203 Ahn et al. 2009 
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Table 3.3 Divergence in 11 laboratory strains of mouse (adopted from Frazer et al., 
2007)  
   Strains  No. of SNPs  Divergence 
8 classical strains  DBA/2J 1,082,315 0.000726 
 A/J 1,032,854 0.000693 
 BALB/cByJ 946,494 0.000635 
 C3H/HeJ 1,022,933 0.000687 
 AKR/J 1,030,367 0.000692 
 FVB/NJ 998,890 0.000670 
 129S1/SvImJ 1,071,354 0.000719 
 NOD/LtJ 1,045,376 0.000702 
Model of human 
disease 
 NZW/LacJ 1,168,570 0.000784 
 BTBRT+tf/J 911,439 0.000612 
 KK/HlJ 1,190,591 0.000799 
 
3.2.5 Functional significance of coding sequence variants 
3.2.5.1 Variant effect prediction 
The possible functional effects of both small and large variants can be categorised 
according to their location in the BN reference sequence in relation to annotated genes. To 
determine the likely consequences of genetic variation on the gene set ENSEMBL build 54 
was used. As the genomic variants in the coding sequence may explain some of the 
previously observed phenotypic differences between the BN and SHR strains, they were 
prioritised. 
3.2.5.1.1 Single nucleotide variants 
A total of 1,103,149 SNVs were located within the gene region (defined as the exon, intron 
and UTRs) of which the majority were present in non-coding parts of the genes with only 
27,340 SNVs in gene coding regions. Of the SNVs present in the coding region, 11,542 
resulted in the non-synonymous substitution of an amino acid while 15,798 were 
synonymous. Of 11,542 non-synonymous SNVs, a total of 153 resulted in the gain of a 
stop codon and 8 in the loss of a stop codon in the SHR/OlaIpcv compared to the BN 
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reference. A total of 3,358 SNVs were located within splice sites (1-3bp into exons or 3-8 
bp into introns), with 213 of those affecting essential splice sites (the first or last 2 bp of an 
intron) (Table 3.4). 
 
Table 3.4: Classification of SNPs in different categories based on location in the 
genome 
Category  Number of SNVs 
Non synonymous coding   11,142 
Synonymous coding      15,406 
Stop gained    143 
Stop gained at splice site 10 
Stop lost      1 
Stop lost at splice site   7 
Frameshift coding      3 
5’ UTR 2,571 
3’ UTR 6,211 
Essential splice site, non-synonymous coding 20 
Essential splice site, synonymous coding 10 
Essential splice site, 3’ UTR      1 
Essential splice site, intronic  182 
Splice site, synonymous coding   382 
Splice site, non-synonymous coding 380 
Splice site, 5’ UTR  107 
Splice site, 3’ UTR  45 
Splice site, intronic   2,214 
Intronic 1,064,314 
Upstream 143,546 
Downstream 122,556 
Intergenic 2,251,679 
Within mature miRNA 21 
Within non coding gene 1,707 
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3.2.5.1.2 Short insertions and deletions  
A total of 343,243 short indels were predicted in SHR/OlaIpcv of which 629 were present 
in the coding sequences of 771 transcripts from 550 genes. Of 629 indels 562 indels 
resulted in frameshifts in the open reading frame of 483 genes while the length of 67 indels 
was an exact multiple of 3 nucleotides resulting in an in-frame deletion/insertion in 87 
transcripts from 67 genes.  
3.2.5.1.3 Large deletions 
In the SHR/OlaIpcv genome sequence, a total of 60 genes were completely deleted as 
compared to the BN reference genome while 47 genes showed a deletion of one or more 
coding exons. Of the 60 genes which were completely deleted in SHR/OlaIpcv (Table 3.5), 
33 genes were with unknown function, 11 genes encoded ribosomal proteins and one for 
olfactory receptors.  Only 15 of the genes have been assigned distinct rat gene symbols for 
which there was at least a partial functional characterization. Of these 15 genes the 
majority would be expected to code for functional proteins, although some may be 
incorrectly annotated as protein-coding genes in ENSEMBL. Alternatively, there is a high 
possibility that the reads representing these genes remained unmapped due to potential 
errors in the genome assembly. However unmapped reads have not been checked for the 
presence of the transcripts of these genes.  
 
In ENSEMBL, mouse orthologs (one-to-many or many-to-many) were reported for 33 of 
the 60 genes that are completely deleted in the SHR strain.  Mouse knockout models for 
six of the respective mouse orthologs genes (Ybx1, Dstn, Il13ra1, Gapdh, Ppp2ca and Nlk) 
are available. Deletion of these six SHR genes was confirmed by PCR and direct 
sequencing (validation was performed by Catherine Morrissey, a lab scientist in Professor 
Timothy Aitman’s laboratory). Three of the six genes also show very high conservation 
across mammals (>90% amino acid identity). The functional implications of these SHR 
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gene deletions, and their potential effects on cardiovascular and metabolic phenotypes in 
the respective knockout mice are presently unclear, but merit further investigation.  
 
Table 3.5: List of genes completely deleted in SHR/OlaIpcv genome compared to the 
BN reference genome  
Ensembl Gene ID Chromosome 
Gene Start 
(bp) 
Gene End 
(bp) Strand Gene Name 
ENSRNOG00000028931 1 125,924,005 125,924,220 1 
 ENSRNOG00000023058 1 127,524,671 127,528,946 -1 
 ENSRNOG00000020477 1 174,576,031 174,577,363 -1 
 ENSRNOG00000032902 1 175,179,050 175,180,500 -1 Ybx1 
ENSRNOG00000031947 1 185,499,787 185,500,107 1 Rpl36 
ENSRNOG00000018925 1 238,968,938 239,048,197 -1 
 ENSRNOG00000031381 1 258,942,046 258,942,877 1 RGD1561333 
ENSRNOG00000031783 2 54,526,592 54,526,984 -1 Rps15a 
ENSRNOG00000039035 2 76,762,131 76,763,246 1 
 ENSRNOG00000029339 2 189,674,857 189,675,177 1 NP_001025223.1 
ENSRNOG00000030747 2 192,135,618 192,135,830 -1 Rpl38 
ENSRNOG00000025782 2 235,493,531 235,520,334 1 LOC365949 
ENSRNOG00000028021 3 5,696,597 5,697,052 -1 RS13_RAT 
ENSRNOG00000009852 3 69,998,119 69,999,087 1 Olr519_predicted 
ENSRNOG00000036991 3 126,583,094 126,583,405 -1 
 ENSRNOG00000031332 3 158,404,732 158,404,944 1 Rpl38 
ENSRNOG00000029686 4 8,645,371 8,646,045 1 
 ENSRNOG00000029574 4 34,793,785 34,794,576 -1 Rps4x 
ENSRNOG00000031344 5 92,079,075 92,079,551 -1 DPPA3_RAT 
ENSRNOG00000031506 5 152,845,944 152,846,889 1 Ftl1 
ENSRNOG00000036936 5 168,557,300 168,557,611 1 
 ENSRNOG00000040153 6 10,132,918 10,133,937 1 LOC362695 
ENSRNOG00000030349 6 14,577,116 14,577,418 1 
 ENSRNOG00000029751 7 32,398,047 32,398,202 1 RL39_RAT 
ENSRNOG00000029443 7 73,649,396 73,649,566 1 RS29_RAT 
ENSRNOG00000030548 7 91,621,341 91,621,751 1 
 ENSRNOG00000037461 7 106,814,303 106,815,418 -1 
 ENSRNOG00000038545 8 59,639,079 59,639,390 1 
 ENSRNOG00000029377 8 62,132,212 62,132,424 1 Rpl38 
ENSRNOG00000033345 8 93,566,536 93,566,889 1 GBRL2_RAT 
ENSRNOG00000039636 9 17,968,298 17,968,813 -1 
 ENSRNOG00000030807 10 40,444,576 40,445,544 -1 LOC686530 
ENSRNOG00000023563 10 77,751,643 77,752,113 -1 
 ENSRNOG00000020771 10 90,759,106 90,759,567 1 NP_001028857.1 
ENSRNOG00000029311 11 5,434,948 5,435,244 1 Q7M081_RAT 
ENSRNOG00000027686 11 28,383,781 28,384,421 1 LOC363737 
ENSRNOG00000030313 11 48,276,315 48,277,406 1 RGD1559962 
ENSRNOG00000001713 11 73,147,652 73,148,932 -1 NP_665732.2 
ENSRNOG00000001893 11 84,269,897 84,271,800 1 
 ENSRNOG00000028397 12 1,755,995 1,756,775 -1 
 ENSRNOG00000002200 14 10,233,098 10,233,961 1 
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ENSRNOG00000034237 14 33,031,000 33,031,155 -1 Rpl39 
ENSRNOG00000002223 14 55,352,607 55,352,858 1 LOC688386 
ENSRNOG00000038588 14 70,065,067 70,065,375 -1 
 ENSRNOG00000032360 14 96,976,246 96,976,548 1 
 ENSRNOG00000032695 14 97,887,412 97,887,714 1 
 ENSRNOG00000030435 14 97,974,399 97,974,701 -1 
 ENSRNOG00000031625 14 97,975,927 97,976,229 -1 
 ENSRNOG00000032456 14 99,210,932 99,211,234 1 
 ENSRNOG00000031191 14 99,253,806 99,254,108 1 
 ENSRNOG00000033057 16 25,751,194 25,752,195 1 RGD1565735 
ENSRNOG00000011955 17 14,407,615 14,407,959 -1 RLA1_RAT 
ENSRNOG00000033625 17 16,591,884 16,592,216 -1 
 ENSRNOG00000039165 18 45,593,774 45,596,581 -1 Q4JFW4_RAT 
ENSRNOG00000030557 18 50,270,268 50,270,882 1 
 ENSRNOG00000020093 19 36,293,808 36,294,342 1 
 ENSRNOG00000034241 19 55,796,386 55,797,939 1 LOC367277 
ENSRNOG00000000748 20 661,424 661,921 1 LOC296197 
ENSRNOG00000038728 20 7,662,552 7,662,863 1 
 ENSRNOG00000037416 X 145,278,596 145,282,365 -1 Q63290_RAT 
 
3.2.5.2 Gene ontology enrichment 
Gene ontology (GO) analysis was carried out on the 788 distinct genes (Appendix C, Table 
C.5) which fill into one of the following categories; genes which were partially or 
completely deleted in the SHR/OlaIpcv genome, genes which showed stop gain/loss 
variants and the genes which showed frameshifts or inframe indels.  These genes were 
enriched for genes encoding ion transporters (P = 6.51 x 10-06, false discovery rate (FDR) 
= 0.0099) and the gene products localised to the plasma membrane (P = 6.44 x 10-05, FDR 
= 0.087).   
GO analysis of 688 genes which partially or completely overlapped with CNVs showed 
significant enrichment of genes related to i) antigen processing and presentation of peptide 
antigen (P = 2.40 x 10-17, FDR=3.68 x 10-14), ii) regulation of neurological processes (P = 
9.82 x 10-12, FDR=1.51 x 10-8), iii) myeloid leukocyte activation (P =7.07 x 10-12, 
FDR=1.09 x 10-8), iv) response to mechanical stimulus (P =1.16 x 10-10, FDR=1.79 x 10-7), 
and v) regulation of transport (P =1.32 x 10-9, FDR=2.03 x 10-6).   
!
!
91!
!
3.2.6 Genome diversity and distribution of cis-eQTLs 
Large numbers of the expression QTLs (eQTLs) (Hubner et al., 2005; Petretto et al., 2006) 
have been mapped across seven tissues in the BXH/HXB panel of recombinant inbred 
strains derived from SHR and BN parental strains. The eQTLs are genetic loci than have 
been shown by integrated gene expression and linkage analysis to affect the variation in 
expression levels of genes. Cis-eQTLs are caused by genomic sequence variants that reside 
within or close to the gene itself (Cookson et al., 2009; Hubner et al., 2005; Petretto et al., 
2008). This cis–eQTL data was used to explore further how sequence variation correlates 
with variation in gene expression.  
 
A total of 26,754 transcripts on the Affymetrix 230 2.0 rat array could be mapped reliably 
to a unique location on autosomes in the BN reference genome.  Of these 26,754 
transcripts 3,045 represent cis–eQTL genes (with the physical location of the gene within 
10 Mb of the peak of linkage), detected with genome-wide P-value (PGW) of 0.05 and false 
discovery rate (FDR) of 0.05, as previously described (Hubner et al., 2005; Petretto et al., 
2006). 
 
The density of SNPs, short indels and larger deletions (>50bp) in the gene regions, defined 
as the region between the transcription start site (TSS) and the annotated transcript end site 
with 2 kb flanking region upstream and downstream, of all 26,754 genes was estimated. 
The SNP density (Figure 3.10A) and indel density (Figure 3.10B) in cis-eQTL gene 
regions were significantly higher than in non-cis-eQTL gene regions (Mann-Whitney-
Wilcoxon (MWW) test P-value for both comparisons < 2.2x10-16).  In addition only 18.1% 
of cis-eQTL genes overlap with one or more larger deletions compared to 12% of the non 
cis-eQTL genes (Fisher’s exact test P = 2.02 x 10-19). Cis-eQTL gene regions were 
therefore significantly enriched for SNPs, short indels and larger deletions, suggesting that 
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some of these variants may have functional effects on gene expression. 
 
 
!
Figure 3.10: SNV and indel enrichment in cis-eQTL gene regions 
  
A) Box-plot showing SNV density in gene regions containing cis-eQTL genes 
compared to regions containing only non cis-eQTL genes. B) Box-plot showing 
indel density in cis-eQTL-containing gene regions compared to non cis-eQTL-
containing gene regions. Boxes and whiskers indicated inter-quartile range while 
the horizontal line in the box represents median.  
 
 
 
Similarly, significant enrichment for SNV was also observed within promoter regions 
(defined here as 5 kb up and downstream of the TSS) of cis-eQTL genes as compared to 
the promoter regions of non cis-eQTL genes (MWW test P < 2.2 x 10-16; Figure 3.11). 
Interestingly, the SNP density was highest in the 1 kb upstream of the TSS and fell 
inconsistently further upstream of the TSS (Figure 3.12). However at a distance 10 kb or 
more downstream of the promoter, the SNP density fell more consistently, though not to 
the levels seen in the regions of non-cis eQTL genes. 
A! B!
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Figure 3.11: SNV and indel enrichment in cis-eQTL promoter regions 
 
Box plot showing SNV density in 10 kb region of promoter, centred on 
transcription start site, of cis-eQTL genes and non cis-eQTL genes. Boxes and 
whiskers indicated inter-quartile range while the horizontal line in the box 
represents median. 
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Figure 3.12: SNV density in the promoter region 
The graph shows distribution of difference in SNP density between cis-eQTL genes 
and non-cis-eQTL genes in 40 kb region surrounding the transcription start site 
!  
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3.3 Discussion 
3.3.1 Sequencing and variant calling 
The SHR/OlaIpcv genome has been sequenced at 10.7X coverage and 3.6 million SNVs 
were identified between the SHR/OlaIpcv and the BN reference genome. Using two 
independent data sets, de novo sequencing of 66kb of the BN and the SHR/OlaIpcv 
genomic DNA and the STAR genotype (Saar et al., 2008), estimated that the true positive 
rate was more than 99% for SNVs between the SHR/OlaIpcv genome and the BN 
reference genome.  Sensitivity and specificity of SNV calling was increased with the 
increase in average coverage for SHR genome sequence (see Chapter 4, section 4.2.3). 
Though the SHR/OlaIpcv strain is an inbred rat strain, a small but finite number (1.41%) of 
SNVs were heterozygous. The average read depth for the heterozygous SNP was 24X 
while average genome coverage was 10.7X suggesting that heterozygous SNPs might be 
the result of CNV regions. However when considering the overlap between the 
heterozygous SNP and CNV regions only 30.38% of the heterozygous SNPs overlapped 
with CNV regions suggesting that there may be multiple explanations for the observed 
heterozygosity in the SHR/OlaIpcv genome. Firstly this may be true heterozygosity either 
due to incomplete fixation during inbreeding or de-novo mutations in the SHR/OlaIpcv 
strain after complete fixation. Secondly, this may be due to copy number variants between 
the SHR/OlaIpcv and the BN reference genomes. Reads from regions of segmental 
duplications in the SHR/OlaIpcv sequence are bound to map to a single copy in the BN 
reference genome, which appears likely from the increased read depth observed at 
heterozygous SNV positions. Similar observations have been reported previously at 
heterozygous SNP locations (Sudbery et al., 2009) in mouse models. Thirdly, assembly 
errors in the BN reference genome such as the collapse of recent segmental duplications in 
the BN assembly may have resulted in near-identical reads for SHR/OlaIpcv being mapped 
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to these collapsed regions and resulting in heterozygosity. 
 
MAQ, the only software available and specifically designed for mapping and variant 
calling using next generation sequencing data at the time of the analysis of the 
SHR/OlaIpcv genome, was not capable of mapping single end reads with gaps and thus did 
not permit indel calling from single end reads. However, using MAQ paired-end reads 
could be mapped with gaps thus indels could be identified from paired end reads. 
Furthermore, paired end sequencing provides the advantage over single fragment 
sequencing in being able to predict SVs larger than 50bp. Using paired end and/or mate 
pair reads, insertions of smaller than the insert size can be predicted, thus multiple large 
insert-size libraries in this study permitted prediction of insertions that are smaller than the 
size of the insert (~2kb). A total of 13,438 large deletions were predicted in the 
SHR/OlaIpcv genome compared to the BN reference genome, of which 73.7% deletions 
were comprised of repeat elements. It has been shown that retrotransposons play a role in 
the regulation of gene expression (Faulkner et al., 2009), thus the identification of deletions 
or insertions of repeat elements is of particular interest as the specific difference in 
expression of protein coding genes between the SHR/OlaIpcv and the reference BN may 
therefore be influenced by the action of expressed repeat elements. 
 
A total of 588 CNVs were identified, the smallest of which was 7 kb in length. Using 
aCGH only 134 CNVs were predicted between the SHR/OlaIpcv and the BN strains, the 
smallest of which was 22 kb. Of these 134 CNVs, 101 CNVs were also predicted using 
NGS data.   A large proportion of CNVs predicted using NGS data did not overlap with the 
aCGH data mainly because of the larger proportion (244 of 588) of CNVs detected using 
NGS data were smaller than 22 kb in length, which is the smallest CNV that can be 
detected using aCGH.  The present platform (NGS) thus provides better scope for CNV 
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prediction than the current generation of aCGH platforms for the rat. By combining various 
algorithms to predict SNV, short indels, SV and CNV, most but not all of the genomic 
variants in the SHR genome compared to the BN reference have been detected. However, 
current NGS data and the analysis technology were unable to detect the medium sized 
deletions (15 to 50 bp) and large insertions in the SHR genome.  
 
The BN reference sequence was sequenced with the pooled library strategy and contains 
only limited amounts of finished sequence (Gibbs et al., 2004). The errors in the BN 
genome assembly may therefore affect the accuracy of all types of genomic variants (SNV, 
short indels, SV and CNV) between SHR/OlaIpcv and the BN reference genome. The 
potential false positives due to base call errors in the BN reference genome was estimated 
form discordant BN genotypes in STAR SNPs, while the likely sources of errors in SV and 
CNV were filtered out by removing SVs that were detected around BN assembly gaps and 
by highlighting CNVs which overlap with reported regions of collapse or over prediction 
in the BN assembly. 
3.3.2 Distribution and density of sequence variants 
A strong correlation was observed between the SNV density, indel density and the number 
of SVs per Mb. These correlations most likely due to biological reasons rather than 
technical artefacts in variant calling as paired end reads which resulted in SV calling would 
not have been mapped to the highly divergent regions of the genome between SHR and 
BN. Furthermore, correlation between the SNV density and indel density may not be due 
to the artefacts in read mapping as local realignment has been performed around the indels 
which improves the read alignment. The simplest explanation would be that these genomic 
variants were present between the different founder populations of SHR and BN and while 
selective derivation of the SHR strain for the hypertensive phenotypes these variants were 
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fixed in the SHR genome. However, the correlation would be related to other processes, 
for example that the mechanism for generating structural variation is mechanistically 
correlated with changes in the single nucleotide mutation rate. 
 
The presence of large runs of near identity, referred to as “SNV deserts” (Miller et al., 
2001), on chromosomes 2, 13 and 15 most likely represents recent common ancestry of 
these two strains. Other explanations for SNV deserts may due to the introgression of BN 
chromosomal segments at an early stage in the derivation of current Wistar-derived stocks. 
SNV deserts have been identified previously between Wistar-derived strains (of which 
SHR is one) and the BN reference genome (Saar et al., 2008). Finding similar results 
which were shown previously in SHR/OlaIpcv genome sequence confirms the hypothesis 
that these SNV deserts may represent recent introgression of BN genomic DNA during the 
derivation of Wistar-derived strains.  
 
The estimated sequence diversity between the SHR/OlaIpcv and the BN reference genome 
was comparable to the diversity observed in human populations. Rat strains are derived 
from a single species, in contrast, laboratory mouse strains have been derived from isolated 
sub-species in the mouse and as a result mouse show a complex pattern of diversity 
between any two strains. Though rat strains are derived from a single species, the 
SHR/OlaIpcv and BN genomes show higher diversity than mouse strains and show a 
smooth distribution of diversity outside the three large regions of close sequence identity. 
3.3.3 Genome diversity and regulation of gene expression 
The extensive gene expression and eQTL datasets generated in the SHR/OlaIpcv x BN 
strain combination (Hubner et al., 2005; Petretto et al., 2006) permits a preliminary 
analysis of the functional significance of sequence variations identified between the 
SHR/OlaIpcv and the BN genomes. The density of SNPs, indels and SVs was found to be 
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significantly higher in genomic regions containing cis-eQTL genes than in regions that 
contained non-cis-eQTL genes. An increase in the SNP density in the region of cis-eQTL 
genes has previously been reported in yeast, although this was restricted to the region 
immediately upstream of the TSS. In rats high sequence diversity across the entire regions 
of cis-eQTL genes was observed, with only modest enrichment in the immediate vicinity 
of the TSS. The strong association observed between SNP density and regions containing 
cis-eQTLs is consistent with previous observations of high sequence diversity in cis-eQTL 
regions in the mouse (Doss et al., 2005), and with the view that sequence variants in the 
vicinity of cis-eQTL genes are likely to have functional effects on inter-strain variability in 
gene expression. 
3.3.4 The functional significance of the detected genomic variants  
The SHR is a model of spontaneous hypertension while BN has been used as a 
normotensive control in many pQTL mapping experiments, and also for deriving the 
HXB/BHX RI panel. 
Genomic variant data between these two strains provides a unique resource to investigate 
genetic differences which influence the whole organism phenotype. Genetic differences in 
the coding region of the genome may have a major effect on the phenotypic differences, 
hence these variants were prioritised. A total of 788 genes were affected by major coding 
sequence changes which included deletion of genes, frameshift mutations and stop gain or 
loss mutations. Strikingly, these genes were enriched for genes encoding proteins involved 
in ion transport and localised in the plasma membrane. In addition, 688 genes which 
overlapped with the CNVs showed enrichment for genes with immunological, neurological 
or mechanical functions. The known metabolic, cardiovascular and neurobehavioral 
phenotypic differences between SHR and BN (Okamoto, 1972) suggests that the genomic 
variants in these genes may be causally related to disease phenotype manifested by 
!
!
100!
!
SHR/OlaIpcv.  
 
Previously, integration of gene expression data with QTL linkage mapping and 
physiological studies in experimental crosses and congenic strains led to the identification 
of CNV in the rat Cd36 gene as a cause of Cd36 deficiency, insulin resistance, 
dyslipidaemia and hypertension in the SHR strain (Aitman et al., 1999; Pravenec et al., 
2008a; Pravenec et al., 2001). In this study, sequence analysis also revealed CNV in SHR 
Cd36 gene, confirming previous findings (Glazier et al., 2002). Identification of CNV in 
the Cd36 gene also supports the hypothesis that defects in membrane transport genes, such 
as Cd36, can play a significant role in the development of cardiovascular and metabolic 
phenotypes in SHR. It also highlights the potential functional significance of other CNVs 
detected in the SHR/OlaIpcv genome.   
 
By combined linkage and eQTL analyses, Osteoglycin (Ogn) has been identified as a 
regulator of left ventricular mass in the SHR/OlaIpcv strain (Petretto et al., 2008). The Ogn 
gene shows many sequence variants in the 5' UTR, exon 3 and the 3' UTR of SHR along 
with two insertions in introns and 2bp and 47 bp deletions in the 3' UTR. All of the Ogn 
mutations and indels were detected in the SHR/OlaIpcv genome sequence except the 47 bp 
deletion. The 47 bp deletion was not detected because of the inherent limitation of NGS 
data to detect indels of size range 15-50bp. Several of the likely causal polymorphisms in 
the promoter or coding region of Gstm1 (McBride et al., 2005) and Srebf1 (Pravenec et al., 
2008b), which were positionally cloned as QTL genes in the SHR or the related SHRSP 
strain (Aitman et al., 2008), were also detected in this study. This shows the ability of NGS 
data to identify mutations in known disease genes in the SHR strain and also suggests new 
candidate genes for the cardiovascular and metabolic phenotypes manifested by the SHR 
strains.  
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In the gene ontology enrichment analysis, the 42 genes which were involved in ion 
transport included two genes encoding calcium channels and a gene encoding a potassium 
channel. Cacna1d, a gene encoding a Cav1.3 (α1D) L-type Ca2+ channel, exhibited a 4 bp 
deletion at the start of exon 11 that includes three base pairs of the exon and one base pair 
of the splice site. The Cacna1d gene also shows a mutation in an essential splice site 
between exons 15 and 16. These mutations are likely to reduce greatly or even abolish the 
function of the encoded gene product. Cav1.3 (α1D) is a key regulator of calcium 
homeostasis, electrical activity and maintenance of the normal rhythm of the heart 
(Chahine et al., 2008; Mancarella et al., 2008), and in Cacna1d knockout mice, gene 
deletion was shown to be associated with hypoinsulinaemia, glucose intolerance, and the 
decreased number and size of pancreatic islets (Namkung et al., 2001). It is therefore of 
interest that genome wide association analysis in humans has shown an association 
between a polymorphism in the Cacna1d gene and type 2 diabetes (Sookoian et al., 2009) 
and suggests that investigation of the functional consequences of Cacna1d mutations in the 
SHR/OlaIpcv strain would be worthwhile.  
 
In the Cacna1a gene, which encodes the voltage-dependent Cav2.1 (α1A), P/Q-type Ca2+ 
channel, a single base pair deletion was identified which resulted in a frameshift. This 
calcium channel is expressed in vascular smooth muscle cells, is important for the 
contraction of renal resistance vessels (Andreasen et al., 2006), and could therefore be 
important in blood pressure regulation in the SHR/OlaIpcv strain, particularly given that 
calcium homeostasis is known to be dysregulated in the SHR smooth muscle (Manso et al., 
1999; Wilde et al., 1994).  
 
The SHR gene Kcnj1, which encodes the inwardly-rectifying potassium channel, contains 
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three different single base deletions in its coding region. The impact of these mutations on 
hypertension in SHR/OlaIpcv is of particular interest as the human ortholog has been 
associated with systolic or diastolic blood pressure in human genome-wide association 
studies (Tobin et al., 2008). 
 
Recent data from human genetic studies have shown that insertion of retrotransposons in 
regulatory regions or introns can markedly reduce expression of the primary transcript 
(Bilusic et al., 2004; Faulkner et al., 2009; Ustyugova et al., 2006). A ~6 kb intronic 
deletion of a long terminal repeat (LTR), class II endogenous retroviruses (ERV-Class II), 
was identified in the SHR Echdc2 gene. The protein product of the Echdc2 gene catalyzes 
the second step in the physiologically important beta-oxidation pathway of fatty acid 
metabolism (Agnihotri and Liu, 2003). This gene, which has no mutations in the coding 
region, is over-expressed by up to 31-fold in various SHR tissues compared to BN.Lx 
(Hubner et al., 2005). Similarly, a deletion of a LINE element was identified between the 
4th and 5th exon of the Cyp4a8 gene, a hypertension candidate gene that shows 2.5 fold 
higher expression in the SHR kidney than in BN.Lx (Dunn et al., 2008; Hubner et al., 
2005; Yamaguchi et al., 2002). The recent finding in human genetic studies warrants 
investigation of the association between alterations in gene expression and the deletion of 
ERV or LINE elements in respective genes in the SHR genome and their potential role in 
cardiovascular and metabolic phenotypes. 
 
The 3,642,090 polymorphisms, along with 343,243 indels, 19,572 SVs and 588 CNVs 
observed between the SHR/OlaIpcv and Brown Norway genomes provide an almost 
complete catalogue of genomic differences between these two strains with strikingly 
different physiology, particularly in cardiovascular phenotype. The sequence of SHR 
genome will provide the starting point for complete functional elucidation of variants 
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between two individuals at the molecular level, and thus provide an unprecedented tool for 
elucidation of the extensively studied pathophysiological phenotypes manifested by SHR. 
SHR is one of the many rat models of hypertension. In the past century multiple rat models 
to study various forms of hypertension have been developed along with the control strains 
from various different founder stock and colonies. Genome sequencing and comparative 
analysis of these models of hypertension may provide additional insights in to the various 
molecular mechanisms behind various forms of hypertension.  
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Chapter 4: Next Generation Sequencing of 
28 laboratory rat strains representing 
disease phenotypes  
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4.1 Introduction  
In the past century, more than 500 laboratory rats have been derived to study various 
pathophysiological traits. Scores of pQTLs have been mapped in these rat strains to 
identify genomic loci underlying various pathophysiological phenotypes. Laboratory rat 
strains have been predominantly studied for cardiovascular and metabolic phenotypes as 
more than 50% of the pQTLs mapped in laboratory rat strains have been mapped for 
cardiovascular and metabolic phenotypes (Laulederkind et al., 2013). Although large 
numbers of pQTLs have been mapped in rat strains, identification of underlying disease 
genes and/or variants has been relatively slow. To date, relatively small numbers of genes 
have been positionally cloned in laboratory rat models for these phenotypes (Aitman et al., 
2008). Slow progress in disease gene identification is in part, due to the lack of genome 
sequence availability and lack of a comprehensive catalogue of genomic variants in widely 
used laboratory rat strains. While significant efforts have been made to derive rat disease 
models and map disease phenotypes, limited efforts were made to obtain near complete 
catalogue of genomic variants in classical laboratory rat strains. The current catalogue of 
genomic variants in rat strains contains only 45,718 SNPs in dbSNP v125 (Sherry et al., 
2001) which includes 20,238 SNPs genotyped in 167 rat strains by the STAR genotyping 
consortium (Saar et al., 2008). Furthermore, current catalogues of genomic variants in rats 
are biased towards single nucleotide changes and limited or no data is available for other 
types of variants such as short indels, structural variants and copy number variants.   
With the advent of NGS technologies, whole genome sequences of multiple individuals is 
possible to achieve in a relatively short period of time and within a reasonable cost. 
Recently the genomes of 1000 humans have been sequenced using NGS technology, which 
provided valuable insights in human evolution (Abecasis et al., 2012). Layered on this, 
NGS technology has made it feasible to produce genome sequence data for many model 
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organisms including; Mus Musculus, Arabidopsis, C. Elegance (Gan et al., 2011; Keane et 
al., 2011). This demonstrates the wider adoption of NGS technologies for sequencing 
whole genome sequences and subsequent availability of high quality genomic variant data 
generation. In this study, the genomes of 28 rat strains have been sequenced using NGS 
platforms and an extensive catalogue of high quality genomic variants has been generated.     
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4.2 Results  
4.2.1 Sequencing and mapping statistics of 28 rat genomes 
Using high throughput sequencing platform, the genomes of 28 rat strains were sequenced. 
Genomes of 26 rat strains were sequenced on Illumina sequencing platforms while two 
strains were sequenced on SOLiD sequencing platform. Of the 26 rat strains sequenced on 
the Illumina platform, 23 strains were sequenced on Illumina HiSeq 2000 using paired end 
sequencing technology with insert size ranging from 350-500bp and read lengths of 100bp.  
The genome of the GK/Ox rat was sequenced on Illumina GAII with read lengths of 50bp 
while the genome of the SHRSP/Gla strain was sequenced partly on Illumina GAII and 
partly on Illumina hiseq-2000 with read lengths ranging from 36bp to 100bp. The genome 
of SHR/OlaIpcv described in previous chapter was sequenced with ~10.7 fold average 
coverage. To achieve the average coverage of 20X for SHR, sequencing libraries generated 
in previous study were further sequenced on Illumina HiSeq 2000. Remaining two 
genomes, BN/Mcwi and BN.Lx, were sequenced on SOLiD sequencing platform.  
On average 850 million reads were sequenced per strain with a range of 260 million reads 
(WKY/NHsd) to 2.7 billion reads (BN/Mcwi).  Genomes sequenced on the Illumina 
platform had higher mapability with on an average 92.88% of the reads (range: 86.58% to 
95.14%) successfully mapping to the BN reference genome (Gibbs et al., 2004), while in 
BN.Lx and BN/Mcwi, both genomes sequenced on the SOLiD sequencing platform, 
respectively 62.95% and 65.74% of reads were mapped to the BN reference genome. The 
percentage of clonal reads varied considerably, WKY/Gla contained only 0.34% clonal 
read while the percentage of clonal reads in BN/Mcwi was 30.45% (Table 4.1).  After 
removing clonal reads average coverage for all the strains was more than or close to 20X 
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except for two strains BBDP/Wor and WKY/NHsd (10X and 11.7X respectively; Table 
4.1).   
Nearly 99% of the reference genome was covered with at least one read for the rat strains 
sequenced on Illumina sequencing platform, except for the 2 strain sequenced with 
coverage of ~10X, in which 98% of the reference genome was covered with at least one 
read.  However, in case of both the genomes sequenced on the SOLiD sequencing platform 
only 94% of the genome was covered with the at least one read even though average 
coverage was more than 20X for both the genomes (Figure 4.1).    
4.2.2 Identification of genomic variants 
4.2.2.1 Identification of single nucleotide variants (SNVs) 
Using GATK (DePristo et al., 2011; McKenna et al., 2010), a total of 13,875,209 
polymorphic SNVs were identified across 28 genomes. After filtering potential false 
positive calls using a Gaussian mixture model (GMM), 9,805,978 SNVs were retained. Of 
the 9,805,978 polymorphic loci at 140,638 loci, it was observed that BN/Mcwi sequenced 
on the SOLiD sequencing platform differed from the BN reference genome, both of which 
were sequenced from the same animal, thus suggesting these positions represent base call 
errors in BN reference genome. All polymorphic loci where the BN reference genome and 
the BN/Mcwi genome, sequenced on SOLiD sequencing platform, differed were filtered 
out. This resulted in a final set of 9,665,340 high quality SNVs (Table 4.2), however at 
839,691 positions, the BN/Mcwi allele was not determined by re-sequencing, possibly due 
to low coverage or poor read mapping and/or base quality. The final SNV dataset may 
therefore contain a small proportion (0.001%) of false positives due to base call errors in 
the reference BN genome. It was found that 98.3% of SNV calls were homozygous and 
1.7% were heterozygous, the latter most likely arising from (i) a combination of true 
heterozygote loci due to incomplete fixation of the inbred strain, and (ii), false positive 
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calls due to regions of copy number variation, sequencing errors and mapping errors in 
highly repetitive genomic regions, as previously described (Atanur et al., 2010; Keane et 
al., 2011) and in chapter 3, section 3.2.2.2 of this thesis.     
Table 4.1: Sequencing and mapping statistics 
Rat!strain! No! of! reads!sequenced!!
Number! of!
reads!mapped!
Mappi
ng!%!
Clonal!
reads!!
%!
Clonal!
reads!
Gb! of!
bases!
mapp
ed!
Average!
Coverage!
ACI/EurMcwi! 1,057,981,450! 976,516,552! 92.30! 42,915,522! 4.39! 86.64! 33.69!
BBDP/Wor! 293,769,506! 279,485,544! 95.14! 9,452,015! 3.38! 25.68! 9.99!
BN.Lx! 1,194,012,072! 751,643,323! 62.95! 148,486,415! 19.75! 58.4! 22.71!
BN/Mcwi! 2,766,955,154! 1,818,911,214! 65.74! 553,835,567! 30.45! 58.59! 22.78!
F344/NCrl! 807,260,796! 764,245,118! 94.67! 47,890,477! 6.27! 65.13! 25.33!
FHH/EurMcwi! 706,547,732! 661,201,280! 93.58! 53,808,903! 8.14! 57.98! 22.55!
FHL/EurMcwi! 986,233,360! 928,657,360! 94.16! 214,929,169! 23.14! 53.25! 20.71!
GK/Ox! 1,824,818,348! 1,735,861,882! 95.13! 223,952,868! 12.90! 75.25! 29.26!
LE/Stm! 643,508,550! 598,703,340! 93.04! 22,499,030! 3.76! 56.11! 21.82!
LEW/NCrlBR! 650,585,320! 615,396,175! 94.59! 50,795,986! 8.25! 51.06! 19.86!
LEW/Crl! 885,519,518! 828,855,633! 93.60! 34,170,356! 4.12! 66.3! 25.78!
LH/MavRrrc! 629,817,964! 586,103,284! 93.06! 13,960,692! 2.38! 55.84! 21.71!
LL/MavRrrc! 668,789,966! 617,762,408! 92.37! 22,756,757! 3.68! 58.04! 22.57!
LN/MavRrrc! 638,576,874! 594,150,962! 93.04! 13,867,637! 2.33! 56.54! 21.99!
MHS/Gib! 734,735,736! 690,722,195! 94.01! 27,051,731! 3.92! 64.68! 25.15!
MNS/Gib! 648,339,780! 612,332,705! 94.45! 26,009,806! 4.25! 57.26! 22.27!
SBH/Ygl! 812,184,374! 748,448,731! 92.15! 70,312,719! 9.39! 65.76! 25.57!
SBN/Ygl! 615,582,016! 547,954,754! 89.01! 45,005,836! 8.21! 47.17! 18.34!
SHR/NHsd! 770,620,184! 728,537,822! 94.54! 59,196,933! 8.13! 61.25! 23.82!
SHR/OlaIpcv! 1,204,076,216! 1,082,937,895! 89.94! 82,366,393! 7.61! 52.72! 20.5!
SHRSP/Gla! 960,854,418! 831,940,735! 86.58! 46,399,302! 5.58! 70.03! 27.23!
SR/Jr! 622,068,284! 586,024,824! 94.21! 32,978,464! 5.63! 50.28! 19.55!
SS/JrHsdMcwi! 673,314,546! 598,841,445! 88.94! 31,748,140! 5.30! 55.82! 21.71!
SS/Jr! 656,546,452! 614,309,167! 93.57! 44,421,838! 7.23! 51.42! 19.99!
WAG/Rij! 615,056,794! 580,095,352! 94.32! 16,503,950! 2.85! 53.58! 20.84!
WKY/Gla! 755,030,534! 705,340,639! 93.42! 2,384,205! 0.34! 68.17! 26.51!
WKY/NHsd! 260,200,796! 235,139,204! 90.37! 26,938,885! 11.46! 30.02! 11.67!
WKY/NCrl! 805,602,056! 762,025,447! 94.59! 40,114,965! 5.26! 63.77! 24.8!
Average! 853,163,886! 752,933,750! 90.84! 71,598,377! 7.79! 57.74!
! 
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Figure 4.1: Proportion of genome covered at various read depths   
 
Cumulative coverage distribution was calculated using read depth at each base after 
removing clonal reads for each strain independently. The lines parallel to the ‘y 
axis’ and the lines showing the steep slope indicate even coverage throughout the 
genome while the lines parallel to ‘x axis’ and the lines with mild slope indicate 
uneven coverage throughout the genome.  Irrespective of the overall coverage 
almost all the strains show even coverage throughout the genome with the 
exception of ACI/EurMcwi (dark blue line) and SHRSP/Gla (light green line).    
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4.2.2.2 Identification of short indels 
Across the 28 rat strains, a total of 5,102,862 short indels were identified of which 
3,715,882 indels were retained after filtering for potential false positives using GMM 
(DePristo et al., 2011). At 180,604 positions, the BN/Mcwi allele (sequenced on SOLiD) 
differed from the BN reference allele, suggesting base call error in the BN reference 
genome hence these sites were removed. After the filtering of potential BN reference 
errors, there were 3,502,117 high quality indels retained (Table 4.2). However, in the final 
set of 3,502,117 indels the BN/Mcwi allele (sequence on SOLiD) was not determined at 
479,974 loci, thus the indel dataset may still contain small proportion of false positives due 
to errors in the BN reference genome.  
4.2.2.3 Identification of structural variants (SVs) 
Structural variants (SV), which included large deletions (>=100bp), insertions, inversions 
and translocations, were identified in the 26 rat strains that were sequenced on the Illumina 
platform using BreakDancer-1.2 (Chen et al., 2009). Furthermore, large deletions were 
identified using an in-house Perl script as described in chapter 2, section 2.7.1. A total of 
555,419 SVs were identified using BreakDancer-1.2 (Appendix D, Table D.1 – D.26), 
while an in-house Perl script identified a total of 264,041 large deletions (Appendix D, 
Table D.27).  On average, there were 85.26% large deletions predicted using an in-house 
Perl script overlapped with the large deletions predicted using BreakDancer.  
4.2.2.4 Identification of copy number variants (CNVs) 
Copy number variations (CNVs) in the 26 rat strains sequenced on the Illumina platform 
were predicted using CNVnator (Abyzov et al., 2011). A total of 897,217 CNVs were 
identified in 26 rat strains (Table 4.2, Appendix D, Table D.28 – D.53), which included 
716,263 deletions and 180,854 duplications.    
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Table 4.2: Genomic variants identified in 27 rat strains 
Rat!strain! Number! of!SNVs*!
Number!of!
Indels*!
Number! of!
structural!
variants*!
Number! of!
copy!
number!
variants*!
ACI/EurMcwi! 3,607,275! 1,168,780! 14588! 30,962!
BBDP/Wor! 3,322,410! 1,131,697! 23344! 27,449!
BN.Lx! 51,938! 45,404! NA! NA!
F344/NCrl! 3,433,241! 1,132,993! 31,555! 37,222!
FHH/EurMcwi! 3,471,696! 1,170,337! 17,344! 39,062!
FHL/EurMcwi! 3,422,550! 1,117,039! 9,736! 28,494!
GK/Ox! 3,584,504! 1,147,996! 52,005! 61,123!
LE/Stm! 3,485,480! 1,152,163! 15,512! 34,044!
LEW/NCrlBR! 2,966,945! 1,014,796! 27,779! 33,028!
LEW/Crl! 2,941,368! 1,002,364! 29,915! 38,894!
LH/MavRrrc! 3,459,239! 1,189,791! 17,628! 34,115!
LL/MavRrrc! 3,419,697! 1,177,989! 15,855! 34,842!
LN/MavRrrc! 3,406,103! 1,171,795! 16,373! 34,344!
MHS/Gib! 3,270,047! 1,112,526! 19,183! 35,162!
MNS/Gib! 3,278,667! 1,123,980! 18,034! 35,298!
SBH/Ygl! 3,461,088! 1,134,320! 11,912! 29,526!
SBN/Ygl! 3,334,857! 1,078,851! 8,435! 29,043!
SHR/NHsd! 3,795,348! 1,222,619! 32,695! 38,621!
SHR/OlaIpcv! 3,832,318! 1,276,189! 10,397! 40,935!
SHRSP/Gla! 3,735,521! 1,174,933! 13,287! 21,083!
SR/Jr! 3,421,364! 1,140,725! 26,707! 34,500!
SS/JrHsdMcwi! 3,383,380! 1,136,032! 9,629! 23,466!
SS/Jr! 3,377,708! 1,110,653! 27,659! 35,083!
WAG/Rij! 3,167,781! 1,084,318! 37,616! 36,677!
WKY/Gla! 3,819,860! 1,234,622! 11,310! 39,607!
WKY/NHsd! 3,877,157! 1,313,104! 37,948! 24,920!
WKY/NCrl! 3,718,449! 1,250,041! 30,283! 39,717!
* In comparison with the BN reference genome 
4.2.3 Validation of genomic variants 
Sensitivity and specificity of variant call in SHR genome with increased coverage was 
evaluated using two data sets as described in Chapter 3, section 3.2.2.1. The two datasets 
were 108 SNVs predicted in the 66kb genomic region and the 20,283 SNPs genotyped in 
multiple rat strains by the STAR consortium. Of the 108 SNVs predicted using capillary 
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sequencing 106 SNVs were predicted in SHR with no false positives thus increasing 
sensitivity to 98.15%. Of 13,672 STAR genotypes which differed between SHR/OlaIpcv 
and the BN reference genome 13,431 were predicted to be variable between SHR/OlaIpcv 
and the BN reference genome using SHR genome with increase coverage (20X) while all 
6,461 alleles which were identical between two strains were predicted to non-variable. 
Thus the sensitivity and specificity of SNV calls was increased from 97.96% and 99% in 
10.7X SHR genome to 98.56% and >99.99% respectively in SHR genome sequenced with 
20X coverage.        
Additionally, sensitivity and specificity of the variant calls was assessed by conventional 
capillary sequencing. DNA sequences of 13 bacterial artificial chromosomes (BACs) 
derived from the LE/Stm strain were sequenced using a conventional capillary sequencing 
platform which provided approximately 2Mb control genomic sequence. By comparing the 
LE/Stm BAC sequences with the BN reference sequence, 3,382 SNVs and 1,211 indels 
were identified between LE/Stm and the BN reference genome in a 2Mb control region. In 
same genomic region, 3,120 SNVs and 1,120 indels were identified between the LE/Stm 
strain sequenced on the Illumina platform and the BN reference genome. A total of 3,108 
SNVs and 1,078 indels were identified as overlapping between ~2Mb of the LE/Stm 
genomic region sequenced on Illumina platform and capillary sequencing. The estimated 
false positive and false negative rate for SNV calls in the LE/Stm strain sequenced on the 
Illumina platform was 0.38% and 8.1% respectively, while indels were estimated to give 
3.75% false positives and 10.98% false negatives. Thus overall accuracy of assigning a 
reference allele or alternate allele to each and every individual locus in the 2Mb region of 
the LE/Stm strain was 99.9%. These estimates can be scaled to SNV and indel calls in the 
remaining 25 rat strains sequenced on the Illumina platform as variants were called in all 
the strains simultaneously using same variant predicting software. 
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4.2.4    Functional consequences of genomic variants  
4.2.4.1 Functional consequences of SNVs 
The functional consequences of genomic variants were predicted using variant effect 
predictor v 2.1 (McLaren et al., 2010) on ENSEMBL rat genome annotation version 66. 
Out of the 9,665,340 identified SNVs, 99.29% of these were identified within the non-
protein coding part of the genome which included intergenic, intronic regions and a 5kb 
region upstream and downstream to the gene. Only 69,229 (0.71%) of the SNVs were 
located in the protein coding part of the gene, of which, 39,313 were synonymous coding 
(SC) variants and 29,916 were non-synonymous coding (NSC) variants (Table 4.3). Out of 
29,916 NSC variants, 428 variants resulted in gain of stop codon, 27 variants resulted in 
loss of stop codon while the remaining 29,461 NSC variants resulted in substitution of 
amino acids in 14,907 transcripts (11,012 genes), see Table 4.3 for summary. 
4.2.4.2 Polyphen analysis of NSC variants 
The functional effects of NSC variants that did not result in stop gain or stop loss 
mutations were accessed using Polyphen (Adzhubei et al., 2010). It was found that a total 
of 5,967 transcripts contained at least one deleterious SNV while all the NSC SNVs in 
remaining transcripts were identified as either neutral or as having an unknown effect.         
4.2.4.3 Functional consequences of indels 
Out of the 3,502,117 indels identified across the 27 rat strains, 99.86% of them were found 
to reside in the non-coding part of the genome (Table 4.4). A total of 3,726 indels were 
located in the coding portion of the genes, of which, 2,366 indels resulted in frameshift in 
at least one of the rat strains, while lengths of 1,360 indels were either exactly three or 
multiple of three, thus resulting in an in-frame deletion or insertion of one or more amino 
acids. 
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Table 4.3: Functional consequences of SNVs 
Category! Number!of!SNVs! Percentage!
INTERGENIC! 6,180,484! 63.2455!
INTRONIC! 2,466,088! 25.2357!
UPSTREAM! 509,981! 5.2187!
DOWNSTREAM! 501,050! 5.1273!
3PRIME_UTR! 24,427! 0.2500!
5PRIME_UTR! 5,668! 0.0580!
NON_SYNONYMOUS_CODING! 29,461! 0.3015!
SYNONYMOUS_CODING! 39,313! 0.4023!
STOP_GAINED! 428! 0.0044!
STOP_LOST! 27! 0.0003!
ESSENTIAL_SPLICE_SITE! 426! 0.0044!
SPLICE_SITE! 7,104! 0.0727!
CODING_UNKNOWN! 135! 0.0014!
WITHIN_NON_CODING_GENE! 7,566! 0.0774!
WITHIN_MATURE_miRNA! 53! 0.0005!
PARTIAL_CODON! 1! 0.0000!
 
Table 4.4: Functional consequences of indels 
Category!
Number!of!
indels! Percentage!
INTERGENIC!! 1,812,772! 59.0370!
INTRONIC! 879,817! 28.6532!
UPSTREAM! 185,924! 6.0550!
DOWNSTREAM! 175,983! 5.7313!
3PRIME_UTR! 7,780! 0.2534!
5PRIME_UTR! 847! 0.0276!
FRAMESHIFT_CODING! 2,366! 0.0771!
COMPLEX_INDEL! 175! 0.0057!
CODING_UNKNOWN! 203! 0.0066!
NON_SYNONYMOUS_CODING! 1,360! 0.0443!
STOP_GAINED! 7! 0.0002!
STOP_LOST! 3! 0.0001!
SPLICE_SITE! 1,845! 0.0601!
ESSENTIAL_SPLICE_SITE! 298! 0.0097!
WITHIN_NON_CODING_GENE! 1,125! 0.0366!
WITHIN_MATURE_miRNA! 65! 0.0021!
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4.2.5   Pairwise comparisons between strains 
4.2.5.1   Pairwise comparisons between all possible pairs of strains 
SNVs and indels were identified simultaneously and each polymorphic locus was 
genotyped across the 27 rat strains. This allowed identification of SNVs and indels not 
only in 27 rat strains against the BN reference genome but also between all possible 
pairwise combinations of 27 rat strains. The highest number of SNVs (3,877,157) were 
identified between the WKY/Gla strain and BN reference genome, while the lowest 
number of SNVs (21,918) were identified between two LEW sub-strains, LEW/Crl and 
LEW/NcrlBR (Figure 4.2A). Similarly, the highest numbers of indels were identified 
between WKY/Gla and the BN reference genome, however the lowest numbers of indels 
were identified between the BN.Lx and BN/Mcwi strains (Figure 4.2B).  On average, 116 
stop gain or loss variants were identified between all possible pairs of rat strains. The 
highest number of stop gain or stop loss variants were identified between the WKY/NHsd 
strain and the LN/MacRrrc strain, while the lowest number were identified between two 
substrains of LEW (Figure 4.3A). Similarly on average 688 frameshift variants were 
identified between all possible combinations of rat strains. The highest numbers of 
frameshifts were identified between the BN.Lx and WKY/Gla strains (n=1,000), while the 
lowest numbers of frameshifts were identified between BN.Lx and BN reference genome 
(n=64) (Figure 4.3B).  
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Figure 4.2: Pairwise comparison of SNVs and indels 
Heat maps showing A) Number of SNVs between any pair of 28 rat strains 
including the BN reference genome, calculated by counting the number of alleles 
differing between any pair of strains; B) Number of indels between any pair of 28 
rat strains. 
A 
B 
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Figure 4.3: Pairwise comparison of major coding mutations 
Heat maps showing A) Number of stop gain or stop loss variants between any pair 
of 28 rat strains including the BN reference genome, calculated by counting the 
number of alleles differing between any pair of strains; B) Number of frameshift 
variants between any pair of 28 rat strains. 
A 
B 
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4.2.5.2   Comparisons between pairs of disease model and control strains 
For almost all rat models of hypertension, kidney disease, diabetes and insulin resistance, 
control strains were derived simultaneously but independently from the same founder 
colony. As a consequence, these pairs of disease models and respective control strains 
differ for disease phenotypes. Therefore genomic variants between pairs of disease models 
and respective control strains (FHH/EurMcwi-FHL/EurMcwi, LH/MavRrrc-LN/MavRrrc, 
LH/MavRrrc-LL/MavRrrc, MHS/Gib-MNS/Gib, SBH/Ygl-SBN/Ygl, SHR/OlaIpcv-
WKY/NCrl, SHR/NHsd-WKY/NHsd, SHRSP/Gla-WKY/Gla, SS/Jr-SR/Jr and GK/Ox-
WKY/NCrl) were identified. Relatively small numbers of genomic variants were identified 
between pairwise comparisons of the disease models and the respective control strain. This 
could explain the observed differences between disease phenotypes as well as other 
phenotypic differences between these pairs of rat strains. In these pairs the highest number 
of SNVs and indels were identified between the GK/Ox and WKY/NCrl strains, while the 
lowest number of SNVs and indels were identified between the FHH/EurMcwi and 
FHL/EurMcwi strains (Table 4.5). Similar trends were observed for genomic variants 
which resulted in premature termination of coding region or which disrupted the coding 
frame. 
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Table 4.5: Number of SNVs and indels in pairs of disease models and respective 
control strains 
Strain!pairs! No.!of!SNVs! No.!of!indels! Stop!gain/loss! Frameshift!
FHH/EurMcwi>FHL/EurMcwi! 640,915! 275,609! 24! 270!
LH/MavRrrc>LN/MavRrrc! 767,582! 308,160! 36! 271!
LH/MavRrrc>LL/MavRrrc! 768,070! 304,832! 36! 322!
MHS/Gib>MNS/Gib! 1,804,537! 583,148! 63! 439!
SBH/Ygl>SBN/Ygl! 2,128,649! 679,189! 103! 526!
SHR/OlaIpcv>WKY/NCrl! 2,081,273! 658,855! 95! 543!
SHR/NHsd>WKY/NHsd! 2,076,578! 702,624! 93! 593!
SHRSP/Gla>WKY/Gla! 1,284,177! 476,496! 54! 405!
SS/Jr>SR/Jr! 949,497! 358,370! 32! 297!
GK/Ox>WKY/NCrl! 2,427,973! 760,314! 106! 626!
 
4.2.6   Density and distribution of genomic variants  
To gain insight into the density and distribution of genomic variants from SNVs and indels 
across the 27 rat strains compared to the BN reference genome, the “observed strain 
differences” (OSD) was calculated using non-overlapping 100kb windows, as described in 
Chapter 3. The OSDs were calculated independently for SNVs and indels. The OSD was 
calculated using all 9.6 million SNVs and 3.5million indels across 27 rat genomes, as well 
as the OSD was calculated for each individual strain using SNVs and indels between the 
strain and the BN reference genome. The SNV-based OSD calculated over all polymorphic 
SNVs, across the 27 rat strains, showed a significantly high correlation (r=0.72) with the 
indel-based OSD (Figure 4.4).  Interestingly, the correlations between the SNV-based OSD 
and indel-based OSD were relatively higher (average = 0.83 and range 0.81 to 0.86) at the 
individual strain level (Table 4.6).  
OSD (SNP-based as well as indel-based) calculated using all polymorphic SNVs across 27 
rat strains showed normal distribution with long tail of highly divergent regions (Figure 
4.5). However, individual strain level OSDs showed bimodal distribution with first and the 
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highest peak at zero OSD and second peak at approximately 0.002 OSD with valley 
between the two peaks. All strains showed long tail of high OSD (Figure 4.6).        
 
Figure 4.4: Correlation between SNV-based OSD and indel-based OSD using all 
polymorphic SNVs and indels across 27 rat genomes. 
Observed strain differences (OSD) for SNV and indel was calculated in the 
windows of size 100kb by dividing number of observed polymorphic loci in each 
window with the length of the window. High correlation between SNV-based OSD 
and indel-based OSD indicates that the rate of acquiring single nucleotide 
substitutions was proportional to the rate of acquiring short indels across all 27 rat 
strains.      
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Table 4.6: Correlation between SNV-based OSD and indel-based OSD using SNVs 
and indels predicted in each individual rat strains 
Rat!strain!
Correlation!between!SNV!based!OSD*!
and!indel!based!OSD*!
ACI/EurMcwi! 0.8363!
BBDP/Wor! 0.8369908!
F344/NCrl! 0.8455458!
FHH/EurMcwi! 0.8389278!
FHL/EurMcwi! 0.844355!
GK/Ox! 0.8519012!
LE/Stm! 0.8358525!
LEW/Crl! 0.8621121!
LEW/NCrlBR! 0.8641903!
LH/MavRrrc! 0.8357692!
LL/MavRrrc! 0.8415687!
LN/MavRrrc! 0.8427558!
MHS/Gib! 0.8455073!
MNS/Gib! 0.8457073!
SBH/Ygl! 0.8417469!
SBN/Ygl! 0.8498218!
SHR/OlaIpcv! 0.8272994!
SHR/NHsd! 0.8142247!
SHRSP/Gla! 0.8212253!
SR/Jr! 0.8377718!
SS/Jr! 0.8445564!
SS/JrHsdMcwi! 0.8380757!
WAG/Rij! 0.8516783!
WKY/NCrl! 0.8209942!
WKY/Gla! 0.8102183!
WKY/NHsd! 0.8139153!
 
*Observed strain differences (OSD) between each strain and the BN reference genome was 
calculated using SNV and indel between each strain compared to BN reference genome. 
OSD was calculated in the windows of size 100kb by dividing number of SNV and indels 
(for SNV-based OSD and indels for indel based OSD) in each window with the length of 
the window.  
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Figure 4.5: Distribution of SNV-based OSD and indel based OSD  
Distribution of SNV density (A) and indel density (B), calculated as in Figure 4.4, 
the density on y-axis represents the number of 100 kb windows corresponding to 
each value of OSD on x-axis.    
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Figure 4.6: Distribution of strain level SNV-based OSD 
Distribution of SNV density according to individual strain calculated as in Table 4.6   
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 4.2.7 Features of indels 
At the whole genome level, the majority (38.40%) of indels were single base insertions or 
deletions with a general trend of a decrease in indel number with an increase in indel 
length.  However, indels with length in multiple of two were more frequent than the indels 
of other lengths (Figure 4.7A).  Similar to results observed at the genome level, within the 
coding part of the genome, the majority of indels were single base indels. However, in 
coding parts of the genome, indels with length in multiple of three were more frequent than 
others (Figure 4.7B).  
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Figure 4.7: Distribution of indel length 
Distribution of indel length A) All the indels in the genome B) Indels located in 
protein coding part of the genome. 
  
0 
200 
400 
600 
800 
1,000 
1,200 
1,400 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Indel  length 
N
um
be
r o
f i
nd
el
s 
(T
ho
us
an
ds
) 
0 
200 
400 
600 
800 
1000 
1200 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
Indel  length 
N
um
be
r o
f i
nd
el
s 
A 
B 
!
!
127!
!
4.2.8 Phylogenetic history of laboratory rat strains 
The evolutionary history of laboratory rat strains is complex as they were derived by 
multiple rounds of interbreeding and inbreeding (Jong, 1984; Saar et al., 2008). A 
phylogeny of the rat strains including the BN reference strain was constructed to gain 
insights into the evolutionary history of laboratory rat strains. The phylogenetic tree of 
these rat strains was constructed using a catalogue of 9.6 million SNVs.  
The laboratory rat strains were clustered primarily according to the geographical locations 
from where they have been derived (Figure 4.8). The Wistar-derived strains showed two 
prominent sub-clusters in accordance with the continents from where they were derived. 
Strains which were derived from the Wistar colony in Japan (SHR, SHRSP, GK and 
WKY) formed an independent cluster and this cluster was distant from the remaining 
clusters. Rat strains derived from the Wistar-colony in Europe and the USA (MHS, MNS, 
LEW, WAG and BBDP) formed an independent cluster. 
The Sprague Dawley-derived (SD) strains (SS, SR, LH, LL and LN) also clustered 
together along with the F344 strain and this cluster was closest to the European or North 
American Wistar-derived strains. Other strains formed more isolated clusters, with the BN 
strains forming the most distant cluster. Sub-strains of the rat strains clustered together for 
all strains where two or more sub-strains were sequenced, with the exception of the WKY 
sub-strains. The WKY/Gla strain was found to be closer to the SHR sub-strains 
(SHR/OlaIpcv and SHR/NHsd) and SHRSP/Gla compared to the other WKY substrains 
(WKY/NCrl and WKY/NHsd), possibly reflecting the known diversity of WKY strains 
arising from their distribution to different geographical locations before complete 
inbreeding (Kurtz et al., 1989) or the close relationship of SHR and WKY sublines during 
their establishment and maintenance. 
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Figure 4.8: Phylogenetic tree of laboratory rat strains 
The phylogenetic tree was constructed using 9.6 million SNVs across 28 laboratory 
rat strains including the Brown Norway reference strain (BN/Mcwi). The scale 
represents genetic distance; the distance matrix was calculated by dividing the 
number of SNVs between a given pair of strains by the length of the BN reference 
genome. The phylogenetic tree was constructed using the Fitch-Margoliash method 
with 1000 bootstraps. 
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4.3 Discussion  
4.3.1 Genome sequences and variant calling 
In the past century, major advances have been made in derivation of more than 500 rat 
strains for various pathophysiological phenotypes and mapping these phenotypes.  
However, relatively insignificant efforts have been made to obtain near complete catalogue 
of genomic variants in the widely studied laboratory rat strains. By taking advantage of 
high throughput sequencing platforms, the genomes of 27 rat strains have been sequenced 
which includes widely used models of hypertension, kidney diseases, and diabetes. This is 
the first time such large scale sequencing has been carried out in rat community.  
A near complete catalogue of genomic variants were generated which contain 9.6 million 
SNVs, 3.5 million short indels, 555,419 structural variants and 897,217 copy number 
variants across 27 laboratory rat strains. This extensive catalogue of genomic variants will 
significantly enhance identification of disease genes underlying pQTLs mapped in these rat 
strains over past few decades.  Indeed the SHR variant dataset has already facilitated 
research aimed at understanding mechanisms underlying complex phenotypes manifested 
by the SHR (Heinig et al., 2010; McDermott-Roe et al., 2011; Morrissey et al., 2011; 
Simonis et al., 2012).  Similarly variant data from 27 rat strains will facilitate 
understanding of molecular mechanisms underlying various disease phenotypes shown by 
these rat strains. Furthermore, this dataset can facilitate cross strain as well as cross species 
comparisons and other statistical genetics analysis. 
To estimate false positive and false negative rates of variant calling, ~2Mb of high quality 
DNA sequence was obtained by sequencing 13 BACs derived from the non-reference 
strain LE/Stm on the capillary sequencing platform. The estimated false positive rate for 
SNVs in the LE/Stm genome was 0.38% while for indels it was 3.75%. The genomes of 
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many humans as well as model organisms have been sequenced using NGS platforms in 
past five years (Abecasis et al., 2012; Gan et al., 2011; Keane et al., 2011) and precedents 
exist in estimation of false positive rate of variant calling by capillary sequencing of 
randomly selected variants in these studies.  However, with the exception of mouse 
genomes, none of the studies thus far estimated the proportion of variants missed in NGS 
variant calling. In this study, ~2Mb BAC sequence permitted estimation of false negative 
rates, giving clear estimates of proportion of genomic variants missed by the NGS 
platforms. Although false negative rate has been estimated in the mouse genome 
sequenced using NGS (Keane et al., 2011), it was restricted to the accessible regions of the 
genome, thus false negative as well as false positive rates were underestimated. Here false 
positive rates and false negative rates were estimated at whole genome level without 
restrictions to only accessible regions of the genome. The estimates of false negative rates 
were lower in LE/Stm (8.1 % and 10.98% for SNPs and indels respectively) compared to 
previous reports in other model organisms. Lower estimates of false positive and false 
negative rates in LE/Stm may be due to longer read length and improved algorithms for 
mapping and genomic variant calling.  
4.3.2 Functional consequences of genomic variants 
Functional consequences of genomic variants identified across 27 rat strains were 
predicted using variant effect predictor version 2.2 on rat genes annotated in ENSEMBL 
version 66. As expected, the majority of SNVs and indels were in the non-coding part of 
the genes, while only 0.71% of SNVs were in coding part of the gene with only 0.30% 
resulting in non-synonymous changes in amino acids including 455 stop gain or stop loss 
mutations. In addition, 0.068% of the indels resulted in frameshift coding mutations. These 
predictions were based on rat genome assembly version 3.4 and the ENSEMBL rat genome 
annotation version 66. The variants predicted in NGS data analysis are routinely validated 
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using alternate method before any further functional studies. Similarly variant effects also 
need to be validated by alternate methods before functional studies. There are multiple 
sources of false variant effect prediction. The first source is the false positive variant calls 
in NGS data analysis. Here the estimated false positive rate was 0.37% for SNVs and 
3.75% for indels, which indicates what proportions of false variant effects to be expected 
due to false positive variant calls. The second source is errors in the reference rat genome 
assembly. By re-sequencing the BN/Mcwi genome from the same rat which was used to 
sequence reference genome, and filtering out SNPs and indels between re-sequenced 
BN/Mcwi genome and the reference BN genome, the majority of false positives due to 
errors in BN reference assembly were eliminated.  Thirdly, the source of false variant 
effect prediction can be a result of errors in ENSEMBL annotations of the reference BN 
genome. False positive variant effect predictions due to errors in the ENSEMBL genome 
annotations are difficult to estimate as well as difficult to eliminate. ENSEMBL genome 
annotations are based on an automated annotation pipeline which includes gene predictions 
by gene prediction algorithms such as genescan and annotations based on evidence from 
protein and cDNA sequences (Curwen et al., 2004). In certain instances, to map protein 
sequences to the genome sequences, pseudo-introns are introduced in the predicted gene 
structures. The majority of the predicted stop gain or stop loss mutations and frameshift 
coding mutations may be true, but part of them may also be false predictions due to errors 
in ENSEMBL gene annotations. Almost 64% of the predicted frameshift coding mutations 
were identified in genes encoding for uncharacterised proteins. All of these genes were 
annotated based on protein sequences from TrEMBL, which are not reliable evidence for 
gene predictions. Hence it is necessary to validate predicted stop gain or stop loss and 
frameshift coding mutations at both the DNA and mRNA level before any functional 
studies are carried out on genes.       
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4.3.3 Density and distribution of genomic variants 
Similar to the correlation observed between SNP density and the indel density in SHR 
genome as described in Chapter 3, SNP based OSD showed strong correlation with the 
indels based OSD when the OSD was calculated using all polymorphic loci across the 27 
genomes. The correlation between the SNP based OSD and the indel based OSD was 
increased when the OSDs were calculated in each individual rat strains against reference 
BN genome. This suggests that the rate of acquiring SNPs was similar to the rate of 
acquiring indels irrespective of the strain in which they are acquired. Furthermore, bimodal 
distribution of SNP and indel density with a long tail of high density SNP and indel regions 
suggests that the genomic variants are not uniformly distributed throughout the genome. 
Instead there are distinct regions of the genomes which show high divergence and low 
divergence between the individual rat strains and the reference BN genome. Thus the 
genome could be partitioned in to three distinct parts with regions of low divergence, 
average divergence and high divergence between the individual rat strains and reference 
BN genome. The regions of low divergence may represent the genomic regions which 
were conserved across rat strains and might be under selective constrains. The region of 
average variability may represent the natural variations or inter individual differences 
between the rat strains, while regions of high divergence may represent the regions 
underlying phenotypic differences between the rat strains.      
Indel length showed an irregular pattern in the non-coding part of the genome and the 
coding part of the genome. At the whole genome level, indels with length in multiple of 
two were more frequent than the indels with other lengths. This shows that the majority of 
indels in rat strains occurred in stretches of dinucleotide repeats because of a deletion or 
insertion of one or more copy of dinucleotide. These indels might have been occurred 
because of improper expansion of dinucleotide stretches during DNA replication.  In 
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contrast, in coding part of the genome, indels with length in multiples of three were more 
predominant. Insertion or deletion of three bases or a multiple of three bases in coding 
regions does not affect the reading frame of the transcript, thus may not have deleterious 
effect on function of the proteins. Therefor indels with length multiples of three might be 
more predominant in coding part of the genome than other type of indels.  
4.3.4 Phylogenetic tree of 28 rat strains 
The phylogeny of the laboratory rat strains has been generated previously using a small set 
of the microsatellite markers (Thomas et al., 2003) and the SNP markers (Saar et al., 2008) 
thus phylogenetic inferences were based on small number of markers. In this study, the 
phylogenetic tree of laboratory rat strains was generated using ~9.6 million SNPs 
identified at the whole genome level. Phylogenetic inferences from whole genome SNP 
datasets tend to be more accurate than the randomly selected small number of markers 
across the genome. Phylogenetic tree reconstruction reflects the known history of the 
laboratory rat strains. Rat strains derived from Wistar colony formed two distinct sub-
clusters, which were predominantly based on their geographical locations were they were 
derived. Rat strains derived for Wistar colony in Japan formed a distinct cluster, while rat 
strains derived from Wistar colony in the USA or Europe showed a close proximity with 
Sprague-Dawley derived strains.  This suggests that rats from the Wistar colony might 
have been distributed to Japan early in the process of establishing Wistar colony. Two 
Wistar colonies, the original Wistar colony from the USA and the Wistar colony from 
Japan, might have evolved independently and diverged from one another.  For the majority 
of the rat strains where two or more sub-strains were sequenced, sub-strains clustered 
together with the exception of WKY sub-strains which formed two clusters. Two sub-
strains of WKY (WKY/NCrl and WKY/NHsd) clustered together while the WKY/Gla 
strain clustered with the SHR and SHRSP strains. This indicates that designation of rat 
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strains may be misleading and rat sub-strains with same strain designations can be as 
genetically diverse as two strains. 
The majority of rat disease models and their respective control strains have been derived 
simultaneously but independently from the same founder colony or stock. Pairs of disease 
models and respective control strains show single nucleotide differences in range of 600K 
to 2.4 million. These genetic differences could explain differences in disease phenotypes 
shown by disease models and respective control strains, however, the majority of the 
genetic differences might be due to the random inter individual differences in the founder 
colonies. The large numbers of genetic differences between disease models and control 
strains may not be responsible for differences in disease phenotypes. Hence to identify 
genomic loci and variants that could explain differences between disease phenotypes in rat 
disease models and control strains, a more sophisticated analysis was required.  Two 
independent evolutionary analyses were performed and included, (i) a co-evolutionary 
gene cluster analysis, and (ii), identification of artificial selective sweeps. The co-
evolutionary gene cluster analysis is detailed in chapter 5 and the artificial selective sweep 
analysis is described in chapter 6. 
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Chapter 5: Identification of co-
evolutionary gene clusters 
  
!
!
136!
!
5.1 Introduction  
Hypertension is controlled by multiple susceptibility genes and their interaction with the 
environment (International Consortium for Blood Pressure Genome-Wide Association et 
al., 2011; Kato et al., 2011). Furthermore, the polygenic basis of many common diseases 
such as diabetes and cardiovascular diseases is widely accepted (O'Shaughnessy, 2001). 
Interactions between genes which underlie complex phenotypic traits is maintained by the 
co-evolution of the interacting genes (Tillier and Charlebois, 2009).  Rat models of 
hypertension, insulin resistance and diabetes have been selectively bred for these disease 
phenotypes and therefore genes underling these complex phenotypes may have co-selected 
and co-evolved because of the similar selective pressure exerted on them.  
In the past two decades, there has been substantial progress in the development of 
computational tools to identify interacting genes and gene products (de Juan et al., 2013).  
One of these methods is based on comparisons of distance matrices (using correlation 
coefficient), instead of phylogenetic trees themselves (Pazos et al., 2005). This approach, 
which is called “a mirror tree approach”, was successfully used by many researchers in 
identification of interacting proteins (de Juan et al., 2013) and small RNA pathways 
(Tabach et al., 2013).  
This study is the first of its kind where for a first time mirror tree was applied to identify 
co-evolved disease genes using next generation sequencing data from multiple disease 
models and respective control strains.  The genes which contain polymorphisms in the 
protein coding regions of the genes that alter the amino acid might underlie the disease 
phenotypes selected for in the rat strains. To test this hypothesis, the genes which contain 
non-synonymous coding mutations were used to identify the co-evolutionary gene clusters 
using mirror tree approach. Current analysis is focused on protein coding genes, however 
some of the phenotypic effects may be explained by mutations in non-protein coding genes 
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such as long non-coding RNAs and micro RNAs as well as mutations in the regulatory 
elements. 
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5.2 Results 
5.2.1 Phylogenetic profile 
5.2.1.1 Phylogenetic profile using non-synonymous coding mutations 
A total of 39,549 transcripts representing 29,516 genes were annotated for the rat genome 
in ENSEMBL version 66. Of these 39,549 transcripts only 13,351 transcripts contained 
non-synonymous coding mutations including stop gain or loss mutation in at least one of 
the 26 rat strains compared to the BN reference genome. These 13,351 transcripts were 
used to construct a phylogenetic profile of transcripts containing NSC mutations. The 
phylogenetic profile was constructed by dividing number of NSC mutations in the 
transcript by the number of SC mutations, both normalised by length of the transcript for 
each strain.             
5.2.1.2 Phylogenetic profile using frameshift coding mutations 
Of 39,549 transcripts, reading frames of only 1,099 transcripts were disturbed due to indels 
in at least one of the rat strain. These 1,099 transcripts were used to construct the 
phylogenetic profile of transcript containing frameshift coding mutations. A phylogenetic 
profile was constructed by dividing number of frameshift causing indels by the length of 
the transcript for each strain.  
5.2.2 Correction for population structure 
5.2.2.1 Principal component analysis 
To estimate the genetic relatedness and the variability between the 26 rat strains used for 
co-evolutionary cluster analysis, a principal component analysis (PCA) was performed. A 
PCA was performed using two datasets, (i) the set of 9.6 million SNVs predicted in this 
study, and (ii), the phylogenetic profile obtained as described above. Using SNVs, kinship 
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matrix was derived were the relatedness between strains ranged from 0 to 1 (where 0 
indicates no relatedness between the strains and 1 indicates completely identical strains). 
The first two principal components explained almost 70% of the variability between the rat 
strains (Figure 5.1A). The first two principal components clearly separated Japanese 
Wistar derived strains, Sprague-Dawley derived strains and rest of the rat strains. Similar 
to the phylogenetic tree analysis, the European and North American Wistar derived strains 
clustered with the other strains such as Fawn Hooded rat strains and Sabra rat strains, while 
the Japanese Wistar derived strains formed independent cluster (Figure 5.1B). 
The PCA using phylogenetic profiles also showed similar results because the SNV based 
kinship matrix (Figure 5.2A) and phylogenetic profile based kinship matrix (Figure 5.2B) 
are effectively the same measures. One is estimated at whole genome level and the other is 
estimated at only coding part of the genome, and they show very high correlation 
(r=0.9911).  Hence to correct for the population structure, a phylogenetic profile was 
adjusted for the first two principal components.     
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Figure 5.1: Principal component analysis of rat strains sequenced 
Principal component analysis was carried out using distance matrix derived from 
SNVs across 26 rat strains. A) Principal component analysis shows that the first 
two principal components contribute to 70% of the sequence variability across the 
rat strains; B) the first two principal components separate Japanese Wistar-derived 
strains, Sprague-Dawley-derived strains and remaining rat strains     
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Figure 5.2: Kinship matrices used for the principal component analysis 
Two kinship matrices used for the principle component analysis A) A distance 
matrix derived from the SNVs across 26 genome B) A distance matric derived from 
the NSC mutations.    
A!
B!
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5.2.2.2 Linear mixed model 
To corroborate the correction for population structure using the PCA, associations between 
all possible pairs of transcripts was calculated using the R package EMMA, which is based 
on a linear mixed model to correct for population structure and genetic relatedness in 
model organism association mapping. A kinship matrix generated using the genome wide 
SNV data was used as the measure of relatedness between the strains.   
5.2.3 Co-evolutionary gene cluster analysis using transcript containing 
NSC variants 
5.2.3.1 Population structure correction using PCA  
The co-evolutionary gene networks were constructed using the phylogenetic profiles 
corrected for the population structure using the PCA. The correlation coefficient was 
calculated between all possible pairwise combinations (89,024,496) of transcripts 
containing NSC variants. The FDR was applied to the correlation coefficient to identify 
significantly correlated pairs of transcripts. From all possible pairwise combinations of 
transcripts at FDR < 0.1% (| r | > 0.96; P-value < 9.33 x 10-15), 310,690 showed significant 
correlation. These pairs of transcripts were subsequently used to construct co-evolutionary 
gene clusters. A total of 1,955 clusters (Appendix E, Table E.1) were identified, the 
majority of these contained two (n=1,063) or three (n=383) transcripts, while 109 
contained 10 or more transcripts (Figure 5.3) 
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Figure 5.3: Distribution of cluster size 
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5.2.3.2 Population structure correction using linear mixed model  
Using EMMA (Kang et al., 2008) associations between all possible pairs of transcript were 
calculated. To identify significantly associated transcript pairs, the FDR was calculated 
using FDRtool (Strimmer, 2008). There were 165,346 of 89,024,496 transcript pairs at 
FDR < 0.1%, which showed significant association between each other. These transcript 
pairs were then used to construct co-evolutionary gene clusters. A total of 1,273 clusters 
were identified using the EMMA based population structure correction (Appendix E, Table 
E.2). 
5.2.3.3 Overlap between PCA-based and EMMA-based co-evolutionary gene clusters 
The network obtained from EMMA based population structure correction (Kang et al., 
2008) showed high concordance with the network obtained from PCA based population 
structure correction, with approximately 75% of edges shared between the two networks 
(P-value for significant overlap < 10-16).  The number of shared edges was raised to an 
average of 94% (min 72%, max 100%; Table 5.1), when considering edges in clusters 
identified from the PCA-derived networks that were unique to a single strain. As there was 
high concordance between two independent methods used for population structure 
correction, henceforth in this chapter, only clusters obtained from PCA based population 
structure correction are discussed.  
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Table 5.1: Overlap between the gene clusters identified after the PCA-based and the 
EMMA-based population structure correction 
Strain!
No.!of!edges!in!PCA!
corrected!network!
No.!of!edges!in!EMMA!
corrected!network!
No.!of!edges!in!
common! overlap!
ACI! 15,576! 15,576! 15,576! 1.00!
BBDP! 1,668! 1,605! 1,605! 0.96!
F344! 3,009! 2,701! 2,701! 0.90!
FHH! 1,711! 1,711! 1,711! 1.00!
FHL! 903! 884! 884! 0.98!
GK! 17,656! 16,015! 16,015! 0.91!
LE! 24,753! 24,750! 24,750! 1.00!
LEW! 105! 91! 91! 0.87!
LH! 120! 120! 120! 1.00!
LL! 10! 10! 10! 1.00!
LN! 66! 66! 66! 1.00!
MHS! 1,837! 1,771! 1,771! 0.96!
MNS! 3,081! 3,081! 3,081! 1.00!
SBH! 5,357! 4,462! 4,462! 0.83!
SBN! 2,771! 2,485! 2,485! 0.90!
SHR! 66! 66! 66! 1.00!
SHRSP! 1,275! 1,225! 1,225! 0.96!
SR! 91! 66! 66! 0.73!
SS! 595! 595! 595! 1.00!
WAG! 995! 904! 904! 0.91!
WKY! 4,561! 3,973! 3,973! 0.87!
All!clusters! 220,380! 185,218! 139,386! 0.75!
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5.2.3.4 Linkage disequilibrium (LD) 
To confirm the cluster analysis, linkage disequilibrium between all pairs of NSC variants 
within each cluster was calculated. For 1,133 clusters, more than 40% of the NSC variants 
represented within the cluster showed strong linkage disequilibrium (LD; r2 > 0.8) with 
each other, and the majority of them showed perfect LD (r2 = 1) even though SNVs were 
located on different chromosomes. After random shuffling of the SNVs, this LD structure 
was completely lost (Figure 5.4), suggesting that mutations in these genes may have co-
evolved under the same selection pressures. 
!
Figure 5.4: Linkage disequilibrium (LD) between non-synonymous coding (NSC) 
variants within the cluster genes 
Histogram showing proportion of NSC SNVs with in the cluster showing LD ≥ 0.8 
(Red bars) and proportion of NSC SNVs showing LD ≥ 0.8 after shuffling the 
SNVs (Green Bars).  
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5.2.4 Co-evolutionary gene cluster analysis using transcript containing 
frameshifts  
Significant overlap between the networks obtained by the PCA and EMMA based 
population structure correction was observed for the networks constructed using the 
transcripts containing NSC mutations, therefore for the transcript containing frameshift 
mutations, as for SNV’s only a PCA based population structure correction was performed. 
The correlation coefficient between all possible pairwise combinations (n=603,351) of the 
population structure corrected phylogenetic profiles of 1,099 transcripts calculated using R. 
At a FDR < 0.1%, 5,940 transcript pairs showed significant correlations. These 5,940 
transcript pairs were used to construct co-evolutionary gene clusters of transcript 
containing frameshift coding mutations, a total of 145 clusters were obtained (Appendix E, 
Table E.3).     
5.2.5 Biological significance of co-evolutionary gene clusters  
The largest cluster of NSC SNVs contained 365 transcripts, all of which showed NSC 
variants unique to ACI (Appendix E, Table E.4). The majority of large clusters (> 10 
transcripts) contained transcripts that were mutated uniquely in single rat strain or in the 
strains that were derived simultaneously from the same founder colony, and showed close 
proximity in the phylogenetic tree. Pairs of hypertensive and normotensive rat strains 
derived from same founder colony such as fawn-hooded rat strains: FHH and FHL, Wistar 
derived Japanese strains: SHR, SHRSP and WKY, Sabra rat strains: SBH and SBN, Wistar 
derived Italian rat strains: MHS and MNS, and Sprague-Dawley derived strains: LH, LL 
and LN, each showed a cluster which shared NSC variants in 311, 140, 49, 22 and 43 
transcripts respectively (Appendix E, Table E.5-E.9). However, finding NSC or frameshift 
variants shared between strains that originated from the same founder population 
irrespective of their disease status (for example between a hypertensive strain and its 
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respective normotensive control), indicates that they are unlikely to be responsible for 
disease phenotypes and are more likely a reflection of shared ancestry. 
The clusters of co-evolved transcripts that were unique to a strain selected for disease 
phenotype are of interest as the NSC mutations in these strains were not present in the 
control strains that share immediate ancestry with these disease models, thus minimising 
the likelihood that these clusters arose due to shared ancestry. These co-evolved clusters 
therefore may explain the disease phenotypes harboured by these rat strains. At least one 
unique co-evolutionary cluster was identified in each disease model, the largest of which 
was found in the GK strain (Table 5.2).   
Furthermore, clusters were also identified which contained transcripts that share NSC 
variants between the disease models derived from same founder colony but not in the 
respective control strains. For example, clusters of 31 transcripts showed shared NSC 
variants in all three Japanese Wistar derived disease strains (SHR, SHRSP and GK), but 
these variants were not present in WKY which is control strains these disease models 
(Appendix E, Table E.10). Similarly, clusters of 12 transcripts shared NSC variants 
between two SD derived disease models (LH and SS) but these variants were not present in 
the SD derived control strains (LL, LN and SR) (Appendix E, Table E.11). Since these 
NSC variants were unique to or shared between these disease models and are not present in 
the respective control strains, it is plausible that a proportion of these were co-selected and 
co-evolved throughout the selective inbreeding process and contribute causally to the 
disease phenotype. 
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Table 5.2: Co-evolutionary gene clusters in 11 disease models 
Disease!strain*! Number! of! transcripts! (genes)! in!
NSC!variant!cluster!
Number! of! transcripts! (genes)!
in!frameshift!variant!cluster!
BBDP! 63!(47)! 16!(12)!
FHH! 59!(46)! 4!(4)!
GK! 230!(164)! 22!(22)!
LH! 16!(15)! 3!(2)!
MHS! 65!(47)! 5!(4)!
SBH! 129!(103)! 12!(12)!
SHR! 12!(12)! 2!(2)!
SHRSP! 51!(39)! 3!(2)!
SS! 35!(17)! 4!(2)!
* The control strains for each disease strain were as follows: WAG, FHL, WKY, LN, 
MNS, SBN, BN, WKY, SR.  
5.2.6 Co-evolutionary gene clusters containing known disease genes  
The co-evolutionary cluster analysis identified two genes Add1 and Gimap5, both of which 
have been previously implicated as genes underlying disease phenotypes in MHS and 
BBDP rat strains respectively.  
The Milan hypertensive rat strain (MHS) was derived from an outbred Wistar colony by 
selectively inbreeding rats with high blood pressure (Bianchi et al., 1974) along with the 
normotensive MNS control strain. Hypertension in MHS rats has been shown to be due to 
excess of renal sodium reabsorption (Bianchi et al., 1986). A cluster of 65 transcripts (47 
genes) showing NSC sequence variants and a cluster of 5 transcripts (4 genes) showing 
frameshift coding variants in MHS was identified (Appendix E, Table E.12). Importantly, 
the NSC cluster contains the Add1 gene encoding Alpha-adducin. The single nucleotide 
variant in the Add1 gene which results in F316Y amino acid change in encoded protein has 
been identified as a cause of hypertension in MHS (Bianchi et al., 2005; Ferrandi et al., 
2010). Along with the Add1 gene, MHS cluster also contain ion transporters Slc4a2, 
Slc12a8 and Atp13a4.  
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The BBDP rat strain is an extensively studied model of type 1 diabetes, occurring in 
association with profound T-cell lymphopenia with severe reduction or absence of CD4 
and CD8 T-cells (Jackson et al., 1983). A cluster of 63 transcripts (47 genes) showing NSC 
variants and a cluster of 16 transcripts (12 genes) showing frameshift variants that are 
unique to BBDP were identified using a co-evolutionary cluster analysis (Appendix E, 
Table E.13). The frameshifts include a one base pair deletion in Gimap5, a member of the 
GTPase of the immunity-associated protein family. This frameshift mutation was 
previously identified as the cause of T-cell lymphopenia in BBDP (Dalberg et al., 2007; 
Hornum et al., 2002; MacMurray et al., 2002). The finding that two genes identified 
previously as disease susceptibility genes in MHS and BBDP were amongst the small gene 
sets that were defined as uniquely variant in these strains using co-evolutionary cluster 
analysis, suggests that genes underlying other QTLs are likely to be found within the co-
evolved gene sets of these and other disease strains and that these gene sets should be 
prioritised in future investigation of disease phenotypes in these strains.!
5.2.7 Heterogeneity in molecular basis of disease phenotypes in rat 
models   
Using a co-evolutionary cluster analysis, clusters that were shared between disease models 
derived from different founder colonies such as BBDP and MHS (n=17 transcripts), or GK 
and SBH (n=17 transcripts) were also identified. However, no clusters were found that 
revealed potentially functional mutations across all models of hypertension, diabetes or 
insulin resistance. Surprisingly, clusters were not found even in rat strains showing 
spontaneous hypertension (FHH, MHS, SHR, SHRSP, LH) or salt-induced hypertension 
(SS, SBH), most likely reflecting heterogeneity in hypertension and related phenotypes 
amongst these rat strains. 
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5.2.8 Overlap of co-evolutionary cluster genes with human GWAS genes. 
All genome wide association studies (GWAS) recorded by the National Human Genome 
Research Institute (www.genome.gov/gwastudies) on or before the 26th of October 2012 
for hypertension, metabolic phenotypes or their complications (Appendix E, Table E.14) 
were screened to investigate whether the human orthologs of rat genes either shared 
between or were uniquely mutated in rat disease models, had been associated in human 
GWAS for relevant phenotypes. Of all the annotated rat transcripts, 27,199 had at least one 
one-to-one or one-to-many orthologs in the human genome, of which, 1,499 had been 
shown to be associated with hypertension or metabolism-related phenotypes at a P-value 
threshold of P < 10-5. The human orthologs of rat genes uniquely mutated in the disease 
models of hypertension, insulin resistance and diabetes were significantly over-represented 
in GWAS hits for hypertension or metabolism-related phenotypes (Fisher’s exact test P-
value = 10-4). The significant overlap between the human orthologs of cluster genes and 
GWAS hits for relevant phenotypes suggests that genes represented in clusters containing 
unique NSC mutations in disease models had not only co-evolved, but were also 
functionally related and may also contribute to these or related disease phenotypes in 
humans.  
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5.3 Discussion 
5.3.1 Identification of co-evolutionary gene clusters  
Using the mirror tree approach, co-evolutionary gene clusters of correlated phylogenetic 
profile were identified. Such methods have been widely used to identify co-evolving and 
functionally related proteins as well as miRNA pathways (de Juan et al., 2013; Pagliarini et 
al., 2008; Pazos and Valencia, 2001; Tabach et al., 2013). The mirror tree approach has 
been widely used for predicting protein-protein interactions with the assumption that the 
mutation in one binding partner being compensated by the complementary mutations in 
other. However many researchers questioned the value of the mirror tree approach for 
detecting interacting proteins as the proportion of residues that constitute a binding 
interface is known to be relatively small. Given this issue, researchers have questioned the 
value of detecting localised evolutionary signals using whole protein sequences 
similarities. It has been suggested that the correlated evolution over the length of protein 
sequence is separate from and unrelated to true coevolution that occurs at the binding 
surface (Hakes et al., 2007). Researchers have further suggested that the correlation 
between the protein sequence alignments is most likely due to functional modules of 
proteins having similar evolutionary constrains and thus correlated evolution (Hakes et al., 
2007). 
In this study, as the aim is to identify sets of genes which are under similar evolutionary 
constraints in specific disease models rather than identifying interacting proteins, here for 
the first time, a mirror tree approach has been used to identify co-evolving disease genes 
using next generation sequencing data for multiple rat disease models. The co-evolutionary 
cluster analysis identified two genes Add1 and Gimap5 previously shown by positional 
cloning to underlie susceptibility to hypertension in MHS and lymphopenia and diabetes in 
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BBDP respectively (Bianchi et al., 2005; Dalberg et al., 2007; Ferrandi et al., 2010; 
MacMurray et al., 2002). Relatively small numbers of genes have been positionally cloned 
in the rat models, moreover the majority of the positionally cloned genes were identified 
based on gene expression data and relatively smaller numbers of these genes have been 
positionally cloned on the basis of genomic differences.  Hence, identification of the two 
genes Add1 and Gimap5 as a part of co-evolutionary gene clusters in respective rat strains 
signifies the efficacy of this approach to identify genes underlying disease phenotypes in 
these rat strains. 
5.3.2 Co-evolutionary gene clusters unique to a disease models 
5.3.2.1 Milan hypertensive rat (MHS)     
MHS is the Wistar derived model of hypertension, in which a mutation in the Add1 gene 
has been identified as the cause of hypertension (Bianchi et al., 2005; Ferrandi et al., 
2010). Polymorphisms in the human ADD1 gene have also been associated with 
hypertension and responsiveness to antihypertensive medications in several populations 
(Cusi et al., 1997; Li, 2012). In addition to the Add1 gene, MHS cluster also contains 
multiple genes involved in ion transport. The gene Slc4a2 encodes the anion exchange 
protein 2, which has displayed evidence for association with human hypertension (Sober et 
al., 2009). Slc12a8 belongs to the cation chloride co-transporter family (Hebert et al., 
2004) and Atp13a4 encodes a cation-transporting P-type ATPase (Kwasnicka-Crawford et 
al., 2005). The relationship between ion transport and hypertension in rats and humans is 
well established (Bianchi et al., 1990; Lifton et al., 2001) and in light of this, the 
physiological consequences of mutations in these ion transporters merit further 
investigation. 
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5.3.2.2 Spontaneously hypertensive rat (SHR)  
The SHR strain was selectively bred for high BP by Okamoto and Aoki in Kyoto Japan 
(Okamoto and Aoki, 1963), and also shows many metabolic phenotypes (Atanur et al., 
2010). A cluster of 12 transcripts containing NSC variants and a cluster of 2 transcripts 
containing frameshift coding mutations was identified in SHR (Appendix E, Table E.15). 
The NSC variant cluster included genes such as Slc16a12, Slc37a4 and Noc3l. The gene 
Slc16a12 encodes for the monocarboxylic acid transporter. Mutation in Slc16a12 was 
shown to be associated with a syndrome combining juvenile cataract with microcornea and 
renal glucosuria (Kloeckener-Gruissem et al., 2008), the latter of these being a phenotype 
reported in SHR (Michaelis et al., 1984). The gene Slc37a4 regulates glucose-6-phosphate 
transport from the cytoplasm to the lumen of the endoplasmic reticulum; a mutation in this 
gene has been shown to be associated with various forms of glycogen storage disease 
(Gerin et al., 1997). In the Slc37a4 knockout mouse, it has been shown that this is one of 
the key genes which has a significant effect on plasma cholesterol concentration (van de 
Pas et al., 2010). Another gene, Noc3l also known as FAD24 (factor for adipocyte 
differentiation 24), regulates adipogenesis (Tominaga et al., 2004).    
5.3.2.3 Spontaneously hypertensive rat stroke prone (SHRSP)  
Before complete inbreeding of SHR, a sub-strain of SHR with exceptionally high BP and 
susceptibility to stroke was isolated and bred for occurrence of stroke; this strain is called 
SHRSP (Okamoto, 1974). In SHRSP a cluster of 51 transcripts (39 genes) containing NSC 
mutation was identified, similarly a cluster of 3 transcripts (2 genes) containing frameshift 
coding mutation was also identified in SHRSP (Appendix E, Table E.16). One of the genes 
in the SHRSP specific cluster, F2r, coagulation factor II (thrombin) receptor, plays 
important role in regulating blood pressure and inflammatory response (Damiano et al., 
1999; Gui et al., 2003; Kataoka et al., 2003). Functional genetic variation in F2r has the 
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potential to contribute to SHRSP phenotypes such as hypertension and left ventricular 
hypertrophy. Another gene Nfkbib, nuclear factor of kappa light polypeptide gene enhancer 
in B-cells inhibitor, beta, which serves a similar role to F2r in terms of regulation of 
inflammatory response (Rao et al., 2010) and which is part of the pathophysiological 
component of cardiovascular disease (Savoia and Schiffrin, 2006). In addition, the 
pathogenic role of apoptosis can lead to vascular remodelling and Nfkbib undergoes 
apoptotic cell death when exposed to oxidative stress (Intengan and Schiffrin, 2001) which 
is present in high levels within the SHRSP strain (McBride et al., 2005). Both Nfkbib 
(Denk et al., 2001) and F2r (Bae et al., 2010) can regulate the expression of Vcam1; 
positional candidate genes that determine response to salt in the stroke-prone 
spontaneously hypertensive rat (Graham et al., 2007). 
5.3.2.4 Dahl salt sensitive rat strain (SS) 
In the Dahl SS rat strain, a cluster of 35 transcripts and a cluster of 4 transcripts containing 
NSC variants and a frameshift coding variant was identified (Appendix E, Table E.17). 
One of the genes in SS cluster was Ptprr. In the human cell line, epigenetic silencing of the 
Ptprr gene was shown to activate mitogen-activated protein kinases (MAPK) signalling 
(Su et al., 2012), and PTPRR proteins are shown as physiological regulators of MAPK 
signalling cascades in Ptprr knockout mice (Chirivi et al., 2007). A significant increase in 
the protein expression of glomerular MAPKs including ERK and JNK was observed in 
Dahl-S rats fed with a high-salt diet, which may be responsible for salt-induced glomerular 
injury (Hamaguchi et al., 2000). Collectively, mutation in the Ptprr gene might be 
responsible for over activation of MAPKs which in turn result in salt-induced glomerular 
injury in SS rats.   
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5.3.2.5 Lyon hypertensive rat (LH) 
The LH NSC cluster contained 16 transcripts (Appendix E, Table E.18), the majority of 
which were located on chromosome 1, included gene Sult2al1 (Sult2a6), encoding for 
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring-like 1. Sult2al1 is 
a close functional paralog of Sult2a1, found in mouse and rat. Sult2a1 is a sulfotransferase 
that sulfonates a variety of molecules including DHEA, bile acids and 24-OH 
hydroxycholesterol (Cook et al., 2009; Radominska et al., 1990) and is required for proper 
clearance of cholesterol from the liver (Alnouti, 2009). This gene is of interest because 
raised cholesterol is one of the known phenotypes displayed by LH compared to the 
control LN and LL strains (Vincent et al., 1996). Another gene Ehd2, encoding for EH-
Domain Containing protein 2, has been! implicated in vesicle trafficking. EHD2 interacts 
with GLUT4 in rat adipocytes and may play a key role in insulin-induced GLUT4 
recruitment to the plasma membrane (Park et al., 2004).  The gene PigC encoding for the 
Phosphatidylinositol N-acetylglucosaminyl transferase subunit C has been shown to be 
associated with waist-hip ratio (Heid et al., 2010). Furthermore, an expression level of 
PigC has been shown to be marginally associated with body mass index (Schleinitz et al., 
2013). Given that the LH rat is obese compared to LN and LL, mutations in this might be 
interesting for further study on obesity phenotype shown by LH. 
5.3.2.6 Fawn hooded hypertensive rat (FHH) 
The FHH NSC cluster contained 59 transcripts (46 genes), while the frameshift cluster 
contained 4 transcripts (4 genes) (Appendix E, Table E.19). Nearly 50% of the FHH NSC 
cluster transcripts were located on chromosome 15 and belonged to the granzymes and 
mast cell protein families. Granzymes, which included Gzmb, Gzmf and Gzmn, were shown 
to play role in apoptosis of infected target cells through caspase-dependent or -independent 
!
!
157!
!
mechanisms (Hiebert and Granville, 2012). However, granzymes specifically GzmB is also 
shown to pay role in cardiovascular diseases (Saito et al., 2011).   
5.3.2.7 Goto-Okazaki (GK) 
The GK strain is a widely used rat model to study type 2 diabetes (Goto et al., 1976) and 
displayed the largest cluster for both NSC mutations (230 transcripts) and frameshift 
mutations (22 transcripts) amongst the 11 disease models (Appendix E, Table E.20). Many 
of these genes might be involved in pathophysiology of diabetes in the GK rat. One of the 
genes was Hif1a, a hypoxia-inducible factor 1-alpha which contains a single nucleotide 
substitution C>A that was unique to GK and resulted in amino acid change P492T. This 
amino acid substitution was predicted to be deleterious by Polyphen (Adzhubei et al., 
2010).  It has been previously shown that HIF-1α-deficient mice show more severe glucose 
intolerance and insulin resistance as loss of HIF-1α gene in the liver impairs glucokinase-
mediated glucose disposal (Ochiai et al., 2011).   
5.3.2.8 Bio-breeder diabetes prone (BBDP) 
The BBDP rat strain is an extensively studied model of type 1 diabetes, which occurs in 
association with profound T-cell lymphopenia with severe reduction or absence of CD4 
and CD8 T-cells (Jackson et al., 1983). A cluster of 63 transcripts (47 genes) showing NSC 
variants and a cluster of 16 transcripts (12 genes) showing frameshift variants that are 
unique to BBDP were identified using a co-evolutionary cluster analysis. The frameshift 
coding mutation cluster includes the gene Gimap5, which was previously shown to be 
responsible for T cell lymphopenia in BBDP (Hornum et al., 2002; MacMurray et al., 
2002).  The NSC cluster also contains the gene Scn4b, a Sodium channel subunit beta-4 (a 
beta sub unit of a VGSC). The sustained entry of Ca2+ into CD4+CD8+ double-positive 
thymocytes is required for positive selection. Recently, it has been shown that a voltage-
gated Na+ channel (VGSC) is essential for positive selection of CD4+ T cells (Malissen, 
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2012). In vivo short hairpin RNA (shRNA)-mediated knockdown of the gene encoding a 
regulatory β-subunit of VGSC, specifically inhibited the positive selection of CD4+ T cells 
(Malissen, 2012). In light of these findings, the role of NSC mutation in Scn4b gene may 
call for further investigation as a cause of Type 1 diabetes in BBDP. Another gene from 
the cluster was Adrb2, a Beta-2 adrenergic receptor. The Adrb2 knockout mice featured 
glucose intolerance, and pancreatic islets isolated from these animals displayed impaired 
glucose-induced insulin release (Santulli et al., 2012), thus the role of this gene in type 1 
diabetes in BBDP needs to be further investigated.      
5.3.3 Co-evolutionary gene clusters shared between disease models 
derived from same founder colony  
5.3.3.1 SHR and SHRSP 
The SHR strain was selectively bred for high BP by Okamoto and Aoki in Kyoto Japan 
(Okamoto and Aoki, 1963), which also shows many metabolic phenotypes (Atanur et al., 
2010). Before complete inbreeding, a sub-strain of SHR with exceptionally high BP and 
susceptibility to stroke was isolated and bred for occurrence of stroke; this strain is called 
SHRSP (Okamoto, 1974). A cluster of 61 transcripts was identified, all of which contained 
NSC mutations shared between SHR and SHRSP (Appendix E, Table E.21). Human 
orthologs of three genes, which represent five transcripts in the cluster, were shown to be 
associated with cardiovascular and metabolic disorders in the human GWAS. The gene 
Lactb, which encodes serine beta-lactamase-like protein, was shown to be associated with 
metabolic traits (Suhre et al., 2011a) and HDL cholesterol levels (Teslovich et al., 2010). 
Intronic mutations in Wdr66 were shown to be associated with urinary metabolite (Suhre et 
al., 2011b) and mean platelet volume (Meisinger et al., 2009; Soranzo et al., 2009), while 
the gene KIAA1462 was associated with coronary heart disease (Coronary Artery Disease 
Genetics, 2011) in humans. In addition to Lactb, Wdr66 and KIAA1462, Ppap2b, a 
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homologue of the gene Ppap2c (Lipid phosphate phosphohydrolase 2), was shown to be 
associated with coronary heart disease in human GWAS studies (Coronary Artery Disease 
Genetics, 2011; Schunkert et al., 2011). A homozygous null allele for the gene Trim55 
encoding tripartite motif-containing protein 55 showed increased heart and muscle to body 
weight ratios and cardiac hypertrophy in mouse (Witt et al., 2008), while the gene 
encoding Long-chain acyl-CoA synthetase 3 (Acsl3) was shown to play role in fatty acid 
metabolism, and expression levels of this gene was shown to be linked to hepatic 
triglycerides and fatty acid levels in hamster (Wu et al., 2011).  The gene Slc2a8 encoding 
Solute carrier family 2, facilitated glucose transporter member 8 (which is also known as 
GLUT8) is shown to be expressed in liver and linked to glucose homeostasis (Gorovits et 
al., 2003). Over representation of the genes previously shown to be related to 
cardiovascular and metabolic phenotypes in either human GWAS or mouse models was 
found in the cluster of transcripts showing NSC mutations uniquely in SHR and SHRSP, 
suggesting that NSC mutations in additional transcripts within the cluster might also 
contribute to cardiovascular and metabolic phenotypes shown commonly by SHR and 
SHRSP. The combined effect of these mutations may play a role in the disease phenotype 
shown by SHR and SHRSP.  
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Chapter 6: Identification of artificial 
selective sweeps 
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6.1 Introduction 
Under the process of natural selection, beneficial alleles are often positively selected for 
along with neighbouring linked alleles which can result in reduced variation in the 
population around these beneficial alleles. The resultant haplotype block is termed as 
selective sweep. Rat models of metabolic and cardiovascular phenotypes have been 
derived through selective inbreeding for disease phenotypes. Although the majority of 
disease models have been derived from the Wistar colony, conscious efforts have been 
made to derive disease models from various genetic backgrounds. In addition, disease 
models that have been derived from the Wistar colony have been developed at different 
geographical locations. Furthermore, a relatively small number of rats (<100) were used as 
a founder population to derive various rat models. Each strain that was derived  show 
profound founder effects and therefore should be genetically and phenotypically distinct 
from its founder colony as well as from other strains derived from different founder 
colonies (Doggrell and Brown, 1998).  
Phenotype driven selection and derivation of laboratory rat strains may have resulted in 
“artificial selective sweeps” with fixation of disease variants underlying disease 
phenotypes. Because rat disease models have been derived from the genetically distinct 
founder populations and disease phenotypes are not preferred during natural evolution, 
artificial selective sweeps must therefore be unique to each disease model compared with 
other rat strains.  To test this hypothesis, novel statistical genetic approaches were used to 
identify selective sweeps in rat models and the results of these were confirmed using 
various statistical genetics parameters commonly used to identify regions under selective 
pressure. 
Various population genetic statistics such as test for allele frequency (Fst), Tajima’s D, 
Achaz’s Y, loss of heterozygosity (Achaz, 2008; Rubin et al., 2010; Tajima, 1989; Wright, 
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1950) have been developed to identify genomic regions under selection. These techniques 
have been successfully applied to identify selective sweeps for beneficial traits for 
domestication of maize, silkworm, chicken and dogs previously (Axelsson et al., 2013; 
Rubin et al., 2010; Wright et al., 2005; Xia et al., 2009). However for the first time, 
selective sweeps underlying disease phenotypes have been identified in this study. Detailed 
results are presented in this chapter.     
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6.2 Results 
6.2.1 Identification of artificial selective sweeps 
To identify selective sweeps that may have arisen due to phenotype-driven selective 
breeding, genomic regions that were either unique to or shared between multiple strains 
were identified using methods described in section 2.4.1. 
6.2.1.1 Rat strains and SNVs used for analysis 
SNVs were pooled in the rat strains where more than one sub-strains were sequenced 
(SS/JrHsdMcwi and SS/Jr; LEW/NCrlBR and LEW/Crl; SHR/NHsd and SHR/OlaIpcv). 
However for the WKY sub-strains, WKY/Gla showed substantial diversity from the other 
two WKY sub-strains, and therefore WKY/Gla was considered as a separate strain and 
SNVs were pooled from the other two WKY sub-strains only (WKY/NHsd and 
WKY/NCrl). This defined a set of 22 genomes for selective sweep analysis. All 
polymorphic loci with missing genotypes and/or heterozygous calls in at least one strain 
were excluded, defining a set of 7.8 million high quality SNVs (out of a total of 9.6 million 
SNVs) that were used for further analysis. 
6.2.1.2 Calculation of relative SNV density (RSD) 
To identify genomic regions shared between different rat strains, the RSD of non-
overlapping 10kb windows was calculated. The RSD was calculated by dividing the 
number of SNVs in each strain by the total number of SNVs within the 10kb window, see 
section 2.4.1. The chi-square test was applied to identify genomic regions shared between 
rat strains and the regions which were unique to a rat strain.   
6.2.1.3 Identification of putative artificial selective sweeps   
Using chi-square statistics, the genome was divided into 137,449 contiguous segments 
which were either shared between multiple rat strains or were unique to a single strain. The 
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length of the 94,538 genomic segments was 10kb, which is the size of the window used for 
this analysis. At a FDR of 0.1% (P-value < 10-5), 15,859 genomic segments were 
significantly shared between the multiple rat strains or they were unique to a single rat 
strain (Appendix F, Table F.1). The length of significant genomic regions ranged from 
20kb to 2.9Mb (Figure 6.1). The largest number of segments (n=4,952) were 30kb size and 
24 segments were greater than or equal to 1Mb in size.     
!
Figure 6.1 Distribution of length of the genomic segments significantly shared 
between multiple rat strains of unique to a single rat strain.   
0!
1000!
2000!
3000!
4000!
5000!
6000!
20
!
40
!
60
!
80
!
10
0!
12
0!
14
0!
16
0!
18
0!
20
0!
22
0!
24
0!
26
0!
28
0!
30
0!
32
0!
34
0!
36
0!
38
0!
40
0!
42
0!
44
0!
46
0!
48
0!
50
0!
>5
01
!
Length!(in!Kb)!
N
um
be
r!o
f!s
eg
m
en
ts
!
!
!
165!
!
Of the 15,859 statistically significant genomic regions, there were 189 regions unique to a 
single rat strain (Figure 6.2), in these segments only one rat strain showed SNVs compared 
to the BN reference genome, while the remaining 21 rat strains shared the same allele as 
the BN reference genome. The size of these 189 unique genomic segments ranged from 
30kb to 1.57 Mb. A total of 1,55,118 SNVs were unique to a single rat strain, of which 
more than 50% were located in the 189 genomic regions that were unique to a single rat 
strain. This suggests that these SNVs  did not arise as a result of sequencing errors or false 
positives in variant calls and secondly, that the private SNVs were not randomly 
distributed in the genome but concentrated in a small number of genomic regions. The 
presence of large number of private mutations in 189 distinct genomic segments which 
accounts for only 0.8% of the genome, indicates that these regions were under selective 
pressure during selective breeding of these rat strains. Hence these regions were designated 
as putative artificial selective sweeps (PASS) regions.             
!
Figure 6.2: distribution of number of segments either unique to a strain or shared 
between two or more rat strains. 
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6.2.2 Coalescent simulation 
The 22 laboratory rat strains show uneven relatedness between them and have varying 
demographic history.  The patterns observed in RSD analysis may have resulted from the 
demographic history of the laboratory rat strains or alternatively, may be the result of 
selective pressure exerted on the rat strains during selective breeding of these rat strains. 
Coalescent simulation was performed to assess whether the predicted PASS regions were 
the result of the demographic histories of the rat strains or whether they were to the result 
of selection for disease phenotypes. Coalescent simulation was performed, accounting for 
the known demographic history of the 22 rat strain but with the exclusion of the effects of 
selective pressures, which provided the null model. The null model showed no genomic 
region unique to a single rat strain with a size greater than 40kb. In addition, unique 
genomic regions of length 30kb and 40kb were observed with a very low probability (P-
value = 0.002 and 0.0003 respectively). The length of the PASS regions identified ranged 
from 30kb to 1.57Mb and no statistically significant genomic regions of more than the 
30kb were observed in the null model, suggesting that the PASS regions identified were 
result of the selective pressures exerted on the rat strains during phenotype driven 
derivation and was not the result of the demographic history of these rat strains.   
Further, to test whether genomes of 22 strains are sufficient to predict selective sweeps, 22 
genome were simulated considering selection at single loci. In the sample of 105 simulated 
chromosomes, in 79.3% of the chromosomes selective sweep signals were also identified 
by the RSD analysis. All putative selective sweeps showed negative Tajima’s D; 93.68% 
of the sweeps showed Tajima’s D < -1.99 (FDR< 0.05). This suggests that the 22 genomes 
are sufficient to predict selective sweeps using RSD based method.    
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6.2.3 Linkage disequilibrium in PASS regions 
It has been previously shown that the regions under selective pressure tend to have 
increased LD (Xia et al., 2009). The LD was calculated between the SNVs in the 0.5Mb 
windows within the PASS regions as well as in the whole genome and LD decay was 
estimated. At the whole genome level, a sharp LD decay was observed with the reduction 
of the LD to half of the maximum (r2=0.68) at ~11kb distance, while the LD remained 
above 0.2 even at the distance of 0.5Mb. However, in the PASS regions no LD decay was 
observed and even at distance of 0.5Mb significantly high LD was observed. At 0.5Mb 
distance, the LD in the PASS regions was more than 4 times higher than the genome wide 
average (Figure 6.3).  The strong LD in the PASS regions disappeared after random 
shuffling of the SNVs with in the PASS regions (Figure 6.4). The strong LD observed in 
the PASS region is consistent with the previous observations and validates the RSD 
method used for identification of selective sweeps. Furthermore, strong LD in the PASS 
region suggests that the genomic regions designated as PASS regions were indeed under 
selective pressure during selective breeding of the rat strains.  
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Figure 6.3: Linkage distribution in putative artificial selective sweep (PASS) regions 
Average linkage disequilibrium (LD) between pairs of SNVs within a distance 
ranging from 1bp to 0.5Mb. The blue line represents average LD at whole genome 
level; the red line represents LD in PASS regions. 
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Figure 6.4: Linkage disequilibrium (LD) in putative artificial selective sweep (PASS) 
regions 
Red bars show LD between the SNVs within the putative artificial selective 
sweeps: in the majority of the PASS regions almost all SNVs show strong LD.  
After random shuffling of all SNVs in the genomes of the 27 rat strains, the strong 
LD between SNVs in PASS regions is completely lost (represented as green bars).  
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6.2.4 Calculation of Tajima’s D 
Tajima’s D (Tajima, 1989) is one of the most popular summary statistics of the site 
frequency spectrum (SFS) of mutations (Larsson et al., 2013). The SFS has been the main 
source of information for demographic inferences and identification of selection (Larsson 
et al., 2013). Tajima’s D is calculated by taking the difference of two estimates of 
population mutation rates, i) the average pairwise nucleotide diversity, and ii), the number 
of segregating sites (Tajima, 1989). Negative Tajima’s D indicates the excess of rare 
variants, while positive Tajima’s D indicates excess of intermediate frequency variants 
(Larsson et al., 2013). 
Tajima’s D was calculated in 10kb windows as a further evidence of PASS regions being 
the result of positive selection. The FDR was calculated using coalescent simulated data. 
At the whole genome level, Tajima’s D showed nearly normal distribution with mode at 
the value of 1, while in PASS regions, Tajima’s D was highly negative (Figure 6.5) with 
more than 70% of the windows showing Tajima’s D less than -2.48 (FDR ≤ 0.05).  This 
finding indicates that the identified PASS regions were indeed under selection.  
6.2.5 Ratio of non-synonymous coding mutations to synonymous coding 
mutations in PASS region 
Excess of non-synonymous mutations over synonymous mutation is an important indicator 
of positive selection; hence the ratio of NSC variants to SC variants in PASS region was 
estimated. At the whole genome level the NSC to SC ratio was 0.76 while in PASS region 
ratio was 1.65 (Figure 6.6). This marked enrichment of NSC mutation in PASS region was 
statistically significant (Fishers exact test P-value = 2.19 x 10-5).  
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Figure 6.5: Tajima’s D in putative artificial selective sweep (PASS) regions 
Distribution of Tajima’s D calculated in each 10kb windows. Blue line represents 
distribution at whole genome level and red line represent distribution of Tajima’s D 
in the PASS regions.   
!
Figure 6.6: Ratio of non-synonymous to synonymous coding mutations in putative 
artificial selective sweep (PASS) regions 
Ratio of non-synonymous coding (NSC) variants to synonymous coding (SC) 
variants at genome level (blue bar) and in PASS regions (red bar).  The PASS 
regions show significantly increased NSC to SC ratio. 
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6.2.6 Overlap of PASS regions with the pQTLs 
To understand the functional significance of the identified PASS regions, overlap was 
estimated between the PASS regions and the pQTLs previously mapped for the metabolic 
and cardiovascular phenotypes manifested in these rat strains. A total of 96 PASS regions 
were identified in 11 disease models, of these 25 PASS regions were co-localised with the 
cardio-metabolic QTLs mapped in the same strain in which each PASS region was 
identified. This overlap was marginally significant compared to the overlap expected by 
chance (Permutation test P-value=0.04). Interestingly, the majority (78%) of the PASS 
regions were localised either directly under, or in close proximity (~10Mb) to a peak of at 
least one QTL linkage (Table 6.1).       
6.2.7 Gene ontology enrichment analysis in PASS regions 
GO and KEGG pathway analyses of the genes in the PASS regions of each of the disease 
models was performed to identify genes and pathways that might underlie disease 
phenotypes for which these rat strains have been selected for. Only two strains, SS and 
FHH, showed significant enrichment (P < 0.05) for specific biological processes or 
pathways. In FHH, 44 genes reside within 14 FHH-specific PASS regions and these were 
enriched for genes involved in the renin-angiotensin system (RAS) and in proteolysis (P = 
3.4 x 10-4 and 1.6 x 10-8 respectively). In SS, 16 protein-coding genes reside within 4 SS-
specific PASS regions and these were enriched for aromatic compound catabolic processes 
(P = 3.9 x 10-5).  
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Table 6.1 Overlap selective sweeps with previously known physiological quantitative trait loci for cardiovascular and metabolic traits 
Selective(Sweep(
(chr:start1end)(
QTL(symbol( LOD( Trait(name( Associated(diseases( Location((chr:start1end)( Strain(combination(
BBDP( (( (( (( (( (( ((
chr1:213,920,001-213,980,000 
 Iddm25! 3.03! Glucose!level! Diabetes!Mellitus,!Type!1! 1:193,831,373-230,411,453! ACI.BBDP-
(RT1u),(Gimap5)/Sunn;BBDP/W
orSunn!
GK( !! !! !! !! !! !!
chr1:206,590,001-206,630,000 
 Niddm70! 3.1! Insulin!level! ! 1:181,780,342-226,780,342! BN.GK-(D1Wox18-
D1Got254)/Ox!
! Niddm35! ! Insulin!level! Diabetes!Mellitus,!Type!2! 1:190,677,683-235,677,683! F344.GK-(D1Arb42a-
D1Rat90)/Swe!
! Niddm7! 5.5! Glucose!level! Diabetes!Mellitus,!Type!2! 1:198,139,596-243,139,596! GK/KyoSwe;BN!
! Niddm67! 5.84! Glucose!level! ! 1:200,882,874-264,367,394! GK/KyoSwe;BN/Crl!
! Niddm69! 4.14! Insulin!level! ! 1:200,882,874-264,367,394! GK/KyoSwe;BN/Crl!
! Niddm68! 4.97! Glucose!level! ! 1:200,882,874-264,367,394! BN.GK-(D1Wox18-
D1Got254)/Ox!
! Niddm43! ! Glucose!level! Glucose!Intolerance! 1:204,280,278-267,111,153! F344.GK-(D1Mgh10-
D1Rat90)/Swe!
MHS( !! !! !! !! !! !!
chr14:82,660,001-82,700,000 
 Bp59! 3.2! Blood!pressure! Hypertension! 14:73,956,596-89,192,873! MHS/Gib;MNS/Gib!
SBH( !! !! !! !! !! !!
chr1:61,070,001-61,140,000!
! Bp96! 4.52! Blood!pressure! Hypertension! 1:22,842,898-102,532,417! SBH/Ygl;SBN/Ygl!
chr2:129,100,001-129,270,000 
 Pur12! 5.19! Renal!function! ! 2:116,504,240-153,393,151! SBH/Ygl;SBN/Ygl! !
!
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chr2:129,310,001-129,590,000 
 Pur12! 5.19! Renal!function! ! 2:116,504,240-153,393,151! SBH/Ygl;SBN/Ygl!
chr2:130,310,001-130,350,000 
 Pur12! 5.19! Renal!function! ! 2:116,504,240-153,393,151! SBH/Ygl;SBN/Ygl!
chr2:130,450,001-130,490,000 
 Pur12! 5.19! Renal!function! ! 2:116,504,240-153,393,151! SBH/Ygl;SBN/Ygl!
chr2:130,620,001-130,790,000 
 Pur12! 5.19! Renal!function! ! 2:116,504,240-153,393,151! SBH/Ygl;SBN/Ygl!
chr3:141,990,001-142,160,000 
 Pur13! 2.93! Renal!function! ! 3:76,620,970-148,642,985! SBH/Ygl;SBN/Ygl!
SHR( !! !! !! !! !! !!
chr4:26,390,001-26,420,000!!
! Gluco4! 3.1! Glucose!level! Diabetes!Mellitus,!Type!2;!
Metabolic!Syndrome!X!
4:1-28,615,362! SHR/NCruk;WKY/NCruk!
! BpQTLcluster5! 2.6! Blood!pressure! Hypertension! 4:1-61,646,915! BN;SHR!
! Stl19! 2.8! Lipid!level! Hypertriglyceridemia;!
Metabolic!Syndrome!X!
4:1-64,750,077! WKY/Izm;SHR/Izm!
! Bp79! ! Blood!pressure! Hypertension! 4:456,799-78,039,637! BB/OK;SHR/Mol!
! Bp330! 4.25! Blood!pressure! Hypotension! 4:456,799-149,181,446! WKY/NCrlCrlj;SHR/Kyo!
! Stl2! 3.3! Lipid!level! Hypertriglyceridemia! 4:461,376-54,828,069! BB/OK;SHR/Mol!
! Gluco12! 1.6! Glucose!level! Insulin!Resistance! 4:26,280,781-71,280,781! WKY/Izm;SHR/Izm!
chr15:104,030,001-104,090,000 
 Uae26! 2.4! Renal!function! Albuminuria! 15:75,200,650-109,758,846! MWF/Fub;SHR/Fub!
chr15:104,220,001-104,250,000 
!! Uae26! 2.4! Renal!function! Albuminuria! 15:75,200,650-109,758,846! MWF/Fub;SHR/Fub!
SS( (      
chr1:48,230,001-48,450,000!!
! Hrtrt2! 4.35! Heart!rate! Heart!Diseases! 1:11,859,997-63,434,427! BN/SsNHsd;SS/JrHsdMcwi!
! Rf27! 4.64
3!
Renal!function! Hypertension,!Renal;!
Kidney!Diseases!
1:29,683,185-78,134,446! BN/SsNHsd;SS/JrHsdMcwi!
! Rf28! 4.66! Renal!function! Kidney!Diseases! 1:33,134,446-78,134,446! BN/SsNHsd;SS/JrHsdMcwi!
!
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! Srn4! 4.46
7!
Renin!
concentration!
Kidney!Diseases! 1:33,134,446-78,134,446! BN/SsNHsd;SS/JrHsdMcwi!
! Rf29! 4.58
9!
Renal!function! Kidney!Diseases! 1:33,134,446-78,134,446! BN/SsNHsd;SS/JrHsdMcwi!
chr4:29,750,001-29,860,000 
 Bp178! ! Blood!pressure! Hypertension! 4:5,437,007-36,612,108! BN/SsNHsd;SS/JrHsdMcwi!
! Bp179! 2.85! Blood!pressure! Hypertension! 4:15,744,638-36,612,108! BN/SsNHsd;SS/JrHsdMcwi!
chr4:29,930,001-30,110,000 
 Bp178! ! Blood!pressure! Hypertension! 4:5,437,007-36,612,108! BN/SsNHsd;SS/JrHsdMcwi!
! Bp179! 2.85! Blood!pressure! Hypertension! 4:15,744,638-36,612,108! BN/SsNHsd;SS/JrHsdMcwi!
chr7:54,650,001-55,630,000 
 Srn1! 3.49! Renin!
concentration!
Kidney!Diseases! 7:28,488,298-89,945,095! BN/SsNHsd;SS/JrHsdMcwi!
! Hrtrt9! 4.72! Heart!rate! Hypertension! 7:32,004,504-57,326,584! BN/SsNHsd;SS/JrHsdMcwi!
! Bp182! 3.87! Blood!pressure! Hypertension! 7:32,004,504-89,945,095! BN/SsNHsd;SS/JrHsdMcwi!
! Kidm5! 3.51! Kidney!mass! Kidney!Diseases! 7:47,145,687-124,315,164! BN/SsNHsd;SS/JrHsdMcwi!
!! Cm6! 4.09! Cardiac!mass! Cardiomegaly! 7:47,145,774-107,950,815! BN/SsNHsd;SS/JrHsdMcwi!
SHRSP( (      
chr2:55,680,001-55,750,000!
! Bp14! 3.1! Blood!pressure! Hypertension! 2:42,866,342-210,636,008! SHRSP/Gcrc;WKY/Gcrc!
! Bp132! ! Blood!pressure! Hypertension! 2:46,542,246-210,636,169! SHRSP.WKY-(D2Rat13-
D2Rat157)/Gcrc!
chr15:66,610,001-66,690,000 
 Scl1! 7.7! Lipid!level! Hypercholesterolemia! 15:18,710,622-87,898,700! WKY;SHRSP/A3!
! Bp126! 4! Blood!pressure! Hypertension! 15:65,395,920-109,758,846! WKY/Izm;SHRSP/A3Izm!
chr15:66,840,001-66,900,000 
 Scl1! 7.7! Lipid!level! Hypercholesterolemia! 15:18,710,622-87,898,700! WKY;SHRSP/A3!
!! Bp126! 4! Blood!pressure! Hypertension! 15:65,395,920-109,758,846! WKY/Izm;SHRSP/A3Izm!
WKY( !! !! !! !! !! !!
chr6:28,490,001-28,550,000 
 Stresp10! 6.83! Stress!response! Anxiety!Disorders! 6:1-35,786,687! WKY/NHsd;F344/NHsd!
!
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chr13:85,500,001-85,730,000 
 Stresp12! 3.35! Stress!response! Anxiety!Disorders! 13:40,675,437-85,675,437! WKY/NHsd;F344/NHsd!
! Glom15! 7.4! Renal!pathology! Glomerulonephritis;Nephri
tis!
13:78,189,125-106,076,220! LEW/NHsd;WKY/NCrl!
chr14:71,740,001-72,050,000 
 Hc5! 2.3! Renal!function! Kidney!Calculi! 14:63,969,145-108,969,145! WKY;GHS!
chr14:72,110,001-72,480,000 
 Hc5! 2.3! Renal!function! Kidney!Calculi! 14:63,969,145-108,969,145! WKY;GHS!
chr14:72,540,001-73,110,000 
!! Hc5! 2.3! Renal!function! Kidney!Calculi! 14:63,969,145-108,969,145! WKY;GHS!
!
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6.3 Discussion  
6.3.1 Identification of putative artificial selective sweeps  
A total of 189 putative artificial selective sweeps for disease phenotypes were identified 
using a novel RSD and chi-square test based approach. Multiple statistical genetic tests 
were used to confirm that the majority of the putative selective sweeps, identified using the 
RSD method, were indeed the result of artificial selection for the disease phenotypes.  
First, to determine whether predicted PASS regions arose due to known demographic 
history or due to artificial selection for disease phenotype, a null model was derived 
considering the known demographic histories of rat strains but without selection. In the 
null model, no genomic region unique to a single strain was identified with a length greater 
than 30kb, while identified PASS regions were of size ranging from 30kb to 1.57Mb. This 
suggested that majority of the predicted PASS regions arose due to selective inbreeding of 
rat strains for disease phenotypes.  
Second, it was observed that LD in the predicted PASS regions was significantly elevated 
than the rest of the genome. Elevated LD is indicator of selection pressure acting on the 
genomic region (Xia et al., 2009).  
Third, PASS regions show a highly negative Tajima’s D, which is indicator of the 
purifying selection, which was expected for the genomic regions underlying disease 
phenotypes. This observation strongly supports presence of true selective sweeps in PASS 
regions.  
Finally, the observed ratio of the non-synonymous coding mutations to coding mutation 
was 1.67 in the PASS regions while at whole genome level this ratio was 0.76. Increased 
NSC to SC ratio is indicator of region being under selection.  
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These various approaches, are used as indicators of evolutionary selection in a variety of 
scenarios (Axelsson et al., 2013; Rubin et al., 2010; Wright et al., 2005; Xia et al., 2009) 
and strongly support the identified PASS regions as being significantly enriched for 
genomic segments retained by phenotype selection during derivation of these strains. 
6.3.2 Functional significance of putative artificial selective sweeps  
6.3.2.1 Overlap between PASS regions and pQTLs  
The PASS regions were significantly enriched for the cardiovascular and metabolic pQTLs 
previously mapped in these rat strains. In addition, where there was overlap between the 
PASS regions and pQTLs, PASS regions were either exactly under peak of linkage or were 
located in very close proximity. This indicates that the PASS regions identified in this 
study are of functional importance.   Furthermore, the size of the pQTLs range in Mbs, 
with region containing 100’s of genes, making the identification of QTL genes very 
difficult by positional cloning. However, the size of the PASS regions range from 30kb to 
1.57Mb. A total of 29 PASS regions out of 96, which were unique to disease models, 
contained 3 or less genes with 17 of them containing single gene. Future experiments could 
allow for testing these target genes in knock-in or knockout experiments, which is now 
possible in the rat for any genetic background (Geurts and Moreno, 2010; Jacob et al., 
2010).  
6.3.2.2 Gene ontology enrichment in PASS regions 
Gene ontology analysis was performed using genes within the PASS regions to identify 
gene and pathways that might have been selected for during phenotype driven artificial 
selection of the rat strains. Enrichment for the specific biological process or pathway was 
observed in two rat strains FHH and SS. FHH showed enrichment for the genes involved in 
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RAS pathway and in proteolysis, while the SS PASS regions were enriched for the genes 
involved in aromatic compound catabolic processes.  
6.3.2.2.1 Gene ontology enrichment in FHH PASS regions 
The forty-four genes in 14 FHH-specific PASS regions showed a significant increase in the 
NSC to SC ratio and were highly enriched for biological processes related to proteolysis 
and the RAS pathway.  Three genes Cma1, CtsG and Mcpt10 within FHH PASS regions 
were components of RAS.  Two genes Cma1, a chymase 1  and CtsG, a Cathepsin G were 
reported to mediate the  non-ACE dependent conversion of angiotensin I to angiotensin II 
(Uehara et al., 2012). The RAS system is central to the regulation of blood pressure in all 
mammals and FHH rats show reduced sensitivity to angiotensin II which has been 
proposed as a cause of FHH susceptibility to renal disease (van Rodijnen et al., 2002). In 
humans, a haplotype at Cma1 has been weakly associated (P = 2 x 10-4) with hypertension 
in Han Chinese (Wu et al., 2012) and in mice chymase 1 has been proposed to modulate 
regulation of blood pressure by angiotensin II (Li et al., 2004). In addition, the ACE 
inhibitors and angiotensin receptor blockers are amongst the most widely used anti-
hypertensive agents (Kobori et al., 2007). All three genes Cma1, Ctsg and Mcpt10 contain 
NSC variants that are unique to FHH amongst rat strains.  Polyphen predicted NSC 
mutation in Cma1 and Mcpt10 to be deleterious while mutation in the Ctsg gene was 
benign. Two genes Cma1 and Mcpt10 are therefore compelling candidates as regulators of 
blood pressure in FHH and because of their enzymatic function in non-ACE dependent 
conversion of angiotensin I to angiotensin II, are potential novel anti-hypertensive drug 
targets. 
A total of twelve genes belonged to GO category proteolysis, all of which were mast cell 
proteases or belong to the family of granzymes, which are also expressed in mast cells. Ten 
of these genes contain NSC variants that were unique to FHH. FHH rat strains develop 
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glomerulosclerosis and interstitial fibrosis with glomerular hyperfiltration, albuminuria and 
end stage renal failure (de Keijzer et al., 1988; Kreisberg and Karnovsky, 1978; Kriz et al., 
1998). All 12 genes belonging to the GO category ‘proteolysis’ were located within the 5 
FHH PASS regions on a 2.13 Mb segment of chromosome 15. A consomic study in which 
the FHH chromosomes were substituted with BN chromosomes showed that substitution of 
chromosome 15 resulted in reduced blood pressure, albuminuria and glomerular damage, 
indicating that genetic determinants of these phenotypes reside on FHH chromosome 15 
(Mattson et al., 2007). Mast cell numbers are increased in human hypertensive 
nephropathy and are associated with renal disease in the context of nephrectomy-induced 
hyperfiltration (Welker et al., 2008). Amongst the 10 genes which contained NSC variants, 
NSC variant in two genes GzmF and Mcpt10 were predicted to be deleterious by Polyphen 
redictions. Taken together, these data implicate this segment of chromosome 15 and 
specifically the unique FHH variation in granzymes and mast cell proteases in the 
development of hypertension-induced renal damage in this rat strain. 
6.3.2.2.2 Gene ontology enrichment in SS PASS regions 
In SS, 16 protein-coding genes reside within 4 SS-specific PASS regions and these were 
enriched for aromatic compound catabolic processes (P = 3.9 x 10-5), owing to the presence 
of three paraoxonase genes Pon1, Pon2 and Pon3, in one of the SS PASS regions on 
chromosome 4. Paraoxonase genes protect against oxidative stress and have been 
implicated in atherosclerosis and diabetes mellitus in humans (Precourt et al., 2011) and 
blood pressure regulation in mice (Gamliel-Lazarovich et al., 2012). Oxidative stress is 
associated with endothelial dysfunction and hypertension in humans and in a wide range of 
experimental models including the Dahl SS rat (Kushiro et al., 2005; Swei et al., 1997; 
Vaziri and Rodriguez-Iturbe, 2006). Since the paraoxonase genes overlap with the SS 
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QTLs for hypertension, the paraoxonase genes are compelling candidates as contributors to 
the hypertension phenotype in the SS strain. 
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Chapter 7: General discussion  
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The aim of the work presented in this thesis was to functionally characterise the genome 
sequences of rat models of human diseases to give insight into molecular mechanisms 
underlying disease phenotypes, particularly cardiovascular and metabolic phenotypes. This 
was achieved by sequencing the genomes of rat models of hypertension, diabetes and 
metabolic syndrome along with their respective control strains followed by evolutionary 
and population genetic analysis of these genome sequences. 
Throughout the duration of this project, significant advances occurred in next generation 
sequencing technologies in sequencing throughput, cost per base of sequencing as well as 
algorithms used for analysis of next generation sequencing data. The earlier section of this 
study involved the sequencing of the genome of the SHR when next generation sequencing 
technology was relatively new and throughput was lower compared to the throughput of 
current generation sequencing platforms.   In addition algorithms that predict and filter 
variants were not well established. For the analysis of the SHR genome as described in 
Chapter 2 and 3, I firstly identified a set of parameters which would give an optimal 
balance between sensitivity and specificity for SNV calling by using a known set of 
genomic variants between SHR and the reference genome. Secondly, I developed methods 
to identify short indels, structural variants and copy number variants. MAQ, one of the few 
algorithms available for mapping and variant calling at the time of analysis of the SHR 
genome was not capable of mapping reads which contained indels. To predict indels I 
mapped reads, which remained unmapped by MAQ mapping, using BLAT. To identify 
structural variants, I developed Perl scripts which took advantage of the properties of 
abnormally mapped read pairs and I used read depth information to predict copy number 
variants. Using these approaches, I identified 3,642,090 SNVs, 343,243 short indels, 
19,206 structural variants and 588 copy number variants in SHR genome compared to the 
BN reference genome. The SHR genome was one of the first model organisms sequenced 
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using next generation sequencing technologies. It is also the first time that a near complete 
catalogue of genomic variants was generated in any rat model. A large number of QTLs for 
various disease phenotypes has been mapped in SHR over last two decades. Identification 
of a near complete set of genomic variants between SHR and the BN reference genome 
(BN strain is widely used as a control strain for SHR) has greatly enhanced the 
identification of QTL genes, for example it has facilitated the identification of Ebi2 and 
EndoG as genes underlying insulin resistance and cardiac hypertrophy respectively in SHR 
(Heinig et al., 2010; McDermott-Roe et al., 2011). Using next generation sequencing data 
short indels (<15bp) can be identified using read alignment gaps, and larger indels 
(>100bp) can be identified using paired-end read mapping information. However one of 
the limitations of genomic variant prediction using short read sequencing techniques is that 
mid-range variants (15 bp to 100bp) are difficult to identify. Furthermore, errors in the 
reference genome may result in false positive prediction of genomic variants. The de novo 
assembly of these genomes and subsequent comparative genomics analysis could be useful 
in identifying missing variants, however, de novo assembly of short read sequences 
requires multiple libraries of various insert sizes. By re-sequencing the reference strain the 
issue of false positives due to errors in reference genome can be largely resolved.  
Using genomic variants I performed multiple analyses that showed i) the rate of divergence 
between two strains of rats is similar to the rate of divergence between any two human 
individuals and the extent of divergence is higher than that observed between mouse 
strains, ii) a significant correlation across rat strain exists between the SNV density, indel 
density and the SV densities, and iii) the distribution of genomic variants suggests that 
there are regions of high divergence and low divergence between any two strains. 
Furthermore, I demonstrate that the density of genomic variants was higher in and around 
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cis-eQTL genes compared to other genes, suggesting that some of the variants play a role 
in cis regulation of gene expression differences.  
In Chapter 3, I show that genes that contain major mutations such as stop gain or loss 
mutations, frameshift coding mutations and the genes that are partly or completely deleted 
in the SHR genome are overrepresented for genes involved in ion transport and genes 
localised in the plasma membrane. From these results, I was able to identify potential 
candidate genes (Cacna1d , Cacna1a  and Kcnj1),  which contain frameshift coding 
mutations that could be further studied to understand disease phenotypes in SHR genome. 
By the time that the genome sequencing of SHR has been completed, next generation 
sequencing technologies improved significantly with respect to throughput and read length. 
Similarly improved algorithms for mapping and variant calling became available. These 
advances made it feasible to sequence genomes of multiple individuals as well as multiple 
strains of model organisms (Abecasis et al., 2012; Axelsson et al., 2013; Cao et al., 2011; 
Gan et al., 2011; Keane et al., 2011; Qiu et al., 2012; Rubin et al., 2010). Taking advantage 
of improvements in sequencing technologies and the available analysis pipelines, the 
genomes of 27 additional rat strains were sequenced along with increasing the coverage of 
the SHR genome. This is the first time that such a large scale genome sequencing project 
of rat models of disease was performed.  
Taking advantage of advances in the variant calling algorithms, I predicted the genotype of 
every polymorphic locus across 28 rat genomes instead of calling variants in each of the 28 
rat genomes independently. This allowed me to carry out comparative as well as 
evolutionary and population genetics analyses in the 28 rat genomes using variant data. 
Added to this, instead of using fixed filtering criteria such as mapping quality, base quality, 
SNP quality and read depth, I used GATK, a tool used to predict variant, which facilitated 
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modelling filtering parameters based on a known set of genomic variants. However, in the 
rat there was limited information on genomic variants available, therefore I used high 
quality variants (top 30% of variants) to model the optimal parameters for variant filtering. 
After filtering variants I identified 9,665,340 SNVs, 3,502,117 indels, 555,419 SVs and 
897,217 CNVs across 28 genomes of rat strains that include models of cardiovascular and 
metabolic phenotypes.  This is the largest set of genomic variants ever identified in a 
laboratory rat strains and one of the largest for any species apart from humans. Nearly 
1,000 QTLs have been mapped for cardiovascular and metabolic phenotypes in these rat 
strains as reported in RGD (http://rgd.mcw.edu/), thus identification of such a large data set 
for genomic variants in these rat strains will greatly enhance efforts to identify the 
underlying QTL genes.  The whole genome variant dataset will also facilitate a 
comparative genomics analysis of disease models and respective control strains as well as 
population genetics analyses.  
In Chapter 4 I show that the genetic differences between pairs of disease model and 
respective control strain vary significantly, owing to the differing breeding strategies used 
to derive these pairs from the same founder colonies.  The number of SNVs alone range 
from 0.6 million to 2.4 million between the pairs of hypertensive and the normotensive 
control rat strains. Thus genomic differences between these pairs of strains alone may not 
provide clues for differences in disease phenotypes. The majority of these differences may 
represent random variations observed between any two strains, therefore more 
sophisticated evolutionary analysis is required to identify regions under selection for 
disease phenotypes.      
In addition in Chapter 4 I show that, across all the rat strains i) significant correlation was 
observed between SNV density and indel density, and ii), the distribution of SNV and 
indels across the rat genome showed marked variation, containing in each genome regions 
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of low, high and average divergence. These observations suggest that different genomic 
regions in the rat strains are under differential selective constrains. The regions with low 
genomic diversity suggests that they are under selective constraints across all the rat 
strains, while regions of high divergence are less constrained and genomic variants of all 
types are acquired in these regions at equal rate.  
A phylogenetic tree was constructed using 9.6 million SNVs across 28 rat strains, which 
reflects the known demographic history of these rat strains and also supports the previous 
findings using microsatellite markers and SNP markers (Saar et al., 2008; Thomas et al., 
2003).                 
Both hypertension and diabetes are complex diseases where the interaction between the 
environment and multiple genetic factors gives rise to disease phenotypes.  For this reason 
mutations in multiple genes may underlie disease phenotypes shown by rat models of 
hypertension and diabetes. Functionally related genes tend to evolve together. Being 
polygenic in nature, genes underlying hypertension and diabetes may have been co-
selected and co-evolved during the selective breeding of the rat strains for these disease 
phenotypes.  
Various approaches such as phylogenetic profiling and mirror tree have been widely used 
to identify functionally related and interacting proteins (Clark et al., 2012; de Juan et al., 
2013; Pellegrini et al., 1999; Sato et al., 2005). However, these techniques have never been 
used to identify clusters of genes underlying disease phenotypes.  I adopted the mirror tree 
approach to identify clusters of genes which may underlie the disease phenotypes in the rat 
models of complex diseases, the results of which are described in Chapter 5.  I used genes 
which contain genomic variants to construct distance matrices and then used the 
correlation between the distance matrices as a proxy to the gene tree to construct the co-
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evolutionary gene clusters.  Strong correlation between the distance matrices of two genes 
may be due to the demographic history of the rat strains used in this study, to correct for 
the population structure I used two independent methods. First, I used a PCA to identify 
major components that contribute to the variability in the rat strains and then I corrected 
the distance matrices for the first two components, as they explained the major variation 
between the rat strains. Second, I used linear mixed model (EMMA) to correct for the 
population structure. These approaches have been previously used for correcting 
population structures while identifying clusters of interacting proteins using the mirror tree 
approach (Clark et al., 2012; Sato et al., 2005; Tabach et al., 2013). I found significant 
overlap between the clusters identified using the PCA-based approach and the EMMA-
based approach, suggesting that both methods are equally efficient for correction of 
population structure.            
A small number of genes in rat models have been positionally cloned and the majority of 
these were prioritised based on the gene expression differences between the pair of disease 
models and the control strains. A relatively small number of genes have been positionally 
cloned based on the genomic variants. In the MHS rat strain, a non-synonymous coding 
mutation in the Add1 gene has been shown to underlie hypertension in the MHS rat strains 
(Bianchi et al., 2005; Ferrandi et al., 2010), while a frameshift coding mutation in Gimap5 
has been shown to cause of T-cell lymphopenia, which is the underlying cause of type 1 
diabetes in the BBDP rat strain (Dalberg et al., 2007; Hornum et al., 2002; MacMurray et 
al., 2002). Both of these genes were part of the co-evolutionary gene clusters identified in 
these respective rat strains, thus suggesting that the many of the genes in these clusters may 
play a role in the polygenetic control of the disease phenotype in the rat models. This 
conclusion is further strengthened by the findings, as described in Chapter 5, that the 
human orthologs of the genes in the co-evolutionary cluster of the disease models are 
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overrepresented for the genes implicated in human genome wide association studies for 
cardiovascular and metabolic phenotypes. With the availability of gene manipulation 
techniques in rats (Geurts and Moreno, 2010; Jacob et al., 2010), now these genes can be 
prioritised for testing their role in the disease phenotypes shown by these rat models.  
Finally, in Chapter 6 I present the results of selective sweep analysis. Hypertension and 
diabetes are disease traits which are selected against within a normal population. However, 
to derive the models to study these phenotypes, rat models were artificially selected for 
these disease phenotypes, thus in specific rat models, disease causing mutations along with 
the surrounding neutral mutations were artificially but positively selected.  In contrast, 
purifying selection acts against these disease causing mutations in rat strains that were not 
selected for these phenotypes. Hence when a rat disease model strain is compared with the 
remaining rat strains, artificial selective sweeps can be identified that are unique to the 
disease model. To test this hypothesis I devised a method to identify genomic regions 
unique to a strain and the regions shared between the rat strains using relative SNV density 
and chi-square statistics.  Using this approach I identified 189 regions which were unique 
to a single rat strain, of which there were 96 unique to the disease models. I designated 
them as putative artificial selective sweep (PASS) regions. To determine whether predicted 
PASS regions were truly under selective pressure or whether they were due to the 
demographic history of the rat strains, I performed a coalescent simulation taking in to 
account known demographic history of the rat strain but excluding simulation for selective 
pressure. In this null model, no region of size greater than 30 kb was found to be unique to 
a single rat strain, while all the PASS regions were greater than 30 kb in length, suggesting 
that the predicted PASS regions were indeed due to the selective pressure applied on these 
rat strains during phenotype driven derivation. Coalescent simulation has been effectively 
used to distinguish between the selective pressure and the demographic history in multiple 
!
!
190!
!
studies including studies of C. elegance and silkworms (Andersen et al., 2012; Xia et al., 
2009).  
Furthermore, I used a series of population genetics methods to show that PASS regions 
were under selective pressure. These regions show i) increased LD, ii) negative Tajima’s 
D, iii) increased ratio of non-synonymous coding to synonymous coding mutation, and iv), 
significant overlap with known pQTLs for cardiovascular and metabolic phenotypes 
mapped in respective rat strains. All these observation provide strong evidence that the 
majority of the PASS regions identified in this study represent true selection sweeps 
resulting from artificial selection.  At least one of these indicators has been used in 
previous studies to show that the regions are under selection in maize, silkworm, chicken 
and dog (Axelsson et al., 2013; Rubin et al., 2010; Wright et al., 2005; Xia et al., 2009). 
However, in all of these previous studies, selective sweep analysis was carried out to 
identify regions under selection pressure for the beneficial traits such as domestication, 
adaptation and productivity. In this study, for the first time, I combined newly designed 
and established statistical genetics techniques to identify selective sweeps for disease 
phenotypes.   
To investigate the functional significance of the identified PASS regions I performed a GO 
enrichment analysis of the genes within the PASS regions for each strain independently. 
The GO analysis showed that PASS regions in FHH were enriched for the genes involved 
in the proteolysis and for the genes involved in the renin-angiotensin pathway. The PASS 
regions in SS rat strains were enriched for the genes playing a role in oxidative stress. 
Furthermore, genes in MHS co-evolutionary cluster were enriched for ion transporters. The 
defects in the ion transport, oxidative stress and renin-angiotensin pathways are known to 
be underlying cause of hypertension in respective rat strains (Ferrari et al., 1987; Mattson 
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et al., 2007; Swei et al., 1997). These findings suggest that PASS regions were a result of 
phenotype-driven selection of the rat strains.  
The PASS regions now can be tested in the laboratory by deriving congenic strains for 
PASS regions. Additionally, the genes implicated in this study can be tested using gene 
knock-out and knock-in studies which are now possible in rat strains (Geurts and Moreno, 
2010; Jacob et al., 2010).  
7.1 Concluding remarks  
This study provides a significant advancement towards the understanding of disease 
phenotypes in rat models.  It is the first large scale sequencing and bioinformatics analysis 
of rat strains providing the largest set of the genomic variants across multiple rat strains 
including disease models. Furthermore, this is the first time evolutionary biology and 
population genetics techniques were applied across multiple rat strains to understand their 
lineage specific evolution. Clusters of genes in disease models were identified, 
demonstrating the polygenic architecture of disease phenotypes shown by rat models. In 
addition, I show artificial selective sweeps for disease phenotypes that reflect the 
phenotype-driven derivation of these strains. This body of work will significantly enhance 
the identification of disease genes for hypertension, diabetes and other traits manifested in 
these strains. 
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Appendix A 
Perl code A.1: find_deletions.pl 
Perl code A.2: predict_selective_sweep.pl 
Perl code A.3: calculate_tajimasD.pl 
 
Appendix B 
Table B.1: Primers designed to validate deletions using PCR and sequencing  
Command B.1: To generate null model 
java –Xmx20G –jar msms3.2rc-b80.jar -N 10000 –ms 22 10000 -t 0.0008 -r 720 -s 30000 -
I 22 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 -en 0.0025 19 0.00025 -en 0.0025 20 
0.00025 -ej 0.002525 20 19 -en 0.002525 19 0.0125 -en 0.003125 13 0.00005 -en 
0.003125 14 0.00005 -en 0.003125 15 0.00005 -en 0.003125 17 0.00125 -en 0.003125 18 
0.00125 -ej 0.00315 13 14 -ej 0.00315 17 18 -en 0.00315 18 0.0125 -ej 0.003175 14 15 -en 
0.003175 15 0.00375 -en 0.00325 8 0.0025 -en 0.00325 5 0.005 -en 0.00325 1 0.005 -en 
0.003275 5 0.005275 -en 0.003275 1 0.005275 -en 0.00325 8 0.025 -en 0.003375 6 
0.00025 -en 0.003375 7 0.00025 -en 0.003375 3 0.0025 -ej 0.0034 6 7 -en 0.0034 7 0.0125 
-en 0.0034 4 0.0025 -ej 0.0034 3 2 -en 0.0034 2 0.005275 -en 0.00375 2 0.00005 -en 
0.00375 11 0.0025 -en 0.00375 12 0.0025 -ej 0.00375 11 12 -en 0.003775 12 0.025 -en 
0.003775 2 0.0017 -en 0.004375 10 0.0025 -en 0.0044 10 0.025 -ej 0.0045 15 12 -ej 0.005 
4 2 -en 0.005 2 0.5 -ej 0.005625 2 1 -en 0.005625 1 1 -ej 0.00625 5 1 -ej 0.0068 10 9 -ej 
0.0069 9 8 -ej 0.007 8 7 -ej 0.007125 7 12 -ej 0.0075 12 1 -en 0.0075 1 2.25 -en 0.01 16 
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0.00025 -en 0.010025 16 0.025 -ej 0.010125 16 1 -ej 0.010625 18 1 -ej 0.0107 19 1 -ej 
0.0125 21 1 -ej 0.0125 22 1 -en 0.0125 1 4.5 -threads 8 
Command B.2: To generate the model where selection occurred at a single locus 
java –Xmx20G –jar msms3.2rc-b80.jar -N 10000 -ms 22 100000 -t 0.0008 -r 72 -s 3000 -
SAA 2000 -SaA 1 -SF 0.01  
Command B.3: To generate the corresponding null model for the selection model in 
command B.2 
java –Xmx20G –jar msms3.2rc-b80.jar -ms 22 100000 -t 0.0008 -r 72 -s 3000  
Appendix C 
Table C.1: List of deletions predicted in SHR compared to BN reference genome 
Table C.2: List of Insertions in SHR/OlaIpcv 
Table C.3: List of copy number variations between SHR/OlaIpcv and BN genome 
predicted using Illumina read coverage   
Table C.4: List of copy number variations between SHR/OlaIpcv and BN genome 
predicted using aCGH data   
Table C.5: List of genes containing major coding mutations  
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Appendix D 
Table D.1: List of structural variants in the genome of ACI/EurMcwi rat strain, predicted 
using BreckDancer. 
Table D.2: List of structural variants in the genome of BBDP/Wor rat strain, predicted 
using BreckDancer. 
Table D.3: List of structural variants in the genome of F344/NCrl rat strain, predicted using 
BreckDancer. 
Table D.4: List of structural variants in the genome of FHH/EurMcwi rat strain, predicted 
using BreckDancer. 
Table D.5: List of structural variants in the genome of FHL/EurMcwi rat strain, predicted 
using BreckDancer. 
Table D.6: List of structural variants in the genome of GK/Ox rat strain, predicted using 
BreckDancer. 
Table D.7: List of structural variants in the genome of LE/Stm rat strain, predicted using 
BreckDancer. 
Table D.8: List of structural variants in the genome of LEW/Crl rat strain, predicted using 
BreckDancer. 
Table D.9: List of structural variants in the genome of LEW/NCrlBR rat strain, predicted 
using BreckDancer. 
Table D.10: List of structural variants in the genome of LH/MavRrrc rat strain, predicted 
using BreckDancer. 
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Table D.11: List of structural variants in the genome of LL/MavRrrc rat strain, predicted 
using BreckDancer. 
Table D.12: List of structural variants in the genome of LN/MavRrrc rat strain, predicted 
using BreckDancer. 
Table D.13: List of structural variants in the genome of MHS/Gib rat strain, predicted 
using BreckDancer. 
Table D.14: List of structural variants in the genome of MNS/Gib rat strain, predicted 
using BreckDancer. 
Table D.15: List of structural variants in the genome of SBH/Ygl rat strain, predicted using 
BreckDancer. 
Table D.16: List of structural variants in the genome of SBN/Ygl rat strain, predicted using 
BreckDancer. 
Table D.17: List of structural variants in the genome of SHR/NHsd rat strain, predicted 
using BreckDancer. 
Table D.18: List of structural variants in the genome of SHR/OlaIpcv rat strain, predicted 
using BreckDancer. 
Table D.19: List of structural variants in the genome of SHRSP/Gla rat strain, predicted 
using BreckDancer. 
Table D.20: List of structural variants in the genome of SR/Jr rat strain, predicted using 
BreckDancer. 
Table D.21: List of structural variants in the genome of SS/JrHsdMcwi rat strain, predicted 
using BreckDancer. 
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Table D.22: List of structural variants in the genome of SS/Jr rat strain, predicted using 
BreckDancer. 
Table D.23: List of structural variants in the genome of WAG/Rij rat strain, predicted 
using BreckDancer. 
Table D.24: List of structural variants in the genome of WKY/NCrl rat strain, predicted 
using BreckDancer. 
Table D.25: List of structural variants in the genome of WKY/NHsd rat strain, predicted 
using BreckDancer. 
Table D.26: List of structural variants in the genome of WKY/Gla rat strain, predicted 
using BreckDancer. 
Table D.27: list of large deletions predicted across 26 rat strains using in-house perl script. 
Table D.28: list of CNV in genome of ACI/EurMcwi rat strain. 
Table D.29: list of CNV in genome of BBDP/Wor rat strain. 
Table D.30: list of CNV in genome of F344/NCrl rat strain. 
Table D.31: list of CNV in genome of FHH/EurMcwi rat strain. 
Table D.32: list of CNV in genome of FHL/EurMcwi rat strain. 
Table D.33: list of CNV in genome of GK/Ox rat strain. 
Table D.34: list of CNV in genome of LE/Stm rat strain. 
Table D.35: list of CNV in genome of LEW/Crl rat strain. 
Table D.36: list of CNV in genome of LEW/NCrlBR rat strain. 
Table D.37: list of CNV in genome of LH/MavRrrc rat strain. 
Table D.38: list of CNV in genome of LL/MavRrrc rat strain. 
!
!
216!
!
Table D.39: list of CNV in genome of LN/MavRrrc rat strain. 
Table D.40: list of CNV in genome of MHS/Gib rat strain. 
Table D.41: list of CNV in genome of MNS/Gib rat strain. 
Table D.42: list of CNV in genome of SBH/Ygl rat strain. 
Table D.43: list of CNV in genome of SBN/Ygl rat strain. 
Table D.44: list of CNV in genome of SHR/OlaIpcv rat strain. 
Table D.45: list of CNV in genome of SHR/NHsd rat strain. 
Table D.46: list of CNV in genome of SHRSP/Gla rat strain. 
Table D.47: list of CNV in genome of SR/Jr rat strain. 
Table D.48: list of CNV in genome of SS/Jr rat strain. 
Table D.49: list of CNV in genome of SS/JrHsdMcwi rat strain. 
Table D.50: list of CNV in genome of WAG/Rij rat strain. 
Table D.51: list of CNV in genome of WKY/NCrl rat strain. 
Table D.52: list of CNV in genome of WKY/Gla rat strain. 
Table D.53: list of CNV in genome of WKY/NHsd rat strain. 
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Appendix E 
Table E.1: Cluster of transcripts showing non-synonymous coding SNPs uniquely in a 
single strain or multiple strains (PCA based population structure correction) 
Table E.2: Cluster of transcripts showing non-synonymous coding SNPs uniquely in a 
single strain or multiple strains (EMMA based population structure correction) 
Table E.3: Cluster of transcripts showing frameshift coding mutations uniquely in a single 
strain or multiple strains 
Table E.4: List of transcripts showing non-synonymous coding SNPs unique to ACI 
Table E.5: List of transcripts showing non-synonymous coding SNPs shared between FHH 
and FHL 
Table E.6: List of transcripts showing non-synonymous coding SNPs shared between SHR, 
SHRSP and WKY 
Table E.7: List of transcripts showing non-synonymous coding SNPs shared between SBH 
and SBN 
Table E.8: List of transcripts showing non-synonymous coding SNPs shared between MHS 
and MNS 
Table E.9: List of transcripts showing non-synonymous coding SNPs shared between LH, 
LL and LN 
Table E.10: List of transcripts showing non-synonymous coding SNPs shared between 
SHR, SHRSP and GK 
Table E.11: List of transcripts showing non-synonymous coding SNPs shared between LH 
and SS 
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Table E.12: List of transcripts showing unique non-synonymous coding SNPs and 
frameshift coding variants in MHS 
Table E.13: List of transcripts showing unique frameshift coding and non-synonymous 
coding variants in BBDP 
Table E.14: list of Human GWAS studies on cardiovascular and metabolic phenotypes 
Table E.15: List of transcripts showing non-synonymous coding SNPs unique to SHR 
Table E.16: List of transcripts showing non-synonymous coding SNPs unique to SHRSP 
Table E.17: List of transcripts showing non-synonymous coding SNPs unique to SS 
Table E.18: List of transcripts showing non-synonymous coding SNPs unique to LH 
Table E.19: List of transcripts showing non-synonymous coding SNPs unique to FHH 
Table E.20: List of transcripts showing non-synonymous coding SNPs unique to GK 
Table E.21: List of transcripts showing non-synonymous coding SNPs shared between 
SHR and SHRSP 
 
Appendix F 
Table F.1: Genomic segments unique to a strain or shared between multiple strains 
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